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ABSTRACT 
Chalcones, or 1, 3-diaryl-2-propen-l-ones, are natural/ synthetic comp-
ounds belonging to the flavonoid family. Flavonoids are polyphenolic 
compounds found in rich abundance in all plants and are an integral part 
of the human diet. Chalcone contains a structurally similar moiety to 
curcumin, a known antioxidant. Chalcones and its derivatives have been 
reported to possess various pharmacological activities, including anti-
inflammatory, anti-cancer, and potent antioxidant actions. 
Stress increases vulnerability to anxiety and depression. Recently, 
oxidative stress has been shown to be associated with anxiety and 
cognitive defects in different behavioral models. Studies have shown 
that social phobia, depression, anxiety, and other neuropsychiatric 
disorders result in signs of oxidative stress such as increased reactive 
oxygen generation and decreased antioxidant capacity. Various stresses 
have been associated with enhanced free radical generation and altered 
antioxidants enzymes. With these considerations, we designed eight 
different substituted chalcones to study their effects on the following 
parameters using rats as animal models: 
1). The development of new medications possessing anxiolytic effect 
without the side effects of benzodiazepines such as psychomotor 
impairment, depression and dependence liability would be of great 
importance in the field of anxiety related disorders. The animals were 
administered with chalcones at the dose of 15 and 25 mg/Kg body 
weight daily for three consecutive days and tested for anxiety using 
various behavioral models such as Elevated plus maze, Open field test 
and also on rota rod and traction test. Results were also compared with 
diazepam, a known benzodiazepine. We observed that chalcones possess 
anxiolytic-like and were devoid of sedative effects as associated with 
diazepam. 
2). Enzyme acetylcholinesterase (AChE) has long been an attractive 
target for the rational drug design and discovery of inhibitors for the 
treatment of Alzheimer's disease. Recently, it has been found that BChE 
inhibitors may also be effective for the treatment of Alzheimer and 
related dementias. Chalcones have been shown to be the inhibitors of 
AChE and BChE. Thus, it prompted us to investigate the effects of 
variably substituted chalcones on the memory deficits induced by 
cholinergic disturbances using scopolamine in rats. The behavioral and 
biochemical results obtained in our study suggest that chalcones have the 
ability to improve or ameliorate memory dysfunction, in part, by 
facilitating the cholinergic transmission in brain. 
3). The central nervous system plays a crucial role in regulation of stress 
responses and complex neurochemical pathways have been proposed. 
Stress induce changes in emotional behavior, which are closely related to 
anxiety like states. Restraint / immobilization stress is an easy and 
convenient method to induce both psychological (escape reaction) and 
physical stress (muscle work) resulting in restricted mobility and 
aggression and stress has also been associated with enhanced free radical 
generation and altered antioxidants enzymes. Free radicals are highly 
reactive moieties playing an important role in health and disease. The 
central nervous system is especially vulnerable to free radical damage 
because of brain's high oxygen consumption, abundant lipid content and 
relative paucity of antioxidant enzymes compared with other tissues. 
It was designed to investigate the effect of chalcones on 
neurobehavioral and oxidative changes in rats. Restraint stress (RS) was 
used as an experimental stressor and levels of oxidative stress 
parameters were measured in terms of free radical scavenging enzyme 
activities like superoxide dismutase (SOD), catalase (CAT), and 
glutathione-S-transferase (GST). The treatment with chalcones 
attenuated both stress induced behavioral suppression as well as brain 
oxidative stress in a consistent manner clearly suggest that chalcones 
could have the potential for scavenging free radical generated in the 
brain tissues in order to reduce oxidative stress and may play an 
important role in free radical generated diseases. 
4). Oxidative damage to cellular molecules such as lipids, proteins, and 
DNA, is a major contributor of aging and the degenerative disease to 
aging such as brain dysfunction, cancer, cardiovascular diseases and 
immune system decline. The purpose of this study was to determine if 
chalcones provide a neuroprotective effect against restraint stress 
induced oxidative damage to lipids, proteins and DNA. Oxidative 
damage to lipids, proteins and DNA was recorded in the rats after stress. 
Chalcones decreased the oxidative damage and thus reversed the harmful 
effects of free radicals and may play an important role in degenerative 
diseases related to stress and aging. 
5). Glycogen stores in the brain are small relative to the muscle 
especially liver. The accepted role of glycogen is that of a carbohydrate 
reserve utilized when glucose falls below need. Aldose reductase 
inhibitors have been shown to prevent or delay significantly diabetic 
complications and chalcones display significant inhibitory activity 
towards this enzyme. Thus, the aim of the present study was to 
determine the effects of variably substituted chalcones on glycogen 
contents of liver, brain and spinal cord. Our results showed that 
chalcones, which are potent inhibitors of aldose reductase, caused an 
increase in glycogenolysis rate by decreasing the liver glycogen content. 
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INTRODUCTION 
Introduction 
Chalcones, or 1,3- diaryl-2-propen-l-ones, are natural/ synthetic 
compounds belonging to the flavonoid family. They are the first isolable 
compounds from flavonoid biosynthesis in plants, but do not necessarily 
accumulate to any appreciable degree unless the enzyme chalcone 
isomerase, which catalyses the cyclisation of chalcone to flavanone is 
absent. They are characterized by the opening of oxygenated ring (C) 
that is present in the other classes of flavonoids, leading to the formation 
of a double bond between carbons a and P with respect to the carbonyl 
function. Contrary to the majority of the flavonoids, the nucleus A of 
chalcone is numbered with cardinal numbers followed by a line ( ' ) 
whereas nucleus B is numbered with cardinal numbers alone. 
Basic nucleus of chalcones 
Flavonoids are polyphenolic compounds found in rich abundance 
in all plants (Bors, 1997). Chemically flavonoids are C 6 - C 3 - C 6 
compounds in which the two C 6 groups are substituted benzene rings, 
and the C3 is an aliphatic chain which contains a pyran ring (Bravo, 
1998). In plants, flavonoids and isoflavonoids are synthesized from 
hydroxychalcones which are synthesized from p- coumaroyl- CoA and 
malonyl- CoA by enzyme catalyzed condensation and cyclization 
reactions. 
p- coumaroyl CoA + 3 (malonyl CoA) • chalcone • 
naringenin • flavonoids. 
Owing to their polyphenolic nature, flavonoids often exhibit strong 
antioxidant properties, akin to a-tocopherol, which they structurally 
resemble and can replace in some model systems (Bors, 1997; van 
Acker, 2000). One estimate has the average daily consumption of 
flavonoids by humans as Igm, an amount much greater than that of other 
dietary antioxidants such as ascorbate or a-tocopherol (Bravo, 1998). 
Flavonoids possess both excellent iron chelating and radical scavenging 
properties (Havsteen, 1983; Hanen, 1993). 
The main constitutes of flavonoids are-
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Chalcones occur in a wide variety of plants, and are found in 
different parts (heartwood), bark, leaf, flower, fruit and root (Dewick, 
1997). Chalcones in many cases serve in plant defense mechanism to 
counteract reactive oxygen species (ROS) in order to survive and 
prevent molecular damage and damage by microorganisms, insects and 
herbivores. Chalcones play an important role in ecological system due to 
colors they produce in plants, as attractants of insects and/or birds 
necessary for polinization (Zuanazi, 2001). Biological activities 
exhibited by chalcones include: anti- bacterial (Nielson, 2004) and 
bacteriostatic (Lin, 2002), antiviral (Al-Nakib, 1987), antimalarial 
(Dominguez, 2005), trypanosomiciddal (Lunardi, 2003), antileishmanial 
(Bergmann, 2004), antiulcerogenic (Yamamoto, 1992), antioxidant 
(Mukherjee, 2001), immunomodulatory (Barford, 2002), cytotoxic 
(Sabzevari, 2004), angiogenesis inhibition (Robinson, 2005), anti-
inflammatory (Ko, 2003), antinociceptive, antioedematogenic (Buzzi, 
2006), 
In agriculture certain chalcones are used to destroy 
phytopathogenic organisms, whereas in industry they are used in 
controlling corrosion of steel, as dyes and as U.V. absorbers in cosmetics 
(Augusto, 2006). Chalcones are also effective in vivo as chemo-
preventive agents in several rat carcinogenesis models (Baba, 2002; 
Wattenberg, 1994; Makita, 1996). Induction of phase II enzymes and 
increasing glutathione levels are major chemopreventive strategies for 
preventing chemical carcinogenesis. Various chalcones incubated with 
cultured cells readily induced NAD(P)H: quinone reductase (NQOl) 
(Dinkova- kostava, 2001; Miranda, 2000) as well as glutathione -S-
transferase (GST) (Fiander, 2000) and would be expected to alleviate 
oxidative stress and detoxify mutagenic xenobiotics. Also some 
chalcones such as metochalcone (a cholretic drug) and sofalcone (an 
anticancer agent) have been approved for clinical use (Ni, 2004). 
The entire evolution of living organisms is characterized by the 
mutual rivalry of free radicals and antioxidants. Both free radicals and 
antioxidants have developed and they have always influenced the 
viability of living organisms. Many disease and pathological syndromes 
are caused by oxidative stress, i.e., by an imbalance in favour of free 
radicals. The most frequent consequences of oxidative stress are 
atherosclerosis, diabetes mellitus, tumors, cataract and ageing. The 
nervous system, due to enriched concentrations of polyunsaturated fatty 
acids, is particularly susceptible to the deleterious effects of oxidative 
stress (Beckman, 1991; Cini et. al., 1994; DeLeo et. al., 1986, Eldjam 
and Pihl, 1960). Reactive oxygen species (ROS) are produced in the 
brain during cellular respiration and their rate is accumulated during 
brain insults (Dandekar, 1997) and measured in Alzheimer's (Lovell, 
1995) and Parkinson's (Fahn, 1992) disease, epilepsy (Rokyta, 2001), 
trauma and amylotropical lateral sclerosis. 
Anxiety disorders in a modem society have a relatively high 
prevalence and command considerable financial resources, and also are 
the most common illness associated with unreasonable and disturbing 
sensation of fear and tension. Stress increases vulnerability to anxiety 
and depression. The development of anxiety/ stress- related disorders 
involves complex interactions among various body mechanisms 
involving the limbic system and the hypothalamo-pituitaryadrenal 
axis; their interactions play a significant role in the manifestation of 
disease pathology (Chrousos and Gold, 1992; Ray et. al., 1993). 
Recently, oxidative stress has been shown to be associated with anxiety 
and cognitive defects in different behavioral models (Hovatta et. al., 
2005; Gingrich, 2005; Berry et. al., 2007). Recent studies have also 
shown that social phobia, depression, anxiety, and other neuropsychiatric 
disorders result in signs of oxidative stress such as increased reactive 
oxygen generation and decreased antioxidant capacity (Arranz et. a!., 
2007; Bouayed et. al., 2007). There is increasing evidence that oxidative 
stress in neurons is involved in pathological manifestations of many 
neurological disorders. Further, it is becoming increasingly clear that 
cognitive and emotional biases play an important role in the 
development and maintenance of depression, especially in response to 
stress (Anisman, 2005; Coles, 2002). 
Stress is a state of threatened homeostasis that causes a variety of 
changes in the central nervous, endocrine and immune systems and in 
peripheral tissue metabolism (Black, 1994; Sothman & Kastello, 1997). 
Stress is known to induce alterations in various physiological responses 
even leading to pathological states (Chrousos, 1998). Immobilization-
stress approximates emotional stress in animals, and associates with 
greater oxidative stress: increased free-radical production, decreased 
anti-oxidant enzyme levels, and increased oxidized lipids in tissues, 
including brain (Yokoi et. al., 1999; Liu et. al., 1996). Oxidative 
modification of lipids in brain clearly associates with impaired cognitive 
function (Stark-Reed et. al., 1991; Forster et. al., 1996). Immobilization 
for a single eight-hour period increased brain lipid oxidation, which 
associated with decreased memory and behavior (Radak et. al., 2001), 
and lesser oxidation associated with improved cognitive function 
(Butterfield et. al., 1997; Radak et. al., 2001). Reactive oxygen species 
(ROS) and free radicals induce membrane damage, DNA base oxidation, 
DNA strand breaks, chromosomal aberrations, and protein alterations 
(Olinski, 2002). 
Chalcones continue to attract considerable scientific attention 
because of their association with a variety of biological activities. 
Besides of their association with a number of pharmacological 
properties, no study has been conducted regarding the effect on anxiety, 
cognition, and immobilization-stress induced changes in behavior and 
biochemical parameters. The pathogenesis of several neuropsychiatric 
disorders, including anxiety and depression, has been linked to oxidative 
stress, in part via alternations in cyclic nucleotide signaling. PDE2 
inhibition by increasing cGMP signaling is able to inhibit oxidative-
stress induced anxiety in mice (Masood et. al., 2008). Chalcones caused 
an increase in cGMP and cAMP (Yu et. al., 1995a; Yu et. al., 1995b) 
Many attempts have been made to reverse cognitive deficits by 
increasing brain cholinergic activity via acetylcholinesterase inhibitors 
(AChEIs), acetylcholine precursors, or cholinergic agonists (Davies and 
Maloney, 1976; Perry et. al., 1978) and also BChE inhibitors may also 
be effective for the treatment of Alzheimer and related dementias (Yu et. 
al., 1999). Chalcones have been shown to be the inhibitors of AChE and 
BChE (Ansari et. al., 2005). Chalcones have been reported to have the 
property to scavenge free radicals and have the antioxidative capacity 
toward LDL oxidation and lipid peroxidation (Vaya, 1997; Haraguchi, 
1998; Cheng, 1998; Ante, 1995). Thus, this consideration has induced us 
to explore the possible effects of chalcones on anxiety and cognition. 
The effect of free radicals, as one of the oldest chemical stimuli, in 
the phytogenetically youngest and the best-organized biological 
structure- the central nervous system (CNS) has been relatively seldom 
studied. Living cells protect themselves from oxidative damage by low 
molecular weight antioxidants including enzymatic and non-enzymatic 
antioxidant system (Halliwell and Cross, 1994). These cellular defenses 
reduce the steady- state concentrations of free radical species and repair 
oxidative cellular damage. The antioxidant defense system includes 
enzymes such as superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx), which decrease the concentration of the 
most harmful oxidants. Immobilization stress is a good model for 
investigating the aUerations occurring in oxidant-antioxidant balance in 
tissues of rats. Anti-oxidant nutrients blunt the increase in oxididized 
lipids when administered before or after immobilization- stress (Zaidi, 
2003, 2005). Therefore, keeping in view the antioxidant properties of 
chalcones, we also tested them for their possible antioxidant effects 
against restraint - stress induced oxidative damage to central nervous 
system. 
Thus, in the present study we attempted to investigate: 
(1) Evaluation of chalcones for their anxiolytic effects using elevated 
plus maze and open field behavior tests. 
(2) Inhibitory potential of chalcones on brain parts and spinal cord 
acetylcholinesterase activity and memory in rats using Y- maze. 
(3) Modulation of restraint- stress induced neurobehavioral and 
oxidative changes in antioxidant enzymes by chalcones. 
(4) Protective effects of chalcones against oxidative damage to lipids, 
proteins and DNA induced by restraint stress. 
(5) Differential effects of chalcones on glycogen contents of liver, brain, 
and spinal cord in rats. 
REVIEW 
REVIEW OF LITERATURE 
Review of Literature 
Occurence 
Chalcones are the first isolable compounds from flavonoid biosynthesis 
in plants but do not necessarily accumulate to any appreciable degree 
unless the enzyme chalcone isomerase, which catalyzes the cyclisation 
of chalcone to flavanone is absent (Bohm, 1998). Most naturally 
occurring chalcones are polyhydroxylated (Bohm, 1975). Chalcones 
which are important flavour principles in citrus plants, occur widely in 
green plants (Harbome, 1967). Chalcones are found to be distributed 
throughout the plant kingdom. 
According to Tomas- Barberan and Clifford (2000) chalcones 
have restricted occurrence in foods but both citrus fruits and apples are 
rich dietary sources of chalcones and dihydrochalcones and these 
compounds could even make a greater contribution to the total daily 
intake of natural polyphenolics than the more extensively studied 
flavonoids. The most common chalcones found in foods are phloretin 
and its glucoside phloridzin (phloretin 2'-0- glucose), chalconaringenin 
and arbutin. Dihydrochalcone-phloretin and phloridzin are characteristic 
of apples. Chalconaringenin is characteristic of pears. Arbutin is also 
found in strawberry and bearberry, in wheat, in wheat products and in 
trace amounts in tea, coffee, red wine and broccoli (Robards et. al., 
1999; Clifford, 2000). Chalconaringenin is present in tomato peel and 
may be present in tomato products (juice, paste and ketchup). The 
naringenin chalcone content of tomato skin in post- climacteric fruits is 
64 mg'" kg"' FW but in tomato ketchup, naringenin chalcone is 
transformed to naringenin (flavanone), and the chalcone is present only 
in trace amounts (Macheix et. al., 1990). Muir et. al. (2001) observed 
that the chalconaringenin was absent in the green peel but increased 
sharply during coloring of the fruit. Neohesperidin dihydrochalcone is an 
intense sweetener and permitted for commercial use as a food additive in 
Europe (Gibney et. al., 1995). It may be used in a wide range of foods 
(non-alcoholic drinks, desserts and confectionary) at concentrations in 
the range of 10- 400 mg kg"' o^r mgL~') or as a flavour modifier at 
concentrations of upto 5mgkg"' (Lindley, 1996). A particularly rich 
source of prenylated chalcones are the inforescences of Humulus lupulus 
12 
that are used in the brewing industry to flavor and bitterness to beer 
(Miranda, 2000). 
Butein (2',4',3,4- tetrahydroxychalcone) is a major active 
component of Dalbergia odorofera, have cytotoxic in addition to anti-
oxidant and anti- inflammatory activities (Ramanathan,1992; Yit & Das, 
1994; Cheng 1998; Chan, 1998). It also prevents antiglomerular 
basement membrane antibody- associated glomerulamephritis in rats 
(Hayashi, 1996). Butein, a plant polyphenol, also is one of the major 
active components of the stems of Rhus vemiciflua have been 
traditionally used for the treatment of pain, parasites, and thrombotic 
disease in Korea (Kang, 2003). 
Isoliquiritigenin is a flavonoid with chalcone structure (2',4',4-
trihydroxychalcone), an active compound present in plants like 
Glycyrrhiza and Dalbergia which showed various biological activities 
including anti- inflammatory, anti- carcinogenic and antihistamic (Vaya, 
1997). Also, 2', 4', 4- trihydroxychalcone (isoliquiritigenin) extracted 
from licorice root, is regarded as a promising lead potential cancer 
chemopreventive agent (Kinghorn, 2004). 
13 
Most floral colours present in nature arise from flavonoids 
(Brouillard and Dangles, 1993). In some species chalcones constitute the 
major yellow flower colour pigments. As chalcones are the initial 
intermediate used in the biosynthesis of all flavonoids, those with 2',4',6' 
trihydroxylation of the A- ring are the substrates for the production of 
anthocyanins and flavonols and those without a hydroxyl group at the 6' 
position are precursors of limited number of plant species, primarily in 
the leguminosae (Barz and Welle, 1992; Dixon and Pavia, 1995). 
Chalcones provide yellow pigmentation in the flowers of several 
ornamental species (Brouillard and Dangles, 1993). Yellow- flowered 
varieties of Dianthus caryophyllus (Forkmann and Dangelmayr, 1980), 
Callistephus chinensis (Kuhn et. al., 1978), and Cyclamen persicum 
(Miyajma, 1991). The yellow coloration of snapdragon flowers is prov-
ided by the aureusidin and bracteatin produced from 2',4',6',4- tetrahyd-
roxychalcone or 2',4',6',3,4- pentahydroxychalcone (Sato, 2001). 
Chalcones isolated from 'dragon blood", a resin obtained from 
the Dracaena cinnabari half was evaluated for antioxidant activity 
(Macahala, 2001). Chalcones isolated from the leaf resin of Z. punctata, 
a shrub occurring in Western Argentina possess cytoprotective effects 
14 
(Rocha, 2003). Naringenin chalcone is the intermediate in flavonoid 
biosynthesis in Petunia (Heller and Forkmann, 1988, 1993). 
Interestingly, pollen of Mitchell Petunia is rendered yellow by a small 
amount of naringenin chalcone (Takamura and Miyajima, 1996). Butein-
3-0- glucoside has only been reported in the yellow flowers of Butea 
monosperma (Gupta, 1970). Carthamin is the first natural chalcone 
provide red pigment to the flowers of Safflower (Carthamus tinctorium) 
and has the structure of 2'- glyucosidoxy- 3', 4, 4', 6'- tetrahydroxy-
chalcone (Sheshadri and Thakur, 1960). Yellow- flowered varieties of 
Cosmos, Dahlia, Coreopsis and Bidens (Bohm 1988, 1993) contains 
accumulated 6'- deoxychalcones. 
Chalcone Biosynthesis 
Chalcones are synthesized via the phenylpropanoid pathway. 
Phenylalanine ammonia lyase (PAL) catalyzes the conversion of 
phenylalanine to cinnamate. PAL also shows activity with converting 
tyrosine to p- coumarate, albeit to lower efficiency. The cinnamate 4-
hydroxylase (C4H) catalyzes the synthesis of p- hydroxycinnamate from 
cinnamate and 4- coumarate: CoA ligase (4CL) converts to p- coumarate 
to coenzyme-A ester, activating it for reaction with the condensation of 
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one molecule of its 4- coumaroyl CoA, yielding naringenin chalcones 
(Stafford, 1991). This reaction is carried out by the enzyme chalcones 
synthase (CHS). Chalcone is isomerised to a flavanone by the enzyme 
chalcone flavanone isomerase (CHI). From these central intermediates, 
the pathway diverges into several side branches, each resulting in a 
different class of flavonoids. 
OoC o,c 
EC 4.3.1.5 H NH 
p- coumarate fg^Qp + NADPH *'^ ^"^" '^'""^f"^*^ 
CoA-S 
4-coumaroyl- CoA 
EC 2.3.1.74 
j ^ 3 CoA-S-CO-CH -CO2 
^ 3CoA-SH + 3CO, 
NH, 
0,C 
L- phenylalanine 
L - phenylalanine 
biosynthesis 
OH O 
naringenin chalcone 
EC 4.3.1-5 phenylalanine ammonia-lyase 
EC 1.14-13.1 trans-cinnamate 4-monooxygenase 
EC 6.2.1 -12 4- coumarate- CoA ligase 
EC 2.3.1-74 naringenin- chalcone synthase 
flavonoid 
biosynthesis 
Biosynthesis of Chalcones 
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Metabolism and Excretion 
Although numerous metaboUc studies have been reported on the fate of 
other flavonoids including flavonols, flavans, and flavanones in vivo but 
very few reports have been published on the metabolism of chalcone or 
chalcone derivatives in the mammal (Chanal et. al., 1981) and the fate of 
chalcones in the mammalian systems is largely unknown. 
Chalcones have been reported to undergo extensive metabolism 
by many routes, such as reversible conjugate addition of glutathione, 
demethylation of methoxy groups, oxidation of aromatic rings, and 
reduction of the enone moiety (Hawkins, 1980; Chabannes, 1973; Nozu, 
1980; Brown and Griffiths, 1983). After oral or intravenous 
administration of 3,4- dihydroxychalcone like (2', 5'- dimethoxy-3, 4-
dihydroxychalcone and 2'- ethoxy- 5'- methoxy- 3, 4- dihydroxy-
chalcone), unchanged forms were undetectable in rat plasma using 
HPLC. These chalcones were rapidly and extensively metabolized after 
systemic administration (Sogawa, 1993). Butein (2',4',3,4- tetrahyd-
roxychalcone), isoliquiritigenin (2',4',4 trihydroxychalcone), 2',3,4- trih-
ydroxychalcone following administration to bile duct cannulated rats, 3'-
O- methylbutein and 4'-0- methylbutein are selectively excreted in 
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the urine and bile as conjugates. Formation of demethylated products of 
3-0- methylbutein and 4-0- methylbutein in vivo and vitro suggests that 
certain methylated chalcones excreted from the liver into the duodenum 
by the way of bile may be demethylated by the microflora in the 
gastrointestinal tract. Also administration of Butein; Isoliquiritigenin; 2', 
3, 4- trihydroxychalcone to the non- cannulated rats led to the presence 
of two sulphate conjugates of each chalcone in the faeces (Brown and 
Griffiths, 1983). Trace amounts of Butein in the bile of the rats dosed 
with isoliquiritigenin (2', 4', 4- trihydroxychalcone) indicate that liver 
metabolizes this chalcone by hydroxylation (Hackett, 1979), 
Period of Fraction (%) of administered 
collection dose 
Compound (days) Urine Faeces Total 
Butein (oral dose) 9 39.9(32.2-48.1) 51.0(37.7-68.5) 90.9 
Butein (parenteral dose) 7 40.7(33.4-49.0) 55.6(46.4-61.0) 96.3 
Isoliquiritigenin 7 56.3(47.6-63.6) 40.0(24.1-55.3) 96.3 
(oral dose) 
Excretion of radioactivity after administration of ''^ C- chalcones 
to non- cannulated rats 
In a study by DuPont and co-workers (2002) with alcoholic apple 
cider, 21 % of the Phloretin (dihydrochalcone) was excreted in 24 h 
urine. According to Monge (1984), half of the intragastric dose of 
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phloretin was excreted in the urine, mainly within two days. In contrast 
several dihydrochalcones (not known to occur in foods) were excreted 
predominantly unchanged in the urine and faeces (Skjevrak, 1986). 
When rats were given phloridzin (phloretin 2'-0-glucose) at 5fiM by 
cannula, inhibits the uptake of glucose by the active glucose transporter 
(SGLTI) in the small intestine and impairs the resorption of glucose in 
the kidney, causing glucosuria (Rodriguez, 1982). Dihydrochalcones 
were absorbed in the small intestine of rats following the conjugation 
and, thus, could be recovered intact in plasma (Crespy et. al., 2001 a,b; 
docket, al.,2001). 
Synthesis of Chalcones 
These compounds can be obtained by synthesis through methods as per 
Suzuki (Eddarir et. al., 2003) or aldolic condensation (or condensation of 
Claisen- Schimdt), with reagents, solvents and catalysts submitted to 
ultrasound (Li et. al., 2002) or using inorganic catalyst such as NaNOs 
/NP (natural phosphate) (Sebti et. al, 2001); or even by a simple and 
direct method of reacting acetophenones and aldehydes, with sodium 
hydroxide (NaOH) or potassium hydroxide (KOH) as catalyst and 
methanol or ethanol as solvents, at room temperature (Vogel, 1989). 
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CH. + H 
Synthesis of chalcone by Claisen-Schimdt condensation of 
acetophenone and benzaldehyde 
X + HO 
benzoyl chloride 
(X = CI) 
phenylvinyl 
boronic acid 
Synthesis of chalcones by Suzuki coupling between activated benzoic 
acids and phenyl vinyl boronic acids 
Although these substances are associated with several different 
kinds of biological activities, they are also frequently employed for the 
synthesis of a great variety of important derivatives, including 
flavanones (Sagrera and Seone, 2005), Marmich bases (Pandeya et. al., 
1999), and aryloxypropanolamines (Satyanarayana et. al., 2004), among 
others. 
Also, reaction of chalcones with thioglycolic acid, 3- merca-
ptopropanoic acid or thiosalicylic acid in hot toluene yield phar-
macologically active carboxylic acid deraivatives of dihydrochalcones 
(Levai, 1991). 
R1 
C —CHo—CH 
S 
(CH 2) COOH 
Like chalcones, dihydrochalcones have been reported to have a 
wide range of biological properties (Harborne and Baxter, 1999). Briot 
and CO- workers reported the synthesis of dihydrochalcones which 
involved palladium- catalysed coupling of o- halophenols and 1 -aryl-2-
propen-1-ols (Briot et. al., 2004). 
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OH 
R1 U 
X 
i r R 
Pd catalyst 
X = hatide 
Physicochemical Properties 
Lopez et. al. (2001) and Rastelli et. al. (2000) analyzed the chalcones by 
rotating the bonds about the a, p- unsaturated carbonyl (enone) linkage 
to identify the minimum energy conformation and confirmed the overall 
planarity and rigidity of the extended n system. In compound 1 ring A 
had greater rotational flexibility and deviate from planarity to a greater 
extent than ring B. Thus delocalisation of electrons between ring A and 
the carbonyl group occurs to a lesser extent compared to electron deloca-
lisation between ring B and the a, |3- unsaturated double bond. 
0 02 e3 
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Compound R 
1 H 
2 H 
3 H 
4 H 
5 H 
6 2,4-(Cl)2 
R 
H 
4-NO2 
2-NO2 
2,4-Cl2 
2,4-(CH30)2 
2,4-(Cl)2 
Torsion angles (°) determined by AMI method 
e i 03 
33.5 
0.43 
26.9 
31.5 
34.0 
119.0 
18.7 
0.39 
43.7 
34.5 
17.7 
32.0 
Ring substituents also affect the planarity of the rings A and B 
(Lopez et. al., 2001). Bulky substituents like nitro or chloro at position 2 
of ring B caused an expected sharp increase in 63 values, due to rotation 
of ring from planarity to minimize the steric effects of the ortho-
substituent. The presence of a 2- methoxy substituent caused only a 
small change in 93, indicating that the steric hindrance caused by the 
methoxy group was less compared to nitro or chloro. When ortho- chloro 
substituents were introduced on both rings A and B, there was a large 
increase in 01 compared to 03, and thus ring A was more susceptible to 
distortion than ring B. 
When a 2'- hydroxyl group was introduced on ring A, 
intramolecular hydrogen bonding between the hydroxyl and the carbonyl 
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oxygen gave rise to a stable planar conformation (Rastelli et. al., 2000). 
The Ca- C(3 double bond in the enone moiety of chalcones can adopt Z 
or E configuration. Almost all chalcones isolated in E- form and can be 
isomerised to the Z form by exposing methanolic solution of the 
chalcone to normal light (Iwata et. al., 1997). The Z isomer showed 
more potent antitumourigenic activity than E form. Photoisomerisation 
of the E isomer to the Z isomer may cause changes in biological activity, 
thus it is prudent to protect solutions of chalcones from light. 
Besides E/Z isomerism, carbonyl and Ca- Cp double bond in 
chalcones were positioned cis with respect to each other (Ducki et. al., 
1998). The s- cis conformer was more stable than s- trans conformer. 
Introduction of a methyl group to the Ca position, altered the carbonyl 
and Ca- Cp double bonds to a trans orientation. The a- methyl group 
also caused significant loss of planarity between ring A and the enone 
(01 56- 88°). It contribute to the enhanced biological activity of a-
methylchalcones which were found to have greater cytotoxic effect 
against a human leukemia cell line than the unsubstituted analogues. 
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s-cis conformation s- trans conformation 
Also, the a, P- unsaturated carbonyl entity in chaicones is a soft 
electrophile, and attract soft nucleophiles like thiols, rather than hard 
nucleophiles like amino and hydroxyl groups (Dimmock et. al., 1999). 
On the other hand, chaicones, which are typical Michael reaction 
acceptors, will react readily with glutathione (GSH), the most abundant 
intracellular non protein thiol. 
Ph 
(M^ Ph 
O 
Ph' ^ Ph 
Thiol RSH 
Ph'^^^^^'-^ph 
O H 
Ph 
SR 
Ph 
Sabzevari and co-workers (2004) reported that some hydroxy-
chalcones depleted the GSH content of rat hepatocytes accompanied by 
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a concurrent increase in oxidized glutathione (GSSG) for some 
chalcones. Oxidation of GSH to GSSG may be mediated by phenoxy 
radicals produced from hydroxy chalcones. Alternatively, the chalcone 
may be metabolized to catechols and quinones, which react readily with 
GSH to form conjugates. Christenson (1999) also concurred on the role 
of GSH depletion in chalcone- induced toxicity. 
According to Lopez et. al. (2001), presence of electron with-
drawing groups on ring B enhance the electron deficiency of the P-
carbon, and thus its reactivity to nucleophiles. Similarly, the electron 
deficient carbonyl carbon is made more electron poor when electron 
withdrawing groups are present on ring A. Electron donating groups on 
either rings A and B will have the opposite effect. 
Alston and Fry (2004) investigated that the reduction of the 
carbonyl group was facilitated by the presence of electron withdrawing 
groups and influenced to a greater extent by the inductive effect of the 
substituent. 
The hydroxyl substituent is widespread among chalcones from 
natural sources and synthesized chalcones. Rastelli et. al. (2000) 
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concluded that 4'- hydroxyl was the most acidic (pKa 7.5) while 2'-
hydroxyl was the least acidic. 
(10.1) OH 0 
(7.5) HO OH (8.5) 
Effects on Mammalian Enzyme Systems 
Lipoxygenase and cyclooxygenase activity 
Arachidonic acid released from membrane phospholipids or other 
sources is metabolized by the lipoxygenase and cyclooxygenase pathway 
to the smooth muscle contractile and vasoactive leukotrienes, LTC4, 
LTD4 and LTE4 as well as LTB4 (Lewis et. al., 1990). These molecules 
are intimately involved in inflammation, asthma and allergy, as well as 
other physiologic and pathologic processes. 
Sogawa et. al. (1993) suggested that 3, 4- dihydroxychalcones 
(2',5'-dimethoxy-3,4- dihydroxy- and 2'- ethoxy-5'- methoxy-3,4-
dihydroxy) possessed potent anti-5-lipoxygenase and anticyclo-
oxygenase activities by means of their antioxidative activities and are 
28 
stronger inhibitors than caffeic acid, nordihydroguairetic acid and 
quercetin. They also inhibited arachidonic acid- induced mouse ear 
edema. 2',5'- dihydroxychalcone and 3,4- dihydroxychalcone had potent 
anti- cyclooxygenase and anti- inflammatory activity (Lin et. al., 1997). 
According to Nakadate and coworkers (1985) hydroxychalcone 
derivatives are inhibitors on mouse epidermal 12- LO and CO. In 
addition 3',4',5',3,4,5- hexamethoxychalcone inhibits the prostaglandin 
E2 (PGE2) and nitric oxide by inhibiting the induction of COX-2 and 
inducible nitric oxide synthase in LPS-stimulated mouse peritoneal 
macrophages (Herencia et. al., 1999). 2'- hydroxychalcone derivatives 
(2',4'- dihydroxy- 4'-methoxychalcone ; 2',4- dihydroxy- 6'-methoxy-
chalcone ; 2'- hydroxy- 4'-methoxychalcone) were potent inhibitors of 
TPA- induced prostaglandin E2 production and inhibited COX-1 (Kim et. 
al.,2001). 
Estrogenic activity 
A number of polyhydroxylated chalcones possess estrogenic properties 
(Miksicek, 1995). The chalcone skeleton is structurally similar to adrenal 
androgens and estrogens and their bisphenolic structure makes them 
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particularly intresting for interaction with receptors and enzymes such as 
aromatase 3p-HSD and IVP- HSD. 
Bail et. al. (2001) reported for the first time that chalcones are 
potent inhibitors of aromatase and 17p- hydroxysteroid dehydrogenase, 
enzymes involved in the biosynthesis of estrogens, but found to be 
weaker inhibitors compared to flavones and flavanones. The most potent 
inhibitor of aromatase was naringenin chalcone and eriodictyol 
chalcones (IC50 2.6 and 2.8 |iM respectively) (Blanco et. al., 1997), 
while 4- hydroxy chalcone (IC5016 |a.M) was the most potent inhibitor of 
17(3- HSD. Di- and tri-hydroxylated chalcone derivatives (4,4'-
dihydroxychalcone; 2,4,4'- trihydroxychalcone; Phloretin) are able to 
bind to the human estrogen receptors at micromolar concentrations and 
to serve as effective estrogen agonists (Miksicek, 1993). Non-
hydroxylated chalcones exhibited weak binding to estrogen receptor 
(ER) (Branham et. al., 2002). Multi- hydroxylated chalcones (2',4',4-
trihyd- roxychalcone ; 4,2',4',6'- tetrahydroxychalcone) competed with 
[3H]- E2 for ER but with lower affinity than E2 (17P- estradiol). Also 3'-
methyl-3- hydroxychalcone inhibit the binding of estradiol to type- II 
estrogen binding sites in HGC-27 cells (Satomi, 1993). 
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Dihydrochalcones and methoxylated chalcones had significantly reduced 
inhibitory activity (Lemer et. ai., 1963). 
Although these estrogenic flavonoids are less potent than 17(3-
estradiol, they appear to possess a pharmacological efficacy equivalent 
to that of the biological hormone. 
Inhibition of aldose reductase 
Aldose reductase is a key enzyme of polyol pathway, catalyzes NADPH-
dependent reduction of glucose to sorbitol and an excessive 
accumulation of intracellular sorbitol is considered responsible for 
cataractogenesis, retinopathy, neuropathy of diabetic origin (Kador et. 
al., 1985). 
Severi (1996) tested a series of hydroxy and hydroxy-
methoxychalcones towards bovine lens aldose reductase (AR) and 
showed that 4, 4'- dihydroxychalcon; 2',4'- trihydroxychalcone; 4-
hydroxy- 4'- methoxychalcone and 4- hydroxy- 2',4'-dimethoxychalcone 
displayed a good level of inhibitory activity. A series of 2', 4', 4-
trihydroxychalcone containing modifications on aromatic rings display 
affinity for aldose reductase enzyme (ALRi) (Aida et. al., 1990). Lim et. 
al. (2001) tested flavonoid derivatives on rat lens AR and their 
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antioxidant effects using Cu^ ^ chelation and radical scavenging activities 
in vitro, 2,4, 2', 4'- tetrahydroxy- ; 2, 2', 4'- trihydroxy- ; 2', 4'- dihydr-
oxy-2,4-dimethoxy- ; 3,4, 2', 4'- tetrahydroxychalcone possess good 
inhibitory activity. Also, butein was the most potent promising 
compound for the treatment of diabetic complications. Hesperidin 
chalcone shows 82% inhibition of aldose reductase and polyol accu-
mulation in rat lenses incubated in sugar xylose at a motor concentration 
of 10 "^  (Varma and Kinoshita, 1976). 
Tyrosinase inhibition 
Tyrosinase inhibitors could prove to be effective depigmenting agents. 
The tyrosinase enzyme is involved in two reactions in the melanin 
biosynthesis pathway (Briganti et. al., 2003). Isoliquiritigenin (2', 4', 4-
trihydroxychalcone) can inhibit both mono- and di- phenolase tyrosinase 
activities at IC50 8.1 mM and the effect of isoliquiritigenin was dose 
dependent (Nerya et. al., 2003). Khatib et. al. (2005) showed that 2, 4, 3', 
4'- tetrahydroxychalcone and 2, 4, 2', 4'- tetrahydroxy chalcone are very 
active tyrosinase inhibitors. 
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Mitochondrial enzymes 
A number of chalcones inhibit various enzymes located in the 
mitochondria. 2'-Hydroxychalcone and derivatives (principally methoxy 
and hydroxy) uncoupled oxidative phosphorylation in mitochondria 
isolated from mung bean and potato mitochondria (Ravanel, 1982). 
Included among this group of uncouplers were the naturally occurring 
chalcones, isoliquiritigenin and butein. The dihydrochalcone phloretin 
also demon- strated uncoupling activity. 
Low concentrations of a number of chalcones stimulated 
respiration in rat liver mitochondria which was due to their uncoupling 
activity (Takashi et. al, 1984). However at higher concentrations the 
electron transport chain was inhibhed. 
Butein and various related polyhydroxylated flavonols and other 
flavonoids inhibited succinoxidase activity in beef heart mitochondria 
(Hodnick et. al., 1986). Butein and luteolin, which is a flavone having a 
similar configuration of hydroxy groups as Butein had the greatest 
potencies, suggesting the importance of the number and position of 
hydroxy groups. 
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Chalcones interfered with respiration and oxidative phosphor-
rylation as well as membrane permeability of isolated rat liver 
mitochondria (Inoue et. al., 1982). Isoliquiritigenin isolated from the 
roots of Glycyrrhiza uralensis inhibited mitochondrial monoamine 
oxidase from rat liver (Tanaka et. al., 1987). It displayed a substrate-
competitive inhibition of monoamine oxidase having a K; value of 2.11 
Anti Inflammatory Property 
Mast cells play a central role in the pathogenesis of diseases such as 
allergic asthma, rhinoconjunctivitis, urticaria, anaphylaxis and in chronic 
inflammatory disorders (Middleton & Kandaswami, 1992). The 
neutrophil is an important inflammatory cell and can be triggered by a 
variety of inflammatory stimuli to produce highly reactive oxygen 
species which have potent microbicidal and inflammatory effects 
(Babior, 1978; Tauber and Babior, 1985). 
Study by Hsieh (1998) showed that chalcones (2', 3- dihyd-
roxychalcone; 2'-hydroxy- 3, 4- dimethoxychalcone ; 3'- hydroxy-3,4-
dimethoxychalcone ; 2',5'- dihydroxy-3,4,- dimethoxychalcone) caused 
strong and dose dependent inhibition of mast cell degranulation and also 
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indicated potent inhibitory effects on tiie release of p- glucoronidase and 
iysozyme from neutrophil degranuiation caused by fMLP/CB. Also 2', 
5'- dihydroxy- 3, 4- dimethoxychalcone showed enhancement of 
inhibitory effects on histamine release from mast cell degranuiation. In 
another study, Hsieh et. al. (2000), showed that chalcones caused mast 
cells degranuiation inhibition and inhibitory effects on the activation of 
neutrophils and also that enone moiety of chalcones appears to be 
required for the inhibition of mast cell degranuiation and superoxide 
anion formation from rat neutrophils. Lin et. al. (1997) showed that 
chalcones caused inhibition of mast cells and neutrophils and release of 
P" glucoronidase and Iysozyme from neutrophil degranuiation. 
Dihydrochalcone Phloretin inhibited the histamine release from human 
basophils (Grossman, 1988). 
Interleukin- 1 is liberated when the body reacts to such injurious 
stimuli as microorganisms and antigens and it causes and exacerbates 
inflammatory conditions. 2', 4', 6'- trimethoxychalcone exerted a potent 
inhibitory action towards the biosynthesis of interleukin- 1 (Batt, 1993). 
2'- hydroxychalcone downregulates the TNF- a and LPS induced 
expression of ICAM-1 and VCAM-l in human umbelical vein 
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endothelial cells via inhibition of the alteration of NF-kB (Madan et. al, 
2000). Ban et. al. (2004) showed that 2'- hydroxychalcone derivatives 
(2'-hydroxy-4-dimethoxychalcone;2',4-dihydroxy-4'dimethoxychalcone; 
2',4-dihydroxy-6-dimethoxychalcone) suppressed the LPS production of 
nitrite and TNF-a in the macrophage cell line during the inflammation 
process. Isoliquiritigenin has been reported to suppress cyclo-
oxygenase-2, known to play an important role in inflammation 
(Takahashi et. al., 2000) and also blocked pro- inflammatory cytokine-
induced expression of VCAM-1, E- selectin through NF-KB signal 
disruption (Kwon et. al., 2007). Butein suppressed the nuclear factor 
(NF) kB activation induced by various inflammatory agents and also the 
expression of cyclooxygenase (Pandey et. al., 2007). 
Platelets are also inflammatory cellular elements (Weksler, 1983; 
Metzger and Page, 1998). Chalcones are potent inhibitors of arachidonic 
acid - induced platelet aggregation in rabbit platelets and secondary 
aggregation induced by epinephrine in human PRP. 
Cytotoxic Effects 
A variety of chalcones possess cytotoxicity towards a number of cell 
lines (Wattenberg, 1994; Edwards, 1988; Yit & Das, 1994; Cheng, 
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1998). Unsubstituted chalcone displayed minimal activity towards 
human colon cancer adenocarcinoma cell line 220.1 having an IC50 
greater than lOOfiM. Butein significantly inhibited the incorporation of 
[''^  C]- thymidine, uridine and leucine into colon 220.1 cells at a 
concentration of 2^M by inhibiting the DNA, RNA and Protein 
synthesis (Yit & Das, 1994) while drug 5- fluorouracil used in the 
chemotherapy of colon cancer (Moertal, 1980) inhibited incorporation of 
['"*€]- uridine at a concentration of SOjiM. Butein also displayed potent 
cytotoxicity towards Raji lymphoma and Hela cell lines (Ramanathan, 
1993). Several polyhydroxylated chalcones, particularly isoliquiritigenin 
have shown TPA- induced tumor promotion of the mouse epidermis 
(Yamamoto et. al, 1991). 3'- methyl-3- hydroxychalcone has been 
reported to be a potent inhibitor of proliferation of several cell lines of 
malignant human cells (pancreatic, gastric, neuroblastoma, cervical) in 
vitro and to suppress TPA- induced tumor promoting activity in mouse 
epidermis in vivo. This chalcone also inhibit BaP- induced pulmonary 
edenoma formation in female A/J mice (Satomi, 1993). 4'-
methoxychalcone was found to inhibit the formation of pulmonary 
tumors (Wattenberg, 1995). Makita et. al. (1996) demonstrated that 
dietaiy adminstration of chalcone, 2'- hydroxychalcone during post-
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initiation phase effectively suppresses 4-NQO- induced oral 
carcinogenesis without any toxicity. 2- hydroxychalcone can effect 
proHferation of Hela cells by initially inhibiting DNA and RNA 
(Ramanathan et. al., 1993). Chalcones with carboxylic acid substituents 
were shown to bind to the tryptophan pocket of the p53 binding site of 
MDM2 (mouse double minute 2) oncogene and to promote dissociation 
of the p53/ MDM2 complex (Stoll, 2001). The MDM2 oncogene is over-
expressed in human breast cancer. Thus, disruption of p53/ MDM2 
complex is considered an attractive target in cancer therapy. 
The naturally occurring chalcone calythropsin and its dihydro 
analogue demonstrated differential cytotoxicity towards a variety of 
human tumour cell lines (Beutler et. al., 1993). Naturally occurring 
hydroxychalcones prevented gastric mucosal lesion formation induced 
by necrotising agent suggesting cytoprotective property on gastric 
mucosa (Yamamoto et. al., 1992). 2', 4'- dihydroxychalcone and 2',4'-
dihydroxy- 3'- methoxychalcone showed significant cytoprotective 
effects in gastroduodenal tract in rats (Rocha et. al., 2003). A series of 2', 
5'- dihydroxy chalcones were reported for cytotoxic activity against a 
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variety of tumor cell lines as well as non- tumor endothelial cell line 
(Nam et. al, 2003). 
One of the most widely cited mechanism by which chalcones 
exert their cytotoxic activity is that of interference with the mitotic phase 
of the cell cycle. Edwards and coworkers (1990) found a large number of 
methoxylated chalcones with anti- mitotic activity against HeLa cells. 
Ducki et. al. (1998) investigated a-substituted chalcones as the most 
active chalcones against K562 human leukemia cell line. 2'- oxygenated 
chalcone derivatives showed potent inhibitory activity toward Jurkat cell 
line (Rao, 2004). 
Angiogenesis, the generation of new capillaries from pre existing 
vessels is enhanced in pathological conditions, 2'-hydroxy-4'-
methoxychalcone (HMC) decreased angiogenesis in both chick embryos 
in the chorioallantoic membrane assay and basic fibroblast growth 
factor- induced vessel formation in the mouse matrigel plug assay. 4',4'-
dihydroxychalcone, investigated for inhibition of human myeloid HL 60 
leukemia cells, caused changes in the ladder assay, suggestive of 
apoptosis (Saydam et. al., 2003). Compound, 2-chloro-2', 5'-
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dihydroxychalcone also had good activity against the various cell lines 
(Lopez et. al., 2000). 
A recent study proposed that the cytotoxicity of hydroxychalcones 
may be due to in part to their ability to uncouple mitochondrial 
respiration, thus causing collapse in mitochondrial membrane potential 
(Sabzevari et. al., 2004).The authors noted that chalcones with fewer 
hydroxyl groups on ring A and B were more effective as compared to 
chalcones with more hydroxyl groups. 
Chemoprotective Chalcones 
Chemoprotection by chalcones may be a consequence of their 
antioxidant properties mediated via induction or inhibition of metabolic 
enzymes, by exerting an anti- invasive effect or a reduction in nitric 
oxide production. 
I) Antioxidant chalcones 
Free radicals are involved in different stages of carcinogenesis. 
Chalcones with good antioxidant activities were cytotoxic against tumor 
cell lines and reduced ascites tumour development in mice (Anto et.al, 
1995). Naringenin chalcone and phloretin showed to active scavenger of 
DPPH and hydroxyl free radicals, but no anti- proliferative activity was 
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observed against cancer cell line (MCF-7), while 2'-hydroxychalcone 
showed a biphasic response- anti-proliferative activity at high 
concentration and promoting cell growth at lower concentration (Calliste 
et. al., 2001). Several 2'-hydroxy substituted chalcones possess low 
antioxidant activity but are good inhibitors of CYPIA (Machala, 2001). 
Dihydrochalcone phloretin is a potent antioxidant in peroxynitrite 
scavenging and the inhibition of lipid peroxidation (Rezk et. al., 2002). 
II) Inhibition of induction of metabolizing enzymes 
Cytochrome P450 enzymes activate a number of procarcinogens to 
reactive intermediates that subsequently interact with cellular 
nucleophiles to trigger carcinogens. Hydroxy and methoxy substituted 
chalcones were found to be good inhibitors of CYPIA activities in 
hepatic microsomes isolated from mice (Machala, 2001). In another 
study by Monostory (2003), methoxy lated chalcones (4-
methoxy chalcone; 3-methoxy-chalcone; 2-methoxy chalcone) were 
found to be good inhibitors of CYPIA- dependent metabolism of 
ethoxyresorufm. 
The induction of phase 2 enzymes like GST and NAD(P)H: 
quinone reductase (NQOl) is an effective chemoprotective mechanism. 
The moderate inducer potency of the unsubstituted chalcone (1,3-
diphenyIprop-2-en-l-one, CD 31|LIM) was markedly increased upon 
ortho hydroxylation of either rings A and B (2'-hydroxychalcone, CD 
9.8 ]xM; 2-hydroxychalcone, CD 12 ^M) and enhanced even further 
when both rings carried ortho hydroxyl groups (2, 2'-dihydroxy-
chalcone , CD 4.7 |J.M) (Dinkova-Kostova, 1998) suggesting that the 
ortho hydroxyl group may increase the reactivity of the reacting 
sulfhydryl group, possibly by mechanism(s) involving the inductive and 
hydrogen bonding effects of the hydroxy group (Dinkova- Kostova, 
2001). 
Ill) Anti- invasive ciialcones 
Prenylated chalcones have anti- invasive properties based on an in vitro 
test in which fragments of normal embryonic chick heart were 
confronted with invasive human mammary carcinoma cells (Mukherjee, 
2001). Anti- invasive properties may involve interference with the 
formation of cellular protein complexes, involved in invasion (Parmar, 
2003). 
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IV) Inhibition of nitric oxide- The free radical nitric oxide (NO) is an 
important effector of macrophage induced cytotoxicity (Laslcin, 1995), 
and stimulates the production of inflammatory mediators such as TNF-
a and interleukin- 1(3. Some chalcones inhibitied NO production in 
lipopolysaccharide (LPS) and interferon- activated microglial cells. 
These chalcones with methoxy substituents on ring B and fluorinated 
substituents on ring A, inhibited the expression of inducible nitric oxide 
synthase (iNOS), the enzyme responsible for NO production 2', 5'-
dihydroxychalcones inhibited NO production in LPS- induced 
macrophage, through the expression of iNOS protein expression (Ko, 
2003) and thus showed anti- inflammatory effects. 
Madan (2000) reported that 2'-hydroxychaIcone downregulates 
TNF- a and LPS- induced expression of ICAM-1 and VCAM-1 in in 
human umbilical vein endothelial cells via inhibition of the activation of 
NF-KB. The synthetic chalcone 3',4',5',3,4,5- hexamethoxychalcone is 
an inflammatory compound able to reduce nitric oxide (NO) production 
by inhibition of iNOS protein synthesis (Alcaraz, 2004). 
Miscellaneous Properties 
Antibacterial properties 
Chalcone and analogues in which hydroxy and methoxy groups were 
placed in the aryl rings were evaluated for antibacterial activity using 
Staphylococcus aureus (Pappano et. al., 1985). Chalcone and various 
dihydrochalcones inhibited bacterial growth and in particular 2',4'-
dihydroxy- and 2',4- dihydroxy chalcone were antibacterial at low 
concentrations. Introduction of an additional hydroxy group in 2'-
hydroxychalcone increased antibacterial activity, however the addition 
of methoxy groups to 2- hydroxychalcone led to a reduction in 
bioactivity (Pappano et. al., 1994; Devia et. al., 1998). 
The introduction of alkyloxycarbonylmethoxy groups in the 3 or 4 
position of ring B, led to a series of compounds with activity against 
both Gram- positive and Gram- negative bacteria (Szajda, 1989). 
Antifungal properties 
Chalcone have demonstrated toxicity not only towards bacteria but to 
fungi as well. Thus the introduction of methoxy or 2-
diethylaminoethoxy groups into ring A of chalcones produced a group of 
compounds having bactericidal and fungicidal activity (Sangwan et. al., 
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1983). In another study hydroxy, methoxy or benzyloxy substituents 
displayed activity towards phytopathogenic bacteria and fungi. 
A number of chalcones possess antifungal activity particularly 
when one or more hydroxy groups are present in the aryl rings (Sato, 
1995). 2- hydroxychalcones such as 2',4',4- trihydroxychalcone; 5'-
methyl-2',4,4- trihydroxychalcone; 2,5- dihydroxy chalcone inhibited the 
growth of eleven microorganisms of the Candida genus at a 
concentration of 100 )a.g/ml. 
A report by Bilgin and co-workers (1987) revealed that 4'-
hydroxychalcone was the active compound with comparable activity to 
oxiconazole against some of the fiingi. Among a series of chalcones 
evaluated for antifungal activity 2'-0H; 4-CH 3 chalcone; 2'-0H, S'-CHs 
chalcone; 3'-0H, 5-CH 3 chalcone displayed the highest potency. 
Antiviral properties 
The chalcone (2'-hydroxy,4,6'-methoxy, 4'-ethoxychalcone) is a potent 
inhibitor of rhinovirus uncoating. This chalcone acts synergistically with 
other antiviral agents such as dichloroflavan and enviroxime against the 
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human rhinovirus type 9 (Ahmad and Tyrell, 1986) but it was ineffective 
against human rhinovirus 2 (Al-Naicib et. al., 1987). 
Licochalcone A inhibited giant cell formation in OKM-1 cells 
which were infected with the human immunodeficiency virus (Hatano, 
1988). Hydroxy and methoxy chalcones were effective against the 
tomato ringspot virus on the leaves of Chenopodium quinoa (Onyilagha 
et. al.,1997) 
Antiprotozoal and insecticidal properties 
Leishmaniasis is a group of disease caused by a number of protozoa of 
the genus Leishmania. Licochalcone A demonstrated high activity 
towards the promastigote and amastigote stages of both Leishmania 
major and Leishmania donovani (Chen et. al., 1993). Licochalcone A 
destroyed the ultrastructure of Leishmania parasite mitochondria and 
inhibited the respiration and the activity of mitochondrial 
dehydrogenases of Leishmania parasite (Zhai et. al., 1995). 
The two chalcones exhibited inhibitory effects on the activity of 
FRD in L. major promastigotes. FRD, one of the enzyme of respiratory 
chain, might be the specific target for the chalcones tested (Chen et. al., 
2001). 2',6'- dihydroxychalcone-4'-methoxychalcone showed significant 
46 
activity in vitro against promastigotes and intracellular amastigotes of L. 
amazonensis (Torres- Santos et. al., 1999). Substitution containing 
chalcones exhibited promising leishmanicidal and trypanocidal activities 
weith no cytotoxic effect on mouse macrophages (Lunardi et. al., 2003). 
A series of chalcones displayed toxicity tov^ards the larvae of the 
mosquito Culex quinquefasciatus (Das et. al., 1995). A number of 
chalcones and related were evaluated for molluscicidal activity using the 
snail Biomphalaria glabrata (Adewunmi et. al., 1987). The chalcones 
displayed high potency while the epoxides were either inactive or 
possessed very weak molluscicidal properties. 
47 
GENERAL PROCEDURES FOR 
PREPARATION OF CHALCONES USED IN THE STUDY 
General Procedures for Preparation of Chalcones and 
their Dihydro-thio Derivatives 
General Procedures 
Reagents and solvents were of commercial grade and were used 
without further purification. All melting points were determined on a 
Kofler ho plate apparatus and are uncorrected. IR spectra were 
recorded on a Perkin-Elmer 621 spectrophotmeter. ' H - N M R spectra 
were recorded in CD3 OD or DMSO-de solution with Bruker AC 300 
operating at 400 MHz with tetramethylsilane used as internal 
standards. '^C-NMR was recorded on a varian Unity 75 and 100 
spectrophotometers. Chalcones used in this study were prepared by 
following methods: 
Preparation of 2', 4', 4-Trihydroxychalcone (ISL, isoliquiritigenin): 
2', 4', 4-Trihydroxychalcone was prepared by the method of Severi et. al. 
(1996). 2-Hydroxy-4 (tetrahydropyran-2-yloxy) acetophenone (Igm, 
4.24 mmol), 4-(tetrahydropyran-2-yloxy) benzaldehyde (2 eq.) and 
barium hydroxide octahydrate (2 gm, 6.3 mmol) were dissolved in 
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methanol (50mL) and stirred for 12h at 50°C. The reaction mixture was 
concentrated in vacuo. After water (lOOmL) was added to mixture, it 
was neutralized with IM HCl and extracted with ethyl acetate. The 
organic layer was separated, washed, dried and evaporated in vacuo. The 
residue yielded crude 2'-hydroxy-4'-(tetrahydropyran-2-yloxy) chalcone. 
The compound was suspended in methanol (30 mL) and P-tolune 
sulfonic acid (0.02 g, 0.1 mmol) was added. The reaction mixture was 
stirred for 3 h at room temperature and then evaporated in vacuo. After 
water (30mL) had been added to the mixture it was neutralized with 
sodium carbonate and extracted with ethyl acetate. The organic layer 
was separated, washed with water, dried and evaporated in vacuo. The 
residue was chromato- graphed by MPLC (chloroform/ methanol/ formic 
acid 5: 1: 0.1) to give 2', 4', 4-trihydroxychalcone. 
Physical form: yellow-orange crystalline solid. Yield: 88%, m.p: 210-
211°C. 
The structure of ISL has been established by ' H - N M R and '^ C NMR. 
' H - N M R (200.13MHz, CD30D)5 6.26 (d. J 2.3 Hz, H3'); 6.39 (dd, J 8.9, 
2.3 Hz. H5') 7.96 (d, J 8.9 Hz, H6'); 7.6 (d, J 154 Hz, Ha); 7.78 (d, J 15.6 
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Hz, Hp); 7.61 (d, J 8.6 Hz, H2); 6.83 (d, J 8.6 Hz, H3); 6.83 (d, J 8.6 Hz, 
H5); 7.61 (d, J 8.6 Hz, H6) 
''C NMR (50.33 MHz, CD3OD): 5 103.8 (C3'), 109.2 (C5'), 114.6 (CI), 
116.5 (C5), 116.9(C3), 118.3(Ca), 122.8 (CI), 131.8 (C2), 131.1 (C6'), 
145.6 (C P), 166.4 (C4'), 165.7 (C2'), 161.5 (C4), 193.5 (C=0, p') 
OH 0 
2', 4', 4-Trihydroxychalcone 
Preparation of 2', 4', 3, 4- Tetrahydroxychalcone (BUT, butein) 
2', 4', 3, 4- Tetrahydroxychalcone was prepared by the method of 
Sogawa et. al. (1993). 2,4 Dihyd- roxyacetophenone (3.8 g, 25 mmol) 
and pyridinium p- toluenesulph- onate (0.15 g, 0.6 mmol) were stirred 
for 0.5 h in dichloromethane (80 mL) and then 3,4-dihydro-a-pyran at 
room temperature for 4h. The reaction mixture was washed twice with 
water, dried, and evaporated in vacuo. The residue yielded crude 2, 4-bis 
(tetrahydropyran-2-yloxy) acetophenone (la) or 3, 4-bis (tetrahydro-
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pyran-2-yloxy) benzaldehyde (lb), respectively. Crude la, crude lb, and 
barium hydroxide octahy- drate (8.15 g, 25 mmol) were dissolved in 
MeOH (100 mL) and the mixture was stirred for 12 h at 40° C and then 
evaporated in vacuo. Water (100 mL) was added and the mixture was 
neutralized with HCl (IM, 35 mL) and extracted with EtOAc. The 
organic layer was separated, washed with water, dried, and evaporated in 
vacuo. The residue yielded crude 2', 4', 3, 4-bis (tetrahydro- pyran-2-
yloxy)chalcone (Ic). Crude Ic and p-toluenesulphonic acid (0.2 g, 1.05 
mmol) were dissolved in MeOH. The reaction mixture and stirred for 4 h 
at room temperature and then evaporated in vacuo. Water (100 mL) was 
added and the mixture was neutralized with 5% NaHCOs (50 mL) and 
extracted with EtOAc. The organic layer was separated, washed with 
waster, dried, and evaporated in vacuo. The residue was chromato-
graphed on silica gel with cyclohexane- EtOAc (2:1) as mobile phase to 
yield 2', 4', 3, 4- tetrahydroxychalcone. 
Physical form: Yellow solid. Yield: 72 %, m.p: 251-252° C 
The structure of this compound has been established by IR, ' H - N M R 
and '^ C-NMR spectra. 
IR(KBr)v:3300, 1650 cm'' 
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'H-NMR (200 MHz, CH3OD) 8 7.10 (d, IH, J 2.4 Hz, H-3'), 6.42 (dd, 
IH, J 2.4, 9.0 Hz, H-5'), 6.82 (d, IH, J 8.2 Hz, H-5), 7.12 (dd, IH, J 2.0, 
8.2 Hz, H-6), 7.19 (d, IH, J 2.0 Hz, H-2), 7.53 (d, IH, J 15.3 Hz, H- a), 
7.73 (d, IH, J 15.3 Hz, H-B), 7.94 (d, IH, J 9.0 Hz, H-6') 
'^ C-NMR (100 MHz, CD3OD) 5 104.1 (C-3'), 109.5 (C-5'), 115.0 (C-l'), 
116.1 (C-2), 116.9 (C-5), 118.6 (C- a), 123.9 (C-6), 128.7 (C-l), 133.3 
(C-6'), 146.3 (C-J3), 147.1 (C-3), 150.2 (C-4), 166.6 (C-2'), 167.7 (C-4'), 
193.8 (CO) 
OH O 
Preparation of 2-, 2- Dihydroxychalcone (DHC) 
2-, 2- Dihydroxychalcone was prepared by the method of Hsieh et. al. 
(1998). 2-hydroxyacetophenone (3.4g, 25 mmol), 2-hydroxybenzal-
dehyde (3.05 g, 25 mmol) and barium hydroxide octahydrate (8.15 g, 25 
mmol) were dissolved in MeOH (lOOmL). The reaction mixture was 
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stirred for 12 h at 40°C and then evaporated in vacuo. Water (lOOmL) 
was added and the mixture was neutrahzed with HCl (IM, 35 mL) and 
extracted with ethylacetate. The organic layer was separated, washed 
with water, dried and evaporated in vacuo. The residue was eluated 
through a silica gel column with cyclohexane-ethylacetate (4:1) to give 
2-, 2- dihydroxychalcone. 
Physical form: Yellow amorphous solid. Yield: 38%, m.p: 160-162°C. 
The structure of DHC was determined by IR, ' H N M R , '^C N M R 
IR (KBr)v: 3256, 1636 cm"' 
' H - N M R (200 MHz, DMSO-dfi) 6 12.62 (IH s OH-2'), 8.17 (IH, d, J 
8Hz, H-6), 8.16 (IH, d, J 15.5 Hz, H-P), 7.97 (IH, d, J 16Hz, H-a), 7.90 
(IH, d, J 8Hz, H-6'), 7.55 (IH, dt, J 1, 8.5Hz, H-4), 7.30 (IH, dt, J 1, 
8Hz, H-5), 6.95-7.10 (2H, m, H-3', H-5'), 6.89 (IH, dt, J 1, 8.5 Hz, H-4'). 
' T NMR (100 MHz, DMSO-dg) 6 117.8 (C-3'), 117.8 (C-3), 119.6 (C-
5'), 124.4 (C-a), 121.4 (C-l')„ 121.6 (C-5), 131.8 (C-4), 133.9 (C-6), 
127.8 (C-4'), 142.5 (C-p) 
OH 0 
2-, 2- Dihydroxychalcone (DHC) 
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Preparation of 2'-Hydroxy-3, 4-dimethoxychalcone (HDMC)-
2'-Hydroxy-3, 4-dimethoxychalcone was prepared by the method of 
Hsieh et. al. (2000). 2- hydro- xyacetophenone (3.4 g, 25 mmol), 3,4-
dimethoxybenzaldehyde (4.2 g, 25 mmol) and barium hydroxide 
octahydrate (8.15 g, 25 mmol) were dissolved in MeOH (100 mL). The 
reaction mixture was stirred for 4 h at room temperature, and then 
evaporated in vacuo. Water (100 mL) was added, mixture neutralized 
with 5 % NaHCOs (50 mL) and extracted with EtOAc. The organic layer 
was separated, washed with water, dried and evaporated in vacuo. The 
residue was eluted through a silica gel column with cyclohexane-EtOAc 
(4:1) to give 2'-Hydroxy-3, 4-dimethoxychalcone. 
Physical from: yellow crystalline solid. Yield: 75%, m.p: 61°C 
IR(KBr)v: 1594, 1694 cm"' 
'H N M R (400 MHz, CD3OD): 5 7.36 (d, J 1.8, IH), 6.98 (d, J 9.01, IH), 
7.29 (dd, J 9.3, IH, 1.7 Hz, IH), 7.61 (d, J 15.58, Hz, IH), 7.73 (d, J 
15.53 Hz, IH), 7.81 (ddd, J 1.4, 1.6, 7.8, 2H), 7.81 (ddd, J 7.7, 7.3, 1.5 
Hz, 2H), 7.57-7.59 (m, IH), 3.86 (s, 3H), 3.89 (s, 3H). m/z: 268 (M", 
87), 267 (54), 253 (55), 240 (15), 238 (35), 191 (70), 163 (20), 151 (18), 
105(32), 77(100), 51 (98%) 
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13 C-NMR (lOOMHz, CDCI3) 8 120.0 (C-1'), 163.4 (C-2'), 118.4 (C-3'), 
136.0 (C-4'), 118.6 (C-5'), 129.4 (C-6'), 127.5 (C-l'), 110.2 (C-2), 149.2 
(C-3), 151.7 (C-4), 111.0 (C-5), 123.5 (C-6), 117.6 (C-a), 145.5 (C-p), 
55.9 (OCH3), 193.4 (C=0) 
OCH. 
OCHc 
OH O 
^f^nit:. 
vv*^ 
<" 
tX.Tl 
2'-Hydroxy-3, 4-dimethoxychalcone 
Preparation of 4', 4 - Dichlorochalcone (DCC)-
4', 4 - Dichlorochalcone was prepared following a published but slightly 
modified procedure (Davey and Gwilt, 1957) by condensing p-
chloroacetophenone, with p- chloro-benzylidene diacetate (both prepared 
according to reported procedures of Vogel, 1978) in equimolar ratio in 
the presence of 2.5 equivalents of sodium hydroxide. A mixture of p-
chlorobenzylidene diacetate (6.5g, 0.0268 mol) dissolved in (21 mL) 
ethanol and p- chloroacetophenone (4.13 g, 0.0268) was kept on an ice 
bath in a 500 ml flask. To this sodium hydroxide (2.68 g, 0.0671 mol, 
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10%) was added drop wise with stirring. After complete addition, the 
reaction mixture ftirther stirred for 3 h, then diluted with 300 ml of ice 
cold water and was kept in the refrigerator overnight. The precipitate 
formed was filtered and washed successively with water to make it 
neutral. It was finally washed with 10 ml of cold alcohol and the yellow 
solid thus obtained was crystallized from acetone-benzene to give 4', 4 -
dichlorochalcone. 
Physical form: light yellow crystalline needles, Yield: 6.29 g (85%), 
m.p. 156°C 
C ' ^ ^ Y T ^ 
4', 4 - Dichlorochalcone 
Preparation of Carboxymethyl thioderivative of 4', 4 
Dichlorochalcone (DCCP)-
It was prepared by the method of Levai (1991). A solution of 4',4 -
dichlorochalcone (DCC, 850 mg, 3.07 mmol) and thioglycolic acid (355 
56 
mg, 3.84 mmol) in dry benzene (25 mL) was refluxed for 2 h with 
stirring at 80°C on an oil bath, then cooled, washed with water and the 
organic layer was dried over Na2S04. The light yellow solid thus 
obtained on evaporation of the solvent was crystallized from acetone-
benzene to furnish the desired compound. 
Physical form: white crystalline needles, Yield: 870 mg (76.9 %), m.p. 
116° C 
COOH 
m/z 276/278/280 
(65.97/44.90/8.51) 
l,3-bis(4-chlorophenyl)-3(carboxy 
methylthio)propan-1 -one (DCCP) 
Structure elucidation of DCCP- It was a white needle shaped 
crystalline solid, m.p. 116" C, M.W. 368 and appeared light brown on 
exposure to I2 vapours (TLC). The structure of this compound has been 
13/ 
established by IR, 'H-NMR and 'T-NMR spectra 
IR(KBR)v: 3050, 825 cm''. 
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' H - N M R (400 MHz, CDCI3) 6: 8.16 (d, 2H, H- Ar'- 2,6, J 8.85 Hz); (d, 
2H, H-Ar'-3,5, J 8.85 Hz); 7.32 (d, 2H, H-Ar-2,6, J 8.55 Hz); 7.50 (d, 
2H, H-Ar-3,5, J 8.55 Hz) 3.68 (d, 2H, H-2, J 7.63 Hz); 4.59 (d, IH, H-3, 
J 7.63 Hz ); 3.32 (d, IH, H-l'.p, J 15.32 Hz); 3.50 (d, IH, H-l'dn, J 15.32 
Hz) 
'^C-NMR (75 MHz, CDCl3)5 : 45.51 (C-2), 44.54 (C-3), 196.32 (C-1), 
36.17 ( C-l'), 171,02 (C-2'), 142.46 (C-Ar-1), 129.19 (C-Ar-2,6), 
129.69' (C-Ar, 3,5), 139.46 (C-Ar-4), 136.55 (C-Ar'-l), 130.74 (C-Ar'-
2,6), 130.61 (C-Ar'-3,5), 133.06 (C-Ar'-4) 
Preparation of 4'-ChIoro-4-methoxychalcone (CMC)-
4'-Chloro-4-methoxychalcone was prepared following a published but 
slightly modified procedure (Davey and Gwilt, 1957) by condensing p-
chloroacetophenone with p-methoxybenzaidehyde (commercially 
available). A mixture of p-methoxybenzaldehyde (5 g, 0.0367 mol) 
dissolved in ethanol (15 ml) and p-cloroacetophenone (5.66 g, 0.0367 
mol) was kept on an ice bath and to this sodium hydroxide (3.68 g, 
0.0919 mol, 10%) was added drop wise with stirring. It was further 
stirred for 5h, then diluted with 300 ml of ice cold water and was kept in 
the refrigerator overnight. The precipitate formed was filtered and 
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washed successively with water to make it neutral. It was finally washed 
with 10 ml of cold alcohol and the yellow solid thus obtained was 
recrystallized from acetone-benzene to give 4'- chloro-4-
methoxychalcone. 
Physical form: yellow crystalline needles, Yield: 6.20 g (62 %), m.p. 
121-122°C 
OCH. 
4'- chloro-4-methoxychalcone 
Preparation of Carboxymethyl thioderivative of 4'-Chloro-4-
methoxychalcone (CMC) 
It was prepared by the method of Levai (1991). A mixture of 4'-chloro-
4-methoxychalcone (CMC, 900 mg, 3.30 mmol), thioglycolic acid (759 
mg, 8.25 mmol) in dry benzene was refluxed for 5h with stirring at 80° C 
on an oil bath. After completion, the reaction mixture was worked up, 
which on crystallization from acetone-benzene yielded the above desired 
compound. 
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Physical form: yellow crystalline needles Yield: 55 % yield, m.p: 96° C 
OCH. 
COOH 
m/z 272/274 
(100.0/ 33.84) 
l-(4-chlorophenyl)-3(4-methoxy-
phenyl)-3-(carboxymethylthio) 
propan-1-one (CMCP) 
Structure elucidation of compound- It was in the form of yellow 
crystalline needles, solid, m.p. 96" C and appeared brownish-grey on 
exposure to I2 vapours (TLC). The structure of this compound has been 
established by IR, and ' H - N M R spectra. 
IR(KBR)v: 3050, 800 cm''. 
' H - N M R (300 MHz, CDCI3) 5: 7.83 (d, 2H, H-Ar'-2, 6, J 8.55 Hz); 7.40 
(d, 2H, H-Ar'-3,5, J 8.55 Hz); 7.32 (d, 2H, H-Ar-2, 6, J 8.70 Hz); 6.83 
(d, 2H, H-Ar-3,5 J 8.70 Hz); 3.00 (d, IH, H-l'^p, J 15.40); 3.11 (d, IH, 
H-l'd,„ J 15.40); 3.52 (d, 2H, H-2, J 7.15 Hz); 4.71 (t, IH, H-3, J 7.15 
Hz); 3.77 (s, 3H, OCH3 protons) 
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Figure 1 Chemical structures of the chalcones used in the study 
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CHAPTER 1 
EVALUATION OF CHALCONES FOR THEIR 
ANXIOLYTIC EFFECTS USING ELEVATED PLUS 
MAZE AND OPEN FIELD BEHAVIOR TESTS 
Introduction 
Anxiety is defined as a subjective emotional state of uneasiness, not 
pleasant and even fearful (Pratt, 1992). Anxiety disorders in a modern 
society have a relatively high prevalence and command considerable 
financial resources. Currently, the most widely prescribed medications 
for anxiety disorders are benzodiazepines. However, the clinical uses of 
benzodiazepines are limited by their side effects such as psychomotor 
impairment, potentiation of other central depressant drugs and 
dependence liability. Therefore, the development of new medications 
possessing anxiolytic effect without the complications of 
benzodiazepines would be of great importance in the field of anxiety 
related disorders. 
Flavonoids are polyphenolic compounds found in abundance in all 
plants (Bravo, 1998). Flavonoids with anxiolytic activity have been 
described in many plant species used in folk medicine such as Passiflora 
coerulea (Wolfman, 1994). Also, dihydrochalcone Phloretin (4, 2', 4', 
6'- tetrahydroxychalcone) has the affinity for the benzodiazepine 
receptors (Ai et. al., 1997). Chalcones belong to a group of flavonoids 
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and are components of human diet although their importance to human 
health has remained unclear. Both citrus fruits and apples are rich dietary 
sources of chalcones and dihydrochalcones and these compounds could 
even make a greater contribution to the total daily intake of natural 
polyphenolics than the more extensively studied flavonoids (Tomas-
Barberan and Clifford, 2000). Because many physiological and 
pharmacological functions have been reported for a variety of chalcones 
(Dimmock, 1996), it is interesting to understand the anxiolytic effects of 
chalcones in rat. 
Materials and Methods 
Animals 
Adult male albino rats weighing 200-250 gram were used for the study. 
The animals were procured from the central animal house facility at 
Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh. 
The rats were group housed in polypropylene cages (38 x 23 x 10 cm) 
under standard laboratory conditions with natural light and dark cycle. 
They were allowed free excess of dry rat diet and tap water ad libitum. 
All procedures described were reviewed and approved by the 
Institutional Animal Ethics Committee. 
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Materials 
Chalcones were prepared by the methods described in "review section". 
Chalcones used in the study are: 2',4',4-trihydroxychalcone (ISL, 
isoiiquiritigenin); 2',4',3,4 tetrahydroxychalcone (BUT, butein); 2', 2-
dihydroxychalcone (DHC); 2'- hydroxy- 3, 4- dimethoxychalcone 
(HDMC); 4', 4- dichlorochalcone (DCC); 4'- chloro , 4- methoxy-
chalcone (CMC); 1,3-bis (4-chlorophenyl)-3 (carboxymethyl-thio) 
propan-1-one (DCCP) and 1- (4-chloro phenyl)- 3 ( 4-methoxyphenyl)-
3- (carboxymethylthio) propan-1- one (CMCP). 
Drug 
Diazepam (DZP 1 and 2 mg/kg, Sigma) was used as an anxiolytic drug. 
Diazepam was dissolved in normal saline containing 0.5% DMSO. 
Methods 
Rats were divided into nineteen groups of ten animals each. Chalcones 
were dissolved in DMSO-normal saline and the final concentration of 
DMSO in normal saline did not exceed 0.5%. The animals in 
experimental groups (sixteen groups) were administered intraperi-
toneally (i.p) with variably substituted chalcones at the dose of 15 and 25 
mg/kg body weight daily for three consecutive days. The animals in 
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standard groups (two groups) received diazepam intraperitoneally at the 
dose of 1 and 2 mg/kg body weight. The animals of control group 
received a similar volume of dimethyl sulfoxide (DMSO)-normal saline 
intraperitoneally. To the best of our knowledge the effective dose of the 
chalcones on the anxiety has not been reported till date. However, the 
effective dose of chalcones has been shown in other systems in the range 
of 5 - 20 mg/ kg (Brown and Griffiths, 1983; Chan and Yang, 2006; Wei 
et. al., 2006). Thus, in our system, we carried out a short dose response 
analysis of chalcones (0 - 25 mg / kg). 
Grip test 
Grip test was performed according to the method of Moran et. al. (1995). 
Briefly, the apparatus with a string of 50 cm length, pulled taut between 
two vertical supports was used. The rat was placed on the wire by its 
fore paws and evaluated according to the following scale: 0- fall off, 1-
hangs onto string, 2- as for 1 but attempts to climb on string, 3- hangs 
onto string by two forepaws plus one or both hind paws, 4- hangs onto 
string by all fore and hind paws plus tail wrapped around string, 5-
escape. Rats were tested on the traction wire 15 minutes after the 
administration. This method provided a quantitative estimate of the grip 
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strength and co-ordination ability of the animals. After the grip test rats 
were subjected to elevated plus maze (EPM). 
Elevated plus maze 
The apparatus consisted of a plus- shaped maze elevated 45 cm above 
the ground level with two open (10 x 50 x 10 cm) and two closed arms. 
There was a central square arena (10x10 cm) at the junction of open and 
closed arms where animal is placed at the start of the experiment. The 
apparatus was designed to measure anxiety related behavior in rats with 
closed arms representing security and open arms insecurity and fear of 
heights (Pellow et. al., 1985). The test rat was placed on the center of the 
maze facing an open arm, and the time spent in open and closed arms 
and the numbers of entries into both open and enclosed arms were 
recorded during a 5 minute observation period. Rats of all groups were 
evaluated in the maze after 30 minutes of the treatment on the third day. 
After this test, rats were tested on the rotarod instrument. 
Rota rod 
It consisted of a rotating rod (75mm diameter). The rod was divided by 
circular partitions into four compartments permitting four rats at a time. 
Effects for motor deficit (if any) were evaluated using rota rod. The 
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speed was set at 7RPM. On the third day, rats were tested on the rotating 
rod 50 min after the administration. The number of seconds each rat 
remained on the rotating rod was recorded for a maximum of 300 
seconds. Immediately after this grip test rats were subjected to open field 
test. 
Open field behavior test 
An open field apparatus was similar to that of Holland and Gupta (1966). 
It consisted of a wooden circular open arena (82 cm diameter) 
surrounded by a wall (31 cm high). The wooden floor was marked with 
three centric circles, which were divided into segments by lines radiating 
from the center. Two types of stimuli were presented to the animals: 
white noise 78 dB, Ref intensity (0.0002 dyn/cm") was presented and 
light (165 foot candle). After one hour of the treatment, on the third day, 
each animal was exposed for 5 minutes and the following behaviors 
were noted-
ambulation: it was defined as the walking score derived from the number 
of squares crossed by the animal. 
preening: preening score was determined by the number of times the 
animal scratched its face with the forelimbs. 
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rearing: a rearing score of one was awarded when the rat stood on its 
hind limbs with the support of the wall, and two for standing without 
support. 
Statistical analysis 
The data was represented as mean ± SEM. The statistical analysis of the 
results was carried out with a SPSS 11.0 program and based on an 
analysis of variance (ANOVA) followed by post hoc test (Tukey). 
Student's t - test was used for the comparison of means between 
diazepam and control treated group. Differences were considered as 
significant for p < 0.05 or less. 
Results 
Effects of chalcones and diazepam on the grip test 
The grip test provides the estimation of grip strength of the animal. As 
shown in Table 1 intraperitoneal administration of diazepam at both the 
doses [DZP1 at 1 mg / kg and DZP2 at 2mg/kg] significantly decreased 
the grip strength [t = 6.866, df = 9, P< 0.001, DZPl; t = 5.839, df = 9, 
P < 0.001, DZP2] as compared to vehicle treated control group. 
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ANOVA followed by Tukey post hoc test showed that 
intraperitoneal administration of chalcones significantly reduced the 
grip strength at 15 mg/kg [F (4,45) = 12.250, P < 0.001] and 25 mg/kg 
[F (5,54) = 12.478, P < 0.001] compared to vehicle treated control group, 
except for ISL and BUT which showed only non-significant reduction 
(Table 1). Thus it is clear from our results that chalcones presented a 
more diminution of this parameter at 25mg / kg. 
Effects of chalcones and diazepam on the elevated plus maze 
As seen in Table 2, intraperitoneal administration of diazepam (1 mg/kg), 
increased the amount of time [t = 16.117, df = 9, P < 0.001] spent in the 
open arms, number of entries [t = 17.768, df = 9, P < 0.001] into the 
open arms of the elevated plus maze, decreased the time spent in the 
enclosed arms [t=6.493, df = 9, P < 0.001], without changing the number 
of enclosed arm entries. 
Our study revealed that out of the eight tested chalcones only ISL 
and BUT showed the anxiolytic activity. ANOVA followed by Tukey 
post hoc test showed that the intraperitoneal administration of ISL (15, 
25 mg/kg) and BUT (25mg/kg) increased the amount of time spent in the 
open arms [F (3,36) = 9.115, P < 0.001], number of entries into open arms 
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[F(3,36) = 7.261, P < 0.001] as compared to vehicle treated control group. 
Also, decrease in the time spent in the enclosed arms was only showed 
by ISL [Control = 223.20 ± 3.47, ISL = 176.50 ± 4.77, F (,,,8) = 62.468, P 
< 0.001] as compared to vehicle treated control group. No significant 
changes in the number of enclosed arm entries were observed at this 
dose. 
Effects of chalcones and diazepam on neuromuscular coordination 
- Rotarod 
Table 3 revealed that diazepam at both the doses (1 and 2 mg/kg) 
showed decrease in the time of permanence [t = 33.629,df = 9, P < 
0.001, DZPl; t = 34.901, df = 9, P < 0.001, DZP 2]. Unlike DZP, most 
of the chalcones showed no alteration in the amount of time of 
permanence on the rotating rod (Table 3). 
Intraperitoneal administration of chloro substituted chalcones 
(DCC, CCP, CMC) showed a decrease in the time of permanence [F(3,36) 
= 106.527, P < 0.001, 15 mg/kg; F (3,36)= 114.554, P < 0.001, 25mg/kg] 
on the rotating rod as compared to vehicle treated control group. 
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Effects of chalcones and diazepam on open field behavior test 
Table 4 showed that diazepam (1 and 2 mg/ kg) caused a significant 
decrease in ambulation [t = 3.844, df = 9, P < 0.01, DZPl; t = 10.80, df 
= 9, P < 0.001, DZP2], rearing [t= 7.16, df = 9, P < 0.001, DZPl; t = 
13.931, df = 9, P < 0.001, DZPl], preening [t = 3.972, df = 9, P < 0.003, 
DZPl; t = 6.567, df = 9, P < 0.001, DZP2] as compared to vehicle 
treated control group. 
As shown in Table 4, our anxiolytic compounds, ISL and 
BUT showed no alteration in the open field test different from diazepam. 
ANOVA followed by Tukey post hoc test showed that the 
intraperitoneal administration of rest of the chalcones at both 15 and 25 
mg/ kg showed a significant alteration in ambulation score [F (5 54) = 
8.374, P < 0.001], rearing [F (6.63) = 23.198, P < 0.001], and preening 
[F(4 45) = 13.937, P < 0.001] as compared to vehicle treated control 
group. 
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Table-l.Grip test. The data are expressed as mean ± SEM. 
Groups Grip Score 
15mg/ kg 25mg/ kg 
Control (10) 3.1±0.31 3.1±0.31 
ISL (10) 2.6 ±0.16 2.2 ±0.24 
BUT (10) 2.5 ±0.16 2.4 ±0.33 
DHC (10) 1.4 ±0.13^''^ 1.4 ±0.22^"' 
HDMC (10) 1.4 ± 0.26 '^''= 1.3 ±0.26^^'' 
DCC (10) 1.2 ±0.20^"'= 0.8 ±0.13^'''= 
DCCP (10) 1.3±0.15'''' 1.4 ±0.16 '^"= 
CMC (10) 2.2 ±0.41'" 1.8 ± 0.29^'''' 
CMCP (10) 2.3 ±0.39 2.0 ± 0.30 
DZP 
Img/kg (10) 1.2 ±0.2='''' 
2mg/kg (10) 0.9±0.r'"^ 
Figures in parenthesis indicate number of rats. ^'^ Indicate statistical 
significance in comparison to vehicle treated group at P< 0.05, P < 0.01, 
P < 0.001, respectively with ANOVA followed by post hoc Tukey test. 
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Table-3.Rota rod performance test. The data are expressed as mean ± 
SEM. 
Groups Time spent on rota rod (in seconds) 
15mg/kg 25mg/ kg 
Control (10) 180.00 ±0.00 180.00 ±.00 
ISL (10) 180.00 ±0.00 180.00 ±.00 
BUT (10) 178.90 ±0.54 177.90 ±0.98 
DHC (10) 171.90 ±1.98 167.10 ±3.12 
HDMC (10) 169.80 ±2.88 165.30 ±3.16 
DCC (10) 107.20 ±3.24^"'= 143.30 ±4.46"^^ 
CCP (10) 151.90 ±3.93'"'= 143.30 ±4.46"''' 
CMC (10) 165.70 ±3.35"^ 156.50 ± 3.20 '^=^ 
CMCP (10) 168.80 ±2.48 163.80 ±3.15 
DZP 
Img/kg (10) 92.10± 2.61'*"= 
2mg/kg (10) 65.80 ± 3.27''^' 
Figures in parenthesis indicate number of rats. "^'^  Indicate statistical signifi-
cance in comparison to vehicle treated group at P < 0.05, P < 0.01, 
P < 0.001, respectively with ANOVA followed by post hoc Tukey test. 
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Discussion 
In the present work, effects of chalcones with variable substitutions were 
studied in animal models such as open field test, elevated plus maze test, 
rota rod, and grip test. These tests are classical models for screening 
central nervous system (CNS) actions providing information about 
sedative, anxiety, and psychomotor performance and myorelaxant 
effects. 
The assessment of anxiety- related behavior in animal model is 
based on the assurance that anxiety in animals is comparable to anxiety 
in humans. Although, as a matter of fact, it cannot be proven that an 
animal experiences same anxiety in the same way as human being, it is 
undisputed that distinct behavior pattern in rodents indicate anxiety, i.e. 
behavioral and peripheral changes presumed to accompany high 
sympathetic nervous activity (Hall, 1971). Thus an analogy, if not a 
homology, between anxiety in humans and rodents may be assumed. 
The elevated plus - maze is the most popular test to search for new 
benzodiazepine- like anxiolytic agents (Hoggs, 1996; Rodgers, 1997) 
and has been validated for use with both rats and mice (Lister, 1987). 
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Therefore, we choose this test to investigate the aj^iblytic potentia^^of^  
the chalcones. The indices of anxiety in this test, percentE 
entries and time spent in the open arms are sensitive to agents thought to 
act via the GABAA receptor complex, justifying the use of diazepam as a 
positive control in the study. As expected, diazepam produced 
significant increase in open arm time and decrease in enclosed arm time. 
These data are in agreement with the results of other studies where 
diazepam and other benzodiazepines have been shown to produce robust 
anxiolytic effects in a variety of anxiolytic screening procedures, 
including conflict model (Vogel, 1971), EPM procedures (Pellow, 
1986), and other non - punishment procedures (Winslow and Insel, 
1991). The ratio of openxlosed area entries reflects a specific effect on 
anxiety, provided there is no concomitant change in the total number of 
entries (open and closed), however, this is not totally true for diazepam 
which increases preference for the open areas i.e. total entries (Weiss, 
1998). Diazepam produced significant increases in the number of entries 
into the open arms and the enclosed arms in this study. It is well known 
that benzodiazepines act as anxiolytics (at low doses), anti- convulsants, 
and also produce sedation and a myorelaxant effect at higher doses 
(Helton et. al., 1996; Woods and Winger, 1995; Charney, 2001) thereby 
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we used diazepam at Img/kg in EPM and 1 & 2 mg/kg in open field, 
rota rod and traction tests. In support of this, our study also showed that 
diazepam at both doses produced a reduction in ambulation, preening, 
and rearing scores (open field behaviors), neuromuscular coordination 
and a grip strength (traction test), showing a sedative effect. 
The behavioral alterations induced by the only two chalcones i.e. 
ISL and BUT in the EPM provided anxiolytic effect, whereas rest of the 
chalcones are inactive. Our results showed that ISL (2', 4', 4- trihyd-
roxychalcone) decreased the avoidance to open arms, thereby increasing 
the time of permanence in the open arms, number of entries into open 
arms and decreasing the time in enclosed arms, but showed no alteration 
in entries into enclosed arms. In the open field test this compound does 
not alter the open field behavior different from diazepam. Likewise, it is 
unlikely that these effects of ISL observed in plus maze and open field 
tests are based on the stimulation of general motor activity. Furthermore 
in the rota rod test, ISL at both the doses, different from diazepam, has 
no effect on the motor coordination. 
The role of GABA (gamma-amino butyric acid) in anxiety is well 
documented (Davis et. al., 1994). Furthermore, despite of scarcity in 
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information, encouraging reports are available on GABA-BZD receptor 
acting as potent targets for drugs (Watson and Hughes, 2007; Boulenger, 
1995; Tatarczynska et. al., 2004). Increased 5 HT (serotonin) activity 
leads to decreased GABAergic activity and vice versa (Nishikawa and 
Scatton, 1983; 1985a). Reports indicate that both the intensity of drug 
induced anxiety and addictive drug withdrawal- induced anxiety in rats 
are correlated with increase in the MAO-A (Bhattacharya et. al, 1995a; 
1996). Recently isoliquiritigenin was considered as inhibitor of MAO-A 
(Kong et. al., 2000). This is consistent with our behavioral observation 
that ISL possess anxiolytic activity. In addition, the kinetic study of 
isoliquiritigenin towards MAO-A implied that it combined to different 
sites of the enzyme, independent of the pre- binding of 5HT (Tan et. al., 
2000). Thus, as shown, ISL (isoliquiritigenin) possess anxiolytic activity 
without any effect on the motor coordination, or depressive and sedative 
effects typically associated with benzodiazepines. The central 
histaminergic system is known to have modulatory influence on anxiety-
related behavior both in animals and humans through histamine H, 
and/or H2 receptors (Zarrindast et. al., 2006). Histamine H2 receptors 
inhibit the anxiety (Mitsutoshi et. al., 2000), and also histamine H2 
receptor antagonist showed highly significant and progressive decrease 
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in depression and anxiety scores (Robins et. al., 1984). According to 
Kim et. al. (2006) isoliquiritigenin showed selective H2 histamine 
receptor (H2R) antagonistic effect and remaricably reduced several H2 
mediated physiological responses. Therefore, it might be concluded that 
the anxiolytic like effect of this compound is being probably mediated 
by other mechanism than benzodiazepines (BZD-ps) modulation at the 
GABA receptor. 
Compound BUT (butein; 2', 4', 3, 4- tetrahydroxychalcone) also 
showed an anxiolytic effect in the EPM only at 25 mg/icg by increasing 
the time spent in the open arms, number of entries into open arms and 
decreasing number of entries into open arms but showed no effect on the 
time spent in enclosed arms. Unlike diazepam this compound (both 
doses) also has no effects on the motor coordination as shown by rota 
rod test and also on the ambulatory score (open field test). It shows only 
non-significant decrease in the grip strength and ambulation scores. This 
result suggests that BUT (butein) has anti- anxiety effects on the central 
nervous system and discards the possibility of neurotoxic and sedative 
side effects. 
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However unlike ISL and BUT other chalcones are ineffective in 
the EPM investigation but these compounds (15 and 25 mg/kg) affect rat 
behavior. Therefore, we shall discuss their central effects on the 
locomotor activity, motor coordination and muscle strength, as no study 
is available regarding effects of chalcones on these parameters. 
Chalcones with hydroxy substitution at 2' position such as DHC and 
HDMC at the higher doses reduced the ambulation and rearing scores in 
the open field test as compared to vehicle treated control group. Also, in 
the rotarod test these compounds have no effects on the motor 
coordination but significantly decreased the grip strength at both the 
doses, showing the sedative and muscle relaxant effects. 
The decrease in motor activity gives an indication of the level of 
excitability of the CNS (Masur et. al., 1971) and this decrease in motor 
activity may be related to sedation resulting from depression of CNS 
(Ozturk et. al., 1996). Both the chloro substituted chalcones, DCC and 
CCP showed significant alterations in ambulation, rearing and preening 
in the open field. Furthermore, decrease in grip strength and motor 
coordination was exhibited by both of these chalcones at both the doses, 
showing the sedative and muscle relaxant effects. 
Rest of the two methoxy substituted chalcones (CMC and CMCP) 
showed no significant alterations in all the tested behaviors but 
significantly decrease the grip strength at both the doses, showing the 
muscle relaxant effects and absence of sedative or depressive effects. 
Thus, it is clear that most chalcones have muscle relaxant effects. 
Conclusion 
In conclusion, modification of the chalcone nucleus with different 
substituted groups dramatically alters their activity. We showed that 
intraperitoneal administration of ISL and BUT showed anxiolytic - like 
effects in the elevated plus maze and were devoid of sedative effect as 
assessed by the open field test. Chalcones may also have sedative and 
muscle relaxant effect as shown by rotarod and traction test, although, 
the exact mechanism responsible for their effect is not clear. 
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CHAPTER 2 
INHIBITORY POTENTIAL OF CHALCONES 
ON BRAIN PARTS AND SPINAL 
CORD ACETYLCHOLINESTERASE ACTIVITY AND 
MEMORY IN RATS USING Y-MAZE 
Introduction 
Acetylcholinesterase (AChE) is a key component of cholinergic brain 
synapses and neuromuscular junctions. The major biological role of the 
enzyme is the termination of impulse transmission by rapid hydrolysis of 
the cationic neurotransmitter acetylcholine (Hasan et. al, 2005). The 
central cholinergic pathways play a prominent role in learning and 
memory processes (Nabeshima, 1993). Cholinergic neurons in the 
central nervous system (CNS) are degenerated in patients with 
Alzheimer's disease, and senile dementia severity and degree of 
degeneration are correlated with functional loss in this and similar 
disorders (Davies and Maloney, 1976; Perry et. al., 1978). Based on a 
cholinergic hypothesis, many attempts have been made to reverse 
cognitive deficits by increasing brain cholinergic activity via 
acetylcholinesterase inhibitors (AChEIs), acetylcholine precursors, or 
cholinergic agonists. It has been the prevailing view that the 
symptomatic efficacy of AChEIs is attained through their augmentation 
of acetylcholine- mediated neuron-to-neuron transmission. However, 
there is evidence that AChEIs may slow disease progression and 
hippocampal atrophy and may have disease- modifying effects (Farlow, 
2002; Giacobini, 2001). The choHnergic receptor agonists (muscarinic 
and nicotinic) and enhancers of the endogenous levels of acetylcholine 
(synthesis promoters and inhibitors of its metabolizing enzymes) have 
been examined as potential treatments for senile dementia of the 
Alzheimer's type. Among the various approaches attempted, AChE 
inhibition was the most successful (Giacobini, 1996), and a selective 
AChE inhibitor, donepezil, has been used to treat mild Alzheimer's 
disease (Doody, 1999). Thus, enzyme acetylcholinesterase (AChE) has 
long been an attractive target for the rational drug design and discovery 
of inhibitors for the treatment of Alzheimer's disease. 
Recent evidence also point to a direct role of AChEIs in the 
inhibition of the release of inflammatory substances from specialized 
cells (Giunta et. al., 2004). The role of inflammatory cytokines, 
including TNF a, IL-1 and IL-6, in neurodegenerative diseases has been 
extensively studied in the last several years (Cacabelos et. al., 1991; 
FiUit et. al., 1991; Grimaldi et. al., 2000; Licastro et. al, 2000; Gambi et. 
al., 2004; Lugaresi et. al., 2004; Reale et. al., 2004). The accumulation of 
the cytokines, IL-1, IL-6 and TNF in AD does not appear to be merely a 
consequence of the degenerative process, but may play a role in the 
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cascade of events including neuronal death (Paganelli et. al., 2002; 
Licastro et. al., 2003). Flavonoids, are known to inhibit both LPS 
stimulated necrosis factor alpha and interleukin-6 release which 
modulate pro- inflammatory molecules that have been reported in many 
progressive neurodegenerative disorders. Also 2'- substituted chalcones 
have been shown to inhibit the production of IL-IB monocytes 
stimulated with LPS (Batt et. al., 1993). Recently, it has been found that 
BChE inhibitors may also be effective for the treatment of Alzheimer 
and related dementias (Yu et. al., 1999). Chalcones have been shown to 
be the inhibitors of AChE and BChE (Ansari et. al., 2005). Thus, it 
prompted us to investigate the effects of variably substituted chalcones 
on the memory deficits induced by cholinergic disturbances using 
scopolamine in rats. Memory parameter was evaluated by using Y- maze 
and Elevated plus maze. Here, we report that out of eight tested 
chalcones, two have ameliorating effects on scopolamine- induced 
learning and memory in rats. 
Materials and Methods 
Animals 
Adult male albino rats weighing 200-250 gram were used for the study. 
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The animals were procured from the central animal house facility at 
Jawaharlal Nehru Medical College, Aligarh. The rats were group housed 
in polypropylene cages (38x23xlOcm) under standard laboratory 
conditions with natural light and dark cycle. They were allowed free 
excess of dry rat diet and tap water ad libitum. All procedures described 
were reviewed and approved by the Institutional Animal Ethics 
Committee. 
Materials 
Chalcones were prepared by the methods described in "review section". 
Chalcones used in the study are: 2',4',4-trihydroxychalcone (ISL, 
isoliquiritigenin); 2',4',3,4 tetrahydroxychalcone (BUT, butein) ; 2', 2-
dihydroxychalcone (DHC); 2'- hydroxy - 3, 4 -dimethoxychalcone 
(HDMC); 4', 4- dichlorochalcone (DCC); 4'- chloro , 4-methoxy-
chalcone (CMC); 1,3-bis (4-chlorophenyl) -3 (carboxymethylthio) 
propan-1-one (DCCP) and 1- (4-chlorophenyl)- 3 (4-methoxyphenyl)-
3- (carboxymethylthio) propan-1-one (CMCP). 
(-) scopolamine hydrobromide, acetylthiocholine iodide and 
DTNB [5, 5'-dithiobis (2-nitrobenzoic acid)] were purchased from the 
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Sigma Chemical Co. All other materials were obtained from normal 
commercial sources and were of the highest grade available. 
Methods 
Rats were divided into ten groups of ten animals each. The animals in 
experimental (eight) groups were administered with chalcones intra-
peritoneally at the dose of 25mg/ kg body weight daily for 7 consecutive 
days. Chalcones were dissolved in DMSO-normal saline. The animals of 
control group received a similar volume of dimethylsulfoxide-normal 
saline intraperitoneally for 7 consecutive days. The final concentration 
of DMSO in normal saline did not exceed 0.5 %. Memory impairment 
was induced by the administration of scopolamine (Img/kg, i.p). 
Scopolamine hydrobromide was dissolved in normal saline. Working 
memory performances were assessed by recording spontaneous 
alternation behavior in a single session in a Y- maze and transfer latency 
in the Elevated plus maze immediately after the administration of 
chalcones. 
Y maze task 
Spontaneous alternation behavior, which is regarded as a measure of 
spatial memory (Sarter et. al., 1988), was investigated using the Y- maze 
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test. The Y- maze is a three- arm horizontal maze (40 cm long and 3 cm 
wide with walls 12 cm high) in which the arms are symmetrically 
disposed at 120° to each other. Rats were initially placed within one arm, 
and the sequence (i.e., ABC CBA, etc) and number of arm entries were 
recorded manually for each rat over a 5 min period. An actual alternation 
was defined as entries into all three arms on consecutive choices (ABC, 
CAB, or BCA but not BAB). One hour before this test, rats were treated 
with the seventh and last dose of chalcones (25 mg/kg), and 30 min later 
memory impairment was induced by administration of scopolamine (1 
mg/kg, i.p). Control group animals received vehicle only. Maze arms 
were thoroughly cleaned between tests to remove residual odors. 
Percentage alternation was determined by dividing the total number of 
alternations by the total number of choices minus 2 multiplied by 100 as 
shown in the following equation (Eraser et. al., 1997): 
% Alternation = [(Number of alternations) / (Total arm entries - 2)] x 
100. The number of arm entries serves as an indicator of locomotor 
activity. The rats were subjected to Elevated plus maze after this test. 
Elevated plus maze 
Elevated plus maze serves as the exteroceptive behavioral model to 
evaluate memory in mice. The procedure, technique and end point for 
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testing memory was followed as per the parameters described by the 
investigators (Itoh et. al., 1990; Joshi et. al., 2005). The apparatus 
consisted of a plus- shaped maze elevated 45 cm above the ground level 
with two open (10x50x10 cm) and two closed arms. There was a central 
square arena (10x10 cm) at the junction of open and closed arms where 
animal is placed at the start of the experiment. Each rat was placed at the 
end of an open arm, facing away from the central platform. Transfer 
latency (TL) was defined as the time (in seconds) taken by the animal to 
move from the open arm into one of the closed arms with all its four 
legs. The rat was allowed to explore the maze for 2 min and then 
returned to its home cage. Significant reduction in TL value of retention 
indicated improvement in its memory. One hour before this test, rats 
were treated with the seventh and last dose of chalcones (25 mg/kg), and 
30 min later memory impairment was induced by administration of 
scopolamine (1 mg/kg, i.p). Control group animals received vehicle 
only. Maze arms were thoroughly cleaned between tests to remove 
residual odors. 
Estimation of acetylcholinesterase activity 
Tissue preparation 
On the seventh day, immediately after the Y- maze and Elevated plus 
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maze performances rats were sacrificed by decapitation. Their brains 
along with spinal cords were removed quickly, and placed on the 
petridish, over ice. The brains and spinal cords were washed with ice-
chilled normal saline repeatedly to clean. The brains were dissected out 
into three regions- cerebrum, cerebellum, and brain stem. The assay of 
AChE in brain parts and spinal cord was performed by the method of 
Ellmanet. al. (1961). 
Principle: 
AChE estimation is based on the measurement of the rate of production 
of thiocholine as AChE is hydrolyzed. This is accompanied by the 
continuous reaction of the thiol with 5', 5-dithiobis-2-nitrobenzoate ion 
to produce the yellow anion of 5-thio-2- nitrobenzoic acid. 
Chemicals and reagents: 
1) Phosphate buffer (0.1 M, pH- 8.0). 
2) DTNB reagent: 39.6 mg of 5', 5-dithiobis-2-nitrobenzoic acid 
(DTNB) was dissolved in 10 ml of 0.1 M phosphate buffer (pH- 8.0) 
and 15 mg of sodium bicarbonate was added to it. 
3) Substrate: 0.075 M acetylcholine iodide. 
4) Inhibitor: 10"^  M eserine sulphate was dissolved in 0.1 M phosphate 
buffer (pH- 8.0). 
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Procedure: 
Saline cleaned and accurately weighed tissues were homogenized in 
0.1 M phosphate buffer (pH- 8.0) in a concentration of 10 mg/ml and 
centrifuged at 1500 rpm for 5 min. 0.4 ml of the supernatant was 
pipetted in a cuvette containing 2.6 ml of phosphate buffer. To this 0.1 
ml of DTNB reagent was added and mixed well. O.D was read at 412 
nm using Beckman DU spectrophotometer and the absorbance of the 
suspension was set at zero. 0.02 ml of the substrate was added and the 
changes in the absorbance were recorded from 5 to 10 min at the 
interval of one minute. To determine non- specific esterase, 0.1 ml of 
eserine sulphate (inhibitor) was added to another cuvette containing 0.4 
ml of homogenate supernatant, 2.5 ml of phosphate buffer and 0.1 ml of 
DTNB reagent. The changes in absorbance were recorded as described 
above after adding 0.02 ml of substrate. The rate of change of activity of 
the suspension with eserine was subtracted from that of the suspension 
without eserine. The enzyme activity is expressed as jimoles of substrate 
hydrolyzed per gm tissue per minute. Protein concentration was 
determined by the method of Lowry et. al. (1951). 
^^ A . 1 . 5.74 (10-^) A 
1.36(10") (400/3120) Co Co 
where, 
R= Rate of enzyme activity in moles of substrate hydrolyzed / gm 
tissue / min 
A= Change in absorbance per minute 
Co= Original concentration of tissue (mg/ ml) 
Statistical analysis 
All the data expressed in the table and figures are mean ± SEM. Data 
was analyzed by one way analysis of variance (ANOVA) followed by 
Tukey post test. Differences were considered significant at P < 0.05 or 
less. 
Results 
Effects of scopolamine and chaicones on the Y- maze test 
The effects of chaicones on spontaneous alternation behavior was 
examined using the Y- maze test and the results showed that variably 
substituted chaicones exhibited different pattern of activity. Scopolamine 
(1 mg/ kg, i.p) injected before 30 min of the test significantly decreased 
[F(i,io) = 11.231, P< 0.001] the spontaneous alternations as compared to 
vehicle treated control group, indicating impairment in memory 
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(amnesia). Only two of the tested chalcones (ISL and BUT) increased 
the spontaneous alternations. The spontaneous alternations of rats treated 
with ISL (isoliquiritigenin) and BUT (butein) (25mg/ kg x 7 days) are 
significantly [F (2,15) = 9.975, P< 0.001] higher than that of scopolamine 
treated control group. However, rest of the tested chalcones showed no 
effect on the spontaneous alternation behavior. Thus chalcones exhibited 
no impairment on spatial working memory (Figure 2). Moreover, 
numbers of arm entries were similar in all experimental groups as 
compared to vehicle treated control group, demonstrating that general 
locomotor activity was not affected by chalcones (Figure 3). 
Effects of scopolamine and chalcones on the Elevated plus maze test 
Transfer latency (TL) reflected retention of learned task or memory. The 
rats treated with chalcones (ISL and BUT; 25mg/ kg, i.p) showed 
reduction of TL which is increased by scopolamine, indicating 
significant improvement in memory. Scopolamine (1 mg/kg, i.p) injected 
before 30 min of the test significantly increased [F(i lo) = 35.703, P < 
0.001] the TL as compared to vehicle treated control group, indicating 
impairment in memory (amnesia) (Figure 4). The rats treated with ISL 
and BUT (25 mg/kg, i.p x 7 days) significantly reversed the memory 
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impairment [F (2, is) = 10.779, P < 0.001] as compared to scopolamine 
treated control group. 
Effect of chalcones on acetylcholinesterase activity 
The results of variably substituted chalcones, screened for their activity 
towards acetylcholinesterase inhibition in the different brain parts and 
spinal cords are presented in Table 5. As shown in Table 5, only hydroxy 
substituted chalcones i.e ISL, BUT, DHC and HDMC showed inhibitory 
activity towards acetylcholinesterase while treatment with other 
chalcones such as DCC, DCCP, CMC, and CMC? caused no alteration 
in the acetylcholinesterase activity and were totally inactive. 
ANOVA followed by Tukey post hoc test showed that 
intraperitoneal administration of chalcones (25mg/ kg, i.p x 7 days) 
significantly reduced the acetylcholinesterase activity in cerebrum [F(4 25) 
= 27.820, P < 0.001], cerebellum [F(4,25)= 21.006, P < 0.001], brain stem 
[F(,,,o) = 27.594 , P < 0.001], and spinal cord [F(2,i5) = 5.010 , P < 0.022] 
as compared to vehicle treated control group. 
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Structural requirements for AChE inhibition and memory 
improvement 
From these results it is evident that the hydroxyl (OH) group present in 
ring A has vital role in the inhibition of acetylcholinesterase activity. 
Compounds having hydroxyl group at 2 position such as in ISL 
(isoliquiritigenin, 2',4',4- trihydroxy chalcone), BUT (2',4',3,4-tetrahy-
droxychalcone), DHC (2',2-dihydroxychalcone), and HDMC (2'-
hydroxy-3,4,-dimethoxychalcone) showed inhibitory activity against 
AChE. Compounds having chloro and methoxy substituents as in DCC, 
DCCP, CMC, CMCP showed no inhibition and are totally inactive. 
Thus, it may be concluded that a hydroxyl group ortho to the side chain 
is very much responsible for acetylcholinesterase inhibitory activity. 
Substituents like chloro, methoxy, hydroxyl, carboxymethyl moiety may 
decrease or increase the activity of the variably substituted chalcones in 
the present study. 
Results obtained from Y- maze and Elevated plus maze tests 
showed that only two of the tested chalcones i.e ISL (isoliquiritigenin, 
2',4',4- trihydroxychalcone), and BUT (2',4',3,4-tetrahydroxychalcone) 
having three and four hydroxy groups increased the spontaneous 
alternations and decreased the transfer latency respectively, indicating 
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improvement in memory. Thus, for the ameliorating effects of chalcones 
on memory deficits, presence of more than two hydroxy! groups on both 
the rings is necessary. 
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Figure- 2.Effects of chalcones on Spontaneous alternation behavior of 
scopolamine induced amnesic rats. Data represent mean ± 
S.E.M often rats. 
Cont SCP ISL BUT DHC HDMC DCC DCCP CMC CMCP 
SCP(lmg/kg,i.p) 
Indicate statistical significance in comparison to vehicle treated group 
at P< 0.05, P < 0.01, P < 0.001, respectively with ANOVA followed by 
post hoc Tukey test. 
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Figure- 3. Effects of chalcones on the number of arm entries of 
scopolamine induced amnesic rats. Data represent mean ± 
S.E.M often rats. 
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Figure- 4. Effects of chalcones on Transfer latency of scopolamine 
induced amnesic rats. Data represent mean ± S.E.M of ten 
rats. 
o 
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TO 
Cont SCP ISL BUT DHC HDMC DCC DCCP CMC CMCP 
SCP(lmg/kg,i.p) 
Indicate statistical significance in comparison to vehicle treated group 
at P< 0.05, P < 0.01, P < 0.001, respectively with ANOVA followed by 
post hoc Tukey test. 
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Table- 5.Effects of chalcones on acetylcholinesterase activity of different brain 
parts and spinal cord. Data are expressed as mean ± SEM. 
Groups Specific activity of AChE (fimol/min/mg of protein) 
Cerebrum Cerebellum Brain stem Spinal cord 
Controi (6) 4.2620±0.13 1.7178±0.24 2.1113±0.15 2.1921±0.03 
ISL (6) 2.7633 ±0.17'""= 1.2381 ±0.04' 1.7675 ±0.14 1.9758 ±0.15 
BUT (6) 3.4123 ±0.05' 1.2201 ±0.07' 1.9122±0.18 1.9865±0.19' 
DHC (6) 2.5685 ±0.13'''M.0872± 0.08'^ 1.7493 ±0.15' 1.9758 ±0.15' 
HDMC (6) 3.3053 ± 0.11'"' 1.2391 ± 0.03' 2.0850 ±0.14 1.9865 ± 0.20 
DCC (6) 4.1655 ±0.18 1.7139 ±0.18 2.1083 ±0.17 2.1748 ±0.16 
DCCP (6) 4.1762 ±0.19 1.4686 ±0.12 2.0860 ±0.14 2.1628 ±0.12 
CMC (6) 4.0657 ±0.21 1.5214 ±0.12 2.1167 ±0.15 2.0948 ±0.16 
CMCP(6) 3.9340 ±0.21 1.4187 ±0.11 2.1683 ±0.10 2.1413 ±0.18 
Figures in parenthesis indicate number of rats. '"''Indicate statistical significance in 
comparison to vehicle treated group at P< 0.05, P < 0.01, P < 0.001, respectively 
with ANOVA followed by post hoc Tukey test. 
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Discussion 
In the present study, we examined the effects of variably substituted 
chalcones on scopolamine- induced memory impairment in the Y- maze 
task, and the Elevated plus maze test in rats. Scopolamine, a non 
selective muscarinic antagonist blocks cholinergic signaling without 
changing the acetylcholine concentration, and produces memory deficits 
that are similar to those found in age related senile CNS dysfunction 
(Ebert and Kirch, 1998). Thus the scopolamine- induced amnesic murine 
model is useful for investigating age- related senile CNS dysfunction. 
The ameliorative effects of chalcones (ISL and BUT, 25 mg / kg, 
i.p) on learning and memory was investigated by using the Y- maze task 
because spontaneous alternation behavior in the Y- maze is considered 
to reflect working memory. Scopolamine decreased spontaneous 
alternation to approx 24 %. Chalcones (ISL and BUT, 25 mg/kg, i.p) 
increased spontaneous alternations to approx 22 % by ISL (isoliqui-
ritigenin) and 17.5 % by BUT (butein) respectively of the scopolamine 
treated group. In the Y- maze test, no significant changes in total 
number of arm entries after drug treatment means that the treatment has 
no effect on general locomotor activity (Sarter et. al., 1988), and the 
same is observed in the present study. 
In order to confirm the effects of chalcones on another type of 
learning and memory, we used elevated plus maze. Increase in transfer 
latency of 64 % was observed in the scopolamine- treated group as 
compared to vehicle treated control group. The chalcones, ISL and BUT 
(25 mg/kg, i.p) treated group ameliorated memory impairment due to 
scopolamine by ISL to 24 % and BUT to 18.6 % respectively, i.e. 
decreasing the transfer latencies to vehicle-treated control group level. 
Collectively, these behavioral studies suggest that chalcones improve the 
memory in amnesic rats induced by scopolamine. 
To investigate the mode of action of chalcones, their AChE 
inhibitory activity was assessed using rat brain parts and spinal cord 
homogenates. It is well known that the anti- amnesic effects of tacrine 
and donepezil are due to AChE inhibition in brain (Murray et. al., 1991; 
Dawson and Iverson, 1993). Our study showed that all the four hydroxy 
substituted chalcones i.e. ISL, BUT, DHC, and HDMC significantly 
decreased AChE activity but it is interesting to note that improvement in 
memory is only observed with only two chalcones i.e. ISL and BUT. 
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The central cholinergic system is considered to be most important 
neurotransmitter involved in regulation of cognitive functions (Enz et. 
al., 1993). Cognitive dysfunction has been shown to be associated with 
reduced cholinergic transmission and the facilitation of central 
cholinergic transmission with improved memory (Bhattacharya et. al., 
1993). AChEI (acetylcholinesterase inhibitor) treatment, increasing the 
availability of ACh, improves cognitive function in AD (Evans et. al, 
1989; Ballard, 2002; Wilkinson et. al., 2004). In the present study, 
chalcones when administered for 7 days showed significant reduction of 
brain and spinal cord acetylcholinesterase activity probably facilitating 
cholinergic activity by raising the level of ACh leading to improved 
cognitive action. The fact that in both humans and rats given anti-
muscarinics apparent learning deficits are partially reversed by 
cholinergic agonists (e.g. AChE inhibitors; Collerton, 1986; Drachman, 
1977) appears to support the notion of a specific role of ACh in learning 
and memory processes and the amnesia (Collerton, 1986). Our results 
suggest that the ameliorative activities of chalcones on memory 
dysfunction involve more than AChE inhibition. 
Polyphenols stimulate the SIRTl (a human deacetylase that 
promotes cell survival) (Tanny, 2001) protein and could be potential 
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regulators of aging associated processes. SIRTl activators show promise 
as tlierapies for obesity, diabetes, age-related disease, Alzheimer's 
disease and stroke (Davies and Bozzo, 2006). Also, activation of sirtuin 
extends lifespan and promotes longevity and healthy aging in a variety 
of species, potentially delaying the onset of age-related 
neurodegenerative disorders (Gan, 2007). According to Howitz et. al. 
(2003) isoliquiritigenin and butein are sirtuin activators. Storlin et. al. 
(1990), proposed that the activity of MAO-B (monoamine oxidase-B), 
appears to increase with age in various regions of the human and rat 
brain. This increase in MAO-B is mainly associated with the 
proliferation of astrocytes that accompanies the neuronal loss that occurs 
in aging and AD (Riederer et. al., 1986). MAO inhibitors are potential 
candidates as anti- Alzheimer drugs (Carreiras, 2004). Recently 
isoliquiritigenin was considered as MAO-B inhibitor (Kong et. al., 
2000). Thus, suggesting ISL (2', 4', 4- trihydroxychalcone) as dual 
AChE/MAO inhibitors is of great interest. Angiotensin- converting 
enzyme inhibitors reversed the learning deficits in aged mice or those 
induced by scopolamine (Barnes et. al., 1989). Butein has been shown to 
be a potent inhibitor of angiotensin converting enzyme (Kang, 2003). 
However, the memory enhancing effects of chalcones has not been 
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described previously in animals. Tiiese data also support our present 
findings. The present study suggests that chalcones are responsible for 
the anti- amnesic activity in scopolamine- induced memory deficits in 
rats. These findings also suggest the possible neuroprotective role for 
chalcones. 
Many lines of evidence suggest that uses of antioxidant or anti-
inflammatory agents (Quintanilla et. al., 2005), melatonin (Jang et. al., 
2005), Egb761 (Ahlemeyer and Krieglstein, 2003), blueberry (Joseph et. 
al, 2003), NSAIDs (Hirohata et. al., 2005) effectively alleviate the 
symptoms of AD. Anti- inflammatory and oxidant properties may 
contribute to the memory enhancement effect (Dhingra et. al., 2004; 
Joshi, 2007). Oxygen free- radicals are implicated in the process of age-
related decline in cognitive performance may be responsible for the 
development of Alzheimer's disease in elderly persons (Sinclair et. al., 
1998; Berr, 2002; Butterfield and Lauderback, 2002). Moreover, 
chalcones have been shown to have potent antioxidative potential (Anto 
et. al., 1995). Recently, it has been reported that ACh in vitro, affecting 
the lymphocytic cholinergic system, attenuate the release of cytokines 
(Borovikova et. al., 2000). Overproduction of interleukin-1 within the 
brain is associated with Alzheimer disease and other neurological 
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disorders. AChE inhibitors (AChEIs) have a direct role in the inhibition 
of the release of inflammatory substances from specialized cells (Giunta 
et. al., 2004). Cyclooxygenase-2 and inducible nitric oxide synthase may 
be important in the prevention of memory deficits, one of the symptom 
related to AD (Patil et. al., 2003). Isoliquiritigenin has been reported to 
suppress cyclooxygenase-2, known to play an important role in 
inflammation (Takahashi et. al., 2000) and also blocked pro-
inflammatory cytokine-induced expression of VCAM-1, E- selectin 
through NF-kB signal disruption (Kwon et. al., 2007). Butein suppressed 
the nuclear factor-(NF)kB activation induced by various inflammatory 
agents and also the expression of cyclo-oxygenase (Pandey et. al., 2007). 
These factors may also contribute favorably to the memory enhancement 
effects of our chalcones. 
Conclusion 
The above behavioral and biochemical results suggest that chalcones 
(ISL and BUT) have the ability to improve or ameliorate memory 
dysfunction, in part, by facilitating the cholinergic transmission in brain. 
Moreover, our data indicate that chalcones may represent for the 
development of anti- amnesic. 
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CHAPTER 3 
MODULATION OF RESTRAINT-STRESS INDUCED 
NEUROBEHAVIORAL AND OXIDATIVE CHANGES IN 
ANTIOXIDANT ENZYMES BY CHALCONES 
Introduction 
Stress is any external stimulus that can disturb the physiological 
homeostasis and is known to elicit neurobehavioral alterations (Masood 
et. al., 2003; Masood et. al., 2004). The central nervous system plays a 
crucial role in regulation of stress responses and complex neurochemical 
pathways have been proposed (Carrasco et. al., 2003; Ray et. al, 1990). 
Stress induces changes in emotional behavior, which are closely related 
to anxiety like states (Ray et. al., 2004). Chronic stress exposure may 
lead to breakdown of adaptive mechanisms resulting in precipitation of 
several neuropsychiatric disorders (Kloet et. al., 2005). Although animal 
models have provided considerable information regarding the role of 
stress in development of psychopathology, important discrepancies still 
exist between experimental models and human psychopathology. 
Immobilization / restraint stress is an easy and convenient method 
to induce both psychological (escape reaction) and physical stress 
(muscle work) resulting in restricted mobility and aggression (Zaidi et. 
al., 2003; Singh et. al., 1993). Recently various stresses have been 
associated with enhanced free radical generation and altered antioxidants 
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enzymes (Giralt et. al, 1993; Liu et. al., 1994; Bian at. al, 1997; Seckin 
et. al., 1997; Gumuslu et. al., 2002). Free radicals are highly reactive 
moieties playing an important role in health and disease (Vendemiale et. 
al., 1999). The central nervous system is especially vulnerable to free 
radical damage because of brain's high oxygen consumption, abundant 
lipid content and relative paucity of antioxidant enzymes compared with 
other tissues (Halliwell and Gutteridge, 1985). Oxidative stress mediated 
cell damage in the pathophysiology of several CNS disorders has also 
been suggested (Ozcan et. al., 2004; Dietrich- Muszalaska et. al, 2005). 
Some ROS attack unsaturated fatty acids and cause oxidative damage to 
the cell membrane, therefore, oxidative stress is thought to be closely 
associated with aging, atherosclerosis, and carcinogenesis (Olinski et. 
al., 2002). 
Living cells protect themselves from oxidative damage by low 
molecular weight antioxidants including enzymatic and non-enzymatic 
antioxidant system (Halliwell and Cross, 1994). These cellular defenses 
reduce the steady- state concentrations of free radical species and repair 
oxidative cellular damage. The antioxidant defense system includes 
enzymes such as superoxide dismutase (SOD), catalase (CAT) and 
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glutathione peroxidase (GPx), which decrease the concentration of the 
most harmful oxidants. 
Superoxide anion is a free radical formed by one electron transfer to 
oxygen by so many spontaneous and enzymatic oxidants (Mishra & 
Fridovich, 1972; Marklund & Marklund, 1974). 
O2 + e" • 02° 
Principal sources of superoxide include electron leak during 
mitochondrial electron transport, perturbed mitochondrial metabolism 
and inflammatory responses to injury (Halliwell and Gutteridge, 1999). 
The major oxidative stress produced by superoxide is derived from its 
participation in peroxynitrite formation (Beckman et. al., 1990) and its 
involvement in the iron- catalyzed Haber-Weiss reaction (Liochev and 
Fridovich, 2002), causing hydrogen peroxide to be converted to 
hydroxy 1 radical. 
The antioxidant defense system includes enzymes such as: 
i) Superoxide dismutases are a family of antioxidant enzymes which are 
important in the catalytic decomposition of superoxide radical to 
hydrogen peroxide and oxygen. The benefit is that hydrogen peroxide is 
substantially less toxic than superoxide. 
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superoxide 
20;- + 2H* dismutase^ ^^^^ ^ ^^ 
ii) Catalase is a heme-containing enzyme that significantly catalyzes the 
decomposition of hydrogen peroxide into water and oxygen 
H2O2 • O2+H2O 
iii) Glutathione peroxidases are a family of antioxidant enzymes 
containing selenium which are important in the reduction of 
hydroperoxides, notably, those that result from lipid peroxidation. 
L00H+2GSH • LOH + H2O + GSSG 
(L = Lipid) 
Catalase plays an important role in the acquisition of tolerance to 
oxidative stress in the adaptive response of cells (Mates et. al., 1999). 
Catalase is the marker enzyme for peroxisomes and decomposes the 
H2O2 produced by the peroxisomal oxidases (deDuve and Baudhuin, 
1966), including the acyl- CoA oxidase of the lipid P- oxidation pathway 
(Lazrow and deDuve, 1976; van den Bosch et. al., 1992). Catalase is 
localized in the matrix of peroxisomes in mammalian cells, including 
human and rat hepatocytes (Yamamoto et. al., 1988), bovine and rat 
kidney cells (Zarr, 1992), rat neuronal cells (Zimatkin and Lindros, 
1996), and human neutrophils (Ballinger et. al., 1994). In addition, 
alterations in catalase subcellular localization have been observed with 
disease and stress conditions (Kamei et. al., 1993). Together with 
superoxide dismutases and the glutathione system, it forms the cellular 
defense mechanism against oxidative stress (Halliwell and Gutteridge, 
1989; Sies, 1991). Catalase is much more important for clearance of 
H2O2 in neurons, whereas the glutathione system plays a more significant 
role in glial cells (Dringen et. al., 1999). Catalase inhibition is associated 
with functional and metabolic disturbances of the CNS (Correa et. al., 
2001). 
The Glutathione-S-transferases (GSTs) are a family of 
multifunctional proteins that function both as important enzymes of 
detoxification and intracellular binding proteins (Boyer, 1989). GST is a 
non- selenium dependent glutathione peroxidase (Sies et. al., 1979). 
GSTs are thought to play a physiological role in initiating detoxification 
of potential alkylating agents including toxicants and other 
pharmacologically active compounds (Boyland and Chasseaud, 1969). 
Recent studies have shown that social phobia, depression, anxiety, 
and other neuro-psychiatric disorders result in signs of oxidative stress 
such as increased reactive oxygen generation and decreased antioxidant 
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capacity (Arranz et. al., 2007; Bouayed et. al., 2007). Recently, oxidative 
stress has been shown to be associated with anxiety in different 
behavioral models (Hovatta et. al., 2005; Gingrich, 2005; Berry et. al., 
2007). Oxidative stress has been reported to be associated with anxiety 
and cognitive defects in both human and animal models (Desrumaux et. 
al., 2005) 
As examined in our previous chapters, it has been shown that 
chalcones exhibited anxiolytic activity and memory enhancing effects. 
Hence, the present study was designed to investigate the effect of stress 
on neurobehavioral changes and the possible involvement of free 
radicals in these effects in rats. Restraint stress (RS) was used as an 
experimental stressor and elevated plus maze and open field behavior 
was used as a test of anxiety and levels of oxidative stress parameters 
were measured in terms of free radical scavenging enzyme activities like 
superoxide dismutase (SOD), catalase (CAT), and glutathione- S-
transferase (GST). 
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Materials and Methods 
Animals 
Experimentally adult male albino rats weighing 200-250 gram were 
used for the study. The animals were procured from the central animal 
house facility at Jawaharlal Nehru Medical College, Aligarh Muslim 
University, Aligarh. The rats were group housed in polypropylene cages 
(38x23x10 cm) under standard laboratory conditions with natural light 
and dark cycle and temperature of 24 ± 2° C. They were allowed free 
excess of dry rat diet and tap water ad libitum. All procedures described 
were reviewed and approved by the Institutional Animal Ethics 
Committee. 
Materials 
Chalcones were prepared by the methods described in "review section". 
Chalcones used in the study are: 2',4',4-trihydroxychalcone (ISL, 
isoliquiritigenin); 2',4',3,4 tetrahydroxychalcone (BUT, butein); 2', 2-
dihydroxychalcone (DHC); 2'- hydroxy- 3, 4- dimethoxychalcone 
(HDMC); 4', 4- dichlorochalcone (DCC); 4'-chloro, 4- methoxychalcone 
(CMC); 1,3-bis (4-chloro- phenyl) -3 (carboxymethylthio) propan- 1-
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one (DCCP) and 1- (4-chlorophenyl)- 3 ( 4-methoxyphenyl)-3-
(carboxymethylthio) propan- 1- one (CMCP). 
Methods 
Rats were randomly assigned to ten groups of six animals each. 
Chalcones were dissolved in DMSO- normal saline and the final 
concentration of DMSO in normal saline did not exceed 0.5%. The 
animals in experimental groups (eight groups) were administered with 
chalcones intraperitoneally (i.p) at the dose of 25 mg/kg body weight for 
seven consecutive days. The animals of control groups (restraint control 
and plain control) received a similar volume of dimethylsulfoxide 
(DMSO)-normal saline for seven consecutive days. 
Restraint stress was accompanied by placing individual animals in 
wire mesh cages of their size attached to a wooden board (Hasan and 
AH, 1980). The rats were deprived of food and water during stress 
exposure. On the seventh day, immediately after the treatments all the 
animals except of plain control group were subjected to 6 hour restraint 
stress. Plain controls were handled at the same time as the stressed 
animals and were placed in individual cages during the corresponding 
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time. After restraint stress procedure, the rats were exposed to behavioral 
tests by using elevated plus maze and open field behavior. 
The animals of both the control (restraint control and plain 
control) and experimental groups were then sacrificed by cervical 
dislocation. Their brains along with spinal cords were removed quickly 
and placed on the petridish, over ice. The brains were dissected out into 
three regions-cerebrum, cerebellum and brain stem. The brain parts and 
spinal cord were rinsed with ice cold physiological saline solution. The 
brain parts and spinal cords were then subjected for the assay of 
superoxide dismutase (SOD), catalase (CAT), Glutathione-S-Transferase 
(GST). 
Methods 
Elevated plus maze 
The apparatus consisted of a plus-shaped maze elevated 45 cm above the 
ground level with two open (10 x 50 x 10 cm) and two closed arms 
(Pellow et. al., 1985). There was a central square arena (10 x 10 cm) at 
the junction of open and closed arms where animal was placed at the 
start of the experiment. The test rat was placed on the center of the maze 
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facing an open arm and the time spent in open and closed arms was 
measured during a 5 minutes observation. 
Open field behavior 
An open field was similar to that of Holland and Gupta (1966). It 
consisted of a wooden circular open arena (82 cm diameter) surrounded 
by a wall (31 cm high). The wooden floor was marked with three centric 
circles, which were divided into segments by lines radiating from the 
center. Two types of stimuli were presented to the animals: white noise 
78 dB, Ref. intensity (0.0002 dyn/cm^) was presented and light (165 foot 
candle). Immediately after the stress procedure each animal was placed 
singly in one comer of the open field and (a) latency, (b) ambulation and 
(c) rearing was observed during a 5-min exposure period for both naive 
and pretreated animals. 
Estimation of Superoxide Dismutase (SOD) 
SOD activity was measured by the method of Marklund and Marklund 
(1974). 
Principle: 
SOD principle depends upon auto- oxidation of pyrogallol. 
auto-oxidation 
Pyrogallol + O2 — • oxidation product + O2 (i) 
2 02+2Hr ^2£ • O2 + H2O2 (ii) 
Procedure: 
Different CNS parts (cleaned with normal saline) were homogenized in 
chilled 0.15 M KCl (10 % w/v). Homogenate was centrifuged in cold at 
10,000 rpm for 15 min. A 0.05 ml of clear supernatant was added to 2.85 
ml 0.05 M Tris-succinate buffer (pH 8.2), mixed well and incubated at 
25° for 20 min. The reaction was started by adding 0.1 ml of 8 mM 
pyrogallol solution. The contents were shaken well and change in O.D 
per min was immediately recorded for 3 min at 420 nm. A reference set, 
consisting of 0.05 ml of DDW instead of the sample solution (clear 
supernatant) was also run simultaneously. 
Calculation: 
SOD = (A / min.ref - A / min. sample) x 30 units /10 mg tissue 
(A/min.ref 12 x 0.05 x 1) 
where, 
A / min.ref = change in O.D per minute in reference set. 
A / min. sample = change in O.D per minute in sample set. 
Activity Unit: One unit of the enzyme is defined as the amount of 
enzyme, which causes a 50% inhibition of pyrogallol autooxidation 
under assay conditions. 
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Estimation of Catalase: 
The catalase activity was determined by the method of Aebi et. al. 
(1984). 
Principle: 
The enzyme Catalase catalyze the following reaction 
2H2O2 ^^^^'^'^ , 2H2O2 + O2 
ROOH + AH2 ^^ ^^ '^ ^^  • H2O + ROH + A 
The ultraviolet absorption of H2O2 solution can be easily measured 
between 230-250 nm by monitoring the consumption of potassium 
permanganate by H2O2. On decomposition of H2O2 with catalase, there is 
decrease in the absorbance. From this decrease the catalase activity can 
be calculated. 
Chemicals and Reagents: 
Potassium dihydrogen phosphate. 
Disodium hydrogen phosphate. 
30mM H2O2. 
Procedure: 
Different CNS parts were homogenized (10 % w/v) in 50 mM phosphate 
buffer (pH 7.0) and centrifuged at 12000 x g for 30 minutes in cold. 
Supernatant was used for measuring the catalase activity. To 3 ml assay 
mixture (containing 30 mM H2O2 in 50 mM phosphate buffer, pH 7.0), a 
required amount of enzyme source was added and continuous 
absorbance was recorded at 240 nm against blank containing all 
reagents, except H2O2. Protein content in enzyme was also determined 
by the method of Lowry et. al. (1951). 
Calculation: 
The enzyme activity was calculated on the basis of molar extinction 
coefficient of H2O2 (40cm^), and specific activity of enzyme was 
expressed as [iM of H2O2 decomposed / min/ mg protein. 
Estimation of Glutathione-S- Transferase (GST) 
Glutathione-S- Transferase (GST) was assayed by the method of Habig 
et. al. (1974). 
Principle: 
The enzyme activity is measured by following the increase of 
absorbance at 340 nm of CDNB-GSH conjugate generated as a result of 
catalysis between glutathione and l-chloro-2, 4-dinitrobenzene (CDNB). 
GST 
CDNB + GSH • CDNB- GSH (conjugate product) 
Procedure: 
In 0.1 ml of cytosol fraction (supernatant) (10 % w/v in 0.15M KCl), 2.7 
ml of 1.0 mM glutathione solution (prepared in 0.2 M phosphate buffer), 
and 0.2 ml CDNB (1.0 mM) substrate prepared in acetone were mixed. 
The change in absorbance at 340 nm was recorded at room temperature 
after 15 sec for 3 min against a blank containing 0.1 ml of DDW in place 
of supernatant. Protein in enzyme source was also determined by the 
method of Lowry et. al. (1951). 
Calculation: 
O.D X 6.25 
GST activity =—z, -.—;—- U/mg/min/protein 
Cone of protein (mg) ° ^ 
The values were calculated on the basis of molar extinction coefficient 
of CDNB (9.6 X 10^  M"'cm"') and specific activity of enzyme was 
expressed in nmol of GSH- CDNB conjugate formed per minute per mg 
protein. 
Statistical analysis: 
All the data were expressed as the mean ± SEM of six animals. 
Statistical analysis was performed using one way ANOVA followed by 
post hoc analysis (Tukey) using computerized software SPSS (Version 
11.0). The level of significance was set at P< 0.05 or less. 
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Results 
Effects of stress and chalcones on the elevated plus maze in rats 
The data depicted in Table 6 represents the effect of 6 hrs continuous 
restraint stress and the protective effects of chalcones on the elevated 
plus maze. 
Analysis of elevated plus maze revealed that time spent on closed 
arms and open arms were significantly different between restraint stress 
and no stress groups, [F (i, io)= 51.199, P < 0.001] and [F (i^  io)= 64.312, 
P < 0.001] respectively (one way ANOVA). Pretreatment of chalcones 
(25mg/kg) reversed the restraint stress- induced changes in elevated plus 
maze activity and both, the time spent on closed arms [F (2, is) = 5.704, 
P < 0.014] was lower and time spent on open arms [F (i^  io)= 11.102, P < 
0.008] was markedly greater than those in the vehicle + restraint stress. 
Effects of stress and chalcones on the open field behavior in rats 
The data depicted in Table 7 represents the effect of 6 hrs continuous 
restraint stress and the protective effects of chalcones on the open field 
behavior. 
Analysis of open field data revealed that (a) latency of entry, (b) 
ambulations and (c) rearings were significantly different between 
restraint stress and no stress groups [F (i^  lo )= 66.055 , P < 0.001 for 
latency; F(i^  io)= 15.483, P < 0.003 for ambulations; and F(i, io)= 25.557, 
P < 0.001 for rearing, respectively; one way ANOVA]. Restraint stress 
(6h) induced a marked increase in the latency (s) of entry into the open 
field, whereas ambulation and rearing were reduced. Pretreatment of 
chalcones (25mg/ kg) reversed the restraint stress- induced effects on the 
open field behavior. Chalcones caused a significant reversal in latency [F 
(4,25) = 8.796, P < 0.001]; ambulations [F (2, isr 8-375, P < 0.004]; and 
rearing [F (2, i5)= 8.521, P < 0.003] as compared to restraint stress control. 
Effects of stress and chalcones on the levels of SOD 
The data depicted in Table 8 represents the levels of SOD in the different 
regions of the brain and spinal cord of stress treated rats following 6 hrs 
continuous restraint stress and the protective effects of chalcones against 
oxidative stress. 
Analysis of brain biochemical data showed that the difference 
between the animals of plain control and restraint stress control groups 
was significant in cerebrum [F (i. io)= 40.248, P < 0.001], cerebellum 
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[F (1,10)= 19.347, P < 0.001], brain stem [F (,, jo)= 15.895, P < 0.003], and 
spinal cord [F (i, io)= 19.885, p< 0.001]. Pretreatment with chalcones 
showed a remarkable protection and significantly increased the SOD 
levels in cerebrum [F (4,25)= 11.217, P < 0.001], cerebellum [F (3^  20)= 
8.558, P < 0.001], and non significant increase in brain stem and spinal 
cord in comparison to restraint stress control group. 
Effects of stress and chalcones on the levels of CAT 
The data depicted in Table 9 represents the levels of CAT in the different 
regions of the brain and spinal cord of stress treated rats following 6 hrs 
continuous restraint stress and the protective effects of chalcones against 
oxidative stress. 
Analysis of brain biochemical data showed that the difference 
between the animals of plain control and restraint stress control groups 
was significant in cerebrum [F (i, io)= 24.664, P< 0.001], cerebellum 
[F (,, ,0)= 35.240, P < 0.001], brain stem [F (,, ,o)= 34.249, P< 0.001], and 
spinal cord [F (i, io)= 5.796, P< 0.037]. Pretreatment with chalcones 
significantly increased the CAT levels in cerebrum [F (2,15)= 10.215, P < 
0.001], cerebellum [F (2, ,5)= 10.190, P < 0.002], brain stem [F (2, ,5)= 
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49.599, P < 0.001] and non significant increase in spinal cord in 
comparison to restraint stress control group. 
Effects of stress and chalcones on the levels of GST 
The data depicted in Table 10 represents the levels of GST in the 
different regions of the brain and spinal cord of stress treated rats 
following 6 hrs continuous restraint stress and the protective effects of 
chalcones against oxidative stress. 
Analysis of brain biochemical data showed that the difference 
between the animals of plain control and restraint stress control groups 
was significant in cerebrum [F (i_ io)= 20.742, P< 0.001], cerebellum 
[F (1,10)= 97.766, P < 0 ^ 1 ] , spinal cord [F (i, ,o) = 9.894, P < 0.01], and 
non significant in brain stem. Pretreatment with chalcones significantly 
increased the GST levels in cerebrum [F (2, 15)= 9.625, P < 0.002], 
cerebellum [F (2,15)== 24.289, P < 0.001], and non significant increase in 
brain stem and spinal cord in comparison to restraint stress control 
group. 
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Table- 6. Effects of stress and chalcones on Elevated plus maze behavior 
test. Data are expressed as means ± SEM. 
Groups 
Time spent (in seconds) 
Enclosed arms Open arms 
Plain control 
Rats (6) 
Stress treated 
rats (6) 
Chalcones + 
stress treated 
rats 
ISL (6) 
BUT (6) 
DHC (6) 
HDMC (6) 
DCC (6) 
DCCP (6) 
CMC (6) 
CMCP (6) 
233.3333 ±3.85 
297.8333 ±9.67 abc 
253.0000 ±5.73''' 
264.1667±12.64^ 
273.3333± 5.86 
284.3333 ± 5.30 
296.1667 ±6.40 
296.3333 ±7.18 
291.8333 ±4.25 
294.6667 ± 4.55 
21.8333 ± 1.07 
10.6667 ±0.88 abc 
16.0000 ±0.85''' 
13.5000 ±1.17 
12.1667 ±0.94 
11.3333 ±0.76 
10.3333 ±0.84 
10.5000 ±0.56 
10.8333 ±0.91' 
11.0000 ±0.73 
Figures in parenthesis indicate number of rats. '"'^  Indicate 
statistical significance in comparison to vehicle treated group at P< 0.05, 
P < 0.01, P < 0.001, respectively with ANOVA followed by post hoc Tukey 
test. 
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Table- 7. Effects of stress and chalcones on Open field behavior test. 
Data are expressed as mean ± SEM. 
Groups Ambulation Latency Rearing 
Plain control 
Rats (6) 44.1667 ±3.03 
Stress treated 
Rats (6) 30.6667 ±1.63' 
Chalcones + 
stress treated 
rats 
ISL (6) 40.5000 ±1.72'^ 
BUT (6) 39.333314.52^" 
DHC (6) 31.5000±1.80 
HDMC(6) 31.6667±1.82 
DCC (6) 31.5000 ±1.83 
DCCP(6) 31.5000 ±2.71 
CMC (6) 35.0000 ±1.95 
CMCP (6) 33.8333±2.02 
15.1667± 1.05 12.3333 ± 1.05 
35.1667 ±2.23"''' 5.5000 ± 0.76"'^ ' 
23.8333 ± 1.08"'" 9.6667 ± 0.6 P 
25.8333 ±1.84'"'= 8.5000 ±0.76 
29.0000 ±1.12^ 5.8333 ±0.94 
28.6667 ± 0.84^ 6.3333 ±0.76 
32.6667± 8.40 5.0000 ±0.58 
32.3333 ±0.71 5.6667 ±0.56 
29.5555 ±0.76 9.8333 ±1.07 
2 9.5555 ±1.61 8.3333 ±0.88 
Figures in parenthesis indicate number of rats. ^' " Indicate statistical 
significance in comparison to vehicle treated group at P< 0.05, P < 0.01, P < 
0.001, respectively with ANOVA followed by post hoc Tukey test. 
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Table- 8. Effects of stress and chalcones on the levels of SOD in the 
cerebrum, cerebellum, brain stem and spinal cord of stress 
treated rats. Data are expressed as mean ± SEM. 
SOD U/ mg of protein 
Groups Cerebrum Cerebellum Brain stem Spinal cord 
a be 
Plain control 4.3063±6.66 3.5060±0.15 4.4142±0.81 4.4150±0.90 
Rats (6) 
Stress treated 3.5727±9.45'''" 2.5625±0.15'^' 3.7443±0.44''"= 3.7100±0.13'' 
rats (6) 
Chalcones + 
stress treated 
rats 
ISL (6) 4.1815±7.04'''''''3.3515±0.12''"'''='4.0633±0.59 4.0077±0.66 
BUT (6) 4.0668±5.10'''''' 3.1803±0.12''''' 3.9965±0.58 3.9508±0.80 
DHC (6) 4.0262±6.22'' 3.1662±0.67'' 3.8955±0.69 3.8767±0.91 
HDMC(6) 3.954±4.67'' 3.0267±0.39 3.8777±0.11 3.8100±0.85 
DCC (6) 3.6517±6.69 2.9828±0.64 3.8517±0.9I 3.7267±0.18 
DCMP (6) 3.6383±0.11 2.6700±0.16 3.8467±0.62 3.8228±0.65 
CMC (6) 3.6743±0.]2 2.6908±0.16 3.8043±0.78 3.8012±0.90 
CMCP (6) 3.6414±0.14 2.6428±0.17 3.8733±0.69 3.673 liO.Sl 
Figures in parenthesis indicate number of rats. *^  p < 0.05, ^^ p< 0.01, 
'^^ p< 0.001, where a,b,c as compared to non stressed control rats , 
where a, b, c stressed treated rats. 
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Table- 9. Effects of chalcones and stress on the levels of CAT in the 
cerebrum, cerebellum, brain stem and spinal cord of stress 
treated rats. The data are expressed as mean ± SEM. 
CAT U/ mg of protein 
Groups Cerebrum Cerebellum Brain stem Spinal cord 
Plain control 
Rats (6) 
Stress treated 
rats alone (6) 
Chalcone + 
stress treated 
rats (6) 
ISL (6) 
BUT (6) 
DHC (6) 
HDMC (6) 
DCC (6) 
DCMP (6) 
CMC (6) 
CMCP (6) 
2.3495±0.05 1.7550±0.06 1.5557±0.05 1.2443±0.04 
1.8733±0.08''' 1.1983±0.07""^ 1.1750*0.04''' 1.1217±0.02' 
2.3200±0.04*'''' 1.6433±0.08''''' 1.4983±0.02'' 
1.8918±0.08 l.lOOOiO.ll 1.1767±0.05 
2.2337±0.08'' 1.6233±0.08'' 1.1717 ±0.04 
1.8967±0.06 1.1933±0.09 1.1633±0.05 1.1 
1.9990±0.06 1.1833±0.04 1.1817±0.02 
2.1695±0.07 1.1800±0.05 1.3683±0.04 
1.8850±0.07 1.1500±0.03 1.1483±0.03 
1.9403±0.09 1.1830±0.06 1.1500±0.04 
.2050±0.04 
.1167±0.02 
.1517±0.02 
367±0.02 
1.1317±0.03 
1.1367±0.01 
I.1317±0.01 
1.1433±0.01 
Figures in parenthesis indicate number of rats. ^^' p < 0.05, ^^' p< 0.01, 
p< 0.001, where a,b,c as compared to non stressed control rats , 
where a, b, c stressed treated rats. 
cc 
128 
Table- 10. Effects of stress and chalcones on the levels of GST in 
the cerebrum, cerebellum, brain stem and spinal cord of 
stress treated rats. The data are expressed as mean ± SEM. 
GST U/ mg of protein 
Groups Cerebrum Cerebellum Brain stem Spinal cord 
Plain 165.1550±4.66 146.7517±2.51 133.8589±5.89 148.3233±7.52 
control 
rats (6) 
Stress 130.6000±5.98^'' 111.8793±2.47''^ 110.8233±5.52 120.4417±4.69' 
treated rats 
alone (6) 
Chalcone + 
stress treated 
rats (6) 
ISL (6) 164.5933±4.63''''' 138.2843 ±4.77'''''l29.6957±6.81 135.9277±5.86 
BUT (6) 111.8967±7.99 103.9483±6.41 91.2200±16.48 117.9417±3.07 
DHC (6) 160.1559±7.0r' 140.2112±1.93''^''^'122.9437±7.17 129.8860±5.42 
HDMC(6) 117.5200±4.49 101.2550±9.25 107.9417±7.63 119.8650±2.00 
DCC (6) 123.1300±6.99 112.8150±3.69 108.7867±5.39 117.6083±4.77 
DCMP(6) 125.0450±4.21 111.8150±4.42 107.7461±4.69 124.2798±5.69 
CMC (6) 132.8946±5.86 109.3800±5.64 113.4620±2.89 120.4533±7.00 
CMCP(6) 133.2945±9.16 119.2015±3.96 110.6350±5.59 25.9417±2.64 
Figures in parenthesis indicate number of rats. *'*' p < 0.05, ^^' p< 0.01, 
""^ p< 0.001, where a,b,c as compared to non stressed control rats , 
where a , b, c stressed treated rats. 
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Discussion 
Exposure to stressors can influence the neurobehavioral profile of an 
organism and can participate an anxiety-like syndrome and behavioral 
factors such as emotionality are important predictors of stress 
susceptibility (Henke et. al., 1991; Handley and Blane, 1993). In recent 
years, oxidative stress has been implicated in pathophysiology of several 
human diseases including disorders of the central nervous system (Gulati 
et. al., 2005). However the role of free radicals in stress induced 
behavioral changes is not well documented and thus the present study 
explored the possible involvement of these toxic species in acute 
behavioral response to stress in rats. Further, stress (emotional and 
environmental) is known to be a key factor in the genesis of neurological 
and psychiatric illness (Chrouses and Gold, 1992). 
Experimental pharmacological studies have shown that anti-anxiety 
agents attenuate a variety of autonomic, visceral and immunological 
responses to stress. Both elevated plus maze and open field tests have 
been used very effectively to test the neurobehavioral profile of animals 
under the influence of anxiogenic/ anxiolytic agents (Carli et. al., 1989; 
Bhattacharya and Satyan, 1997). There are studies to indicate that 
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"stress" is one of the factors leading to cognitive deficits, anxiety and 
peptic ulcers. In the elevated plus maze test, increase in the time spent on 
open arms and decrease in the time spent on closed arms are indices of 
anxiolytic activity. Similarly, our study showed reversal of stress-
induced changes in the elevated plus maze and open field behavior. In 
our study chalcones decreased the time spent on closed arms and 
increased the time spent on open arms. However in the open field, 
pretreatment with chalcones significantly reduced the entry latency, and 
increased the rearing behavior with significantly increased ambulations. 
In order to correlate the observed behavioral suppression with 
changes in the levels of brain oxidative stress markers, the levels of 
antioxidant enzymes such as SOD, CAT, and GST are also estimated. 
Our results also showed that response of antioxidant defense system by 
chalcones to stress differs for each tissue. The activities of superoxide 
dismutase (SOD), catalase (CAT), and glutathione- S-transferase (GST) 
are decreased following restraint stress. Restraint / immobilization stress 
is a well-known method for the production of chronic stress (Kvetnansky 
and Mikulaj, 1970). This study was of interest as human beings are 
exposed to both emotional and physical stress daily in their life (Pylman 
et. ai., 2002). 
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Because of the brain's large amount of oxidizable unsaturated 
fatty acids, which are especially sensitive to free radical-induced lipid 
peroxidation, and relatively low activities of antioxidative enzymes 
including SOD, GSH-Px, CAT, it is very vulnerable to reactive oxygen 
species (Anderson et. al., 1985). The activities of SOD, GST and 
catalase were decreased in stress treated rats as compared to plain (no 
stress) control group. Various antioxidants and free radical scavenging 
enzyme system exists in the cell to protect it against the damaging 
effects of free radicals produced as a part of normal cell respiration and 
other cellular processes (Kaplovitz et. al., 1985). Free radicals and free 
radical reactions are involved in the etiology and development of a 
number of diseases, especially those are life limiting (Pryor, 1988). 
Superoxide dismutase, catalase and GSH play an important role in the 
detoxification of oxyradicals and their products (Mannervick and 
Danielson, 1988). In order to maintain stability of a living organism it 
is necessary to reach a balance between the oxidative actions and the 
anti-oxidant defense i.e. anti-FRS. Enhanced free radical production with 
lipid peroxidation has been observed during stress (Clemens, 1991). The 
decreased activities of SOD, GST and catalase as observed in the present 
study may be responsible for the elevated lipid peroxidation as 
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represented by increased TEARS levels in stress (Chaudiere and Ferrari-
lUiou, 1999). Increase in lipid peroxidation is also observed following 
restraint stress and is also discussed in next chapter of our study. Thus, 
restraint stress is found capable of generating oxidative stress in rats. 
Oxidative stress inhibited SOD activity in various regions of brain 
in rats (Shukla et. al., 1987), which is consistent with the results 
observed for our study. The decrease in the SOD activity may have 
occured as a result of oxidative modification of the polypeptide chains of 
the enzymes during restraint stress (Davydov and Shvets, 2003). A 
remarkable decrease in SOD activity after restraint stress detected in our 
work can thus be responsible for the formation of superoxide radical 
during stress. Pretreatment with chalcones shows a remarkable increase 
in SOD activity in comparison to stress treated rats but only ISL, BUT, 
DHC and HDMC exhibited this potential. Isoliquiritigenin has been 
reported to be an inhibitor of xanthine oxidase (Kong et. al., 2000), so it 
may prevent the production of superoxide and hence the other 
components of ROS. Butein has also been reported to be an inhibitor of 
xanthine oxidase (Cheng et. al., 1998). Stress directly or indirectly 
through the inhibition of SOD increase lipid peroxidation in cell 
membrane and this produces damage to associated physiological 
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functions leading to CNS dysfunction (Fridovich, 1981). Thus, present 
observation clearly shows that the administration of chalcones increase 
the levels of SOD and inhibit the production of superoxide radicals in 
various regions of brain and spinal cord following restraint stress and 
thus may be responsible for inhibiting the lipid peroxidation. 
GST has been reported to play an important role in the 
detoxification of potential toxicants through their conjugation and 
biotransformation (Boyland and Chasseaud, 1969). Our study shows a 
decrease in the GST activity following restraint stress. Intraperitoneal 
treatment of chalcones i.e. ISL and DHC increased the GST activity. 
The exciting asppct of this study was the inhibition of GST by the two 
chalcones, BUT and HDMC. The inhibitory effects of plant polyphenols 
such as tannic acid, ellagic acid, ferrulic acid, caffeic acid, silybin, 
quercetin, curcumin and chlorogenic acid against GST activity have 
been reported (Das et. al., 1984). Chalcones react readily with 
glutathione (GSH) (Dimmock et. al., 1998; Christensen et. al., 1999), 
and the depletion of GSH is accompanied by a concurrent increase in 
oxidized glutathione (GSSG). Oxidation of GSH to GSSG may be 
mediated by phenoxy radicals produced from hydroxychalcones 
(Sabzevari et. al., 2004). Our resuhs showed that BUT and HDMC 
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caused a slight decrease in the GST levels. Many investigators have 
suggested that GST offers protection by conjugation with GSH (Jakoby, 
1988) and the depletion of GSH contents also lower the GST activity 
(Yu, 1994). The decrease in GSH by chalcones could be due to the fact 
that the rate limiting enzyme in GSH synthesis (y-glutamylcysteine 
synthetase) is subjected to an inhibitory feedback mechanism (Alcaraz 
et. al., 2004). Therefore, it is concievable these chalcones first reacted 
with the reduced glutathione (GSH) to give the GSH conjugates of the 
chalcones, which actually inhibited GST. Thus, overall inhibition of 
GST by chalcones depends on the rate of GSH conjugation which is 
affected by the position of substituents. The inhibitory activity of GS-
BUT is slightly more than the GS-HDMC and hence the conjugate 
makes a major contribution to the activity. 
In the present study CAT activity decreased following restraint 
stress which is consistent with the earlier study of Yargicoglu (2004) 
who found a decrease in catalase activity. The decline in CAT can be 
attributed to ineffective scavenging of H2O2 levels, which can react with 
o o 
O2 ' to give OH radical and thus increased lipid peroxidation. Catalase 
requires NADPH for its regeneration from its active form (Packer et. al., 
1997; Arivazghan et. al., 2000). SOD and CAT both are scavenger 
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enzymes that are reported to work together to eliminate toxic free 
radicals (Kyle et. al., 1987). Administration of ISL and DHC thus 
contribute to antioxidant defense by significantly increasing CAT 
activity in the stressed control group and thus enhance the capability to 
detoxify the stress-induced oxidative damage. While the other chalcones 
(BUT and HDMC) showed no activity toward CAT which might be due 
to the inhibition of GST activity. 
Both enzymatic in vivo SOD, GST, catalase (Beers and Sizer, 
1952; Marklund and Marklund, 1974; Habig et. al., 1974) and non-
enzymatic (vitamin A, E and C) natural antioxidant defense mechanism 
exists. However, antioxidant mechanism fails either due to excessive 
production of free radicals or decreased activities of scavenging 
enzymes, or both causing lipid peroxidation. Hydroxychalcones have 
protective effects on free radical- induced cell damage (Sogawa and 
Yasunori, 1994). Exogenous supplementation of antioxidants has been 
reported to exert protective effects in various pathological status in 
which free radicals are involved (Vendemiale et. al., 1999). 
Immobilization stress is a good model for investigating the alterations 
occurring in oxidant-antioxidant balance in tissues of rats. 
Pretreatment of chalcones significantly found to attenuate the stress 
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induced biochemical and behavioral alterations in rats. The fact that 
treatment with antioxidants attenuated both stress induced behavioral 
suppression as well as brain oxidative stress clearly suggest that 
alteration of prooxidant-antioxidant balance might be associated to the 
stress induced neurobehavioral changes. The interesting aspect of this 
study is the differential pattern of activity of chalcones. Only hydroxy 
and methoxy substituted chalcones are active while rest of the chalcones 
are inactive. Thus, chalcones may help provide protection against 
restraint stress- induced oxidative damage by contributing along with 
antioxidant defense system. A potential role of the antioxidant chalcone 
in modulating oxidative stress thus generated may determine their 
clinical usefulness. 
Conclusion 
The fact that treatment with antioxidants attenuated both stress-induced 
behavioral suppression as well as brain oxidative stress in a consistent 
manner clearly suggest that alteration of prooxidant- antioxidant balance 
might be associated to the stress-induced behavioral changes. Hydroxy 
and methoxy chalcones were found to be more effective. Thus chalcones 
could have the potential for scavenging free radical generated in the 
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brain tissues in order to reduce oxidative stress and may play an 
important role in free radical generated diseases. 
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CHAPTER 4 
PROTECTIVE EFFECTS OF CHALCONES AGAINST 
OXIDATIVE DAMAGE TO LIPIDS, PROTEINS AND 
DNA INDUCED BY RESTRAINT STRESS 
Introduction 
Stress, both psychological and physical, is common, and the study of 
stress is attracting increasing attention. Circulatory diseases and 
ulceration of the digestive tract are proven to be related to stress. The 
relationship between stress and aging has been noticed for a long time; a 
stress theory of aging was proposed in the 1950s (Pare, 1965) and the 
glucocorticoid hypothesis of brain aging was proposed in the late 1970s 
(Landfield and Eldridge, 1994). There is strong evidence suggesting that, 
in the brain, high levels of glucocorticoids (GCs), may produce 
deleterious effects, including damage to neurons (Mcintosh and 
Sapolsky, 1996). These events have been linked to an increased 
generation of reactive oxygen species (ROS). Oxidative damage to 
cellular molecules such as lipids, proteins, and DNA, is a major 
contributor of aging and the degenerative disease to aging such as brain 
dysfunction, cancer, cardiovascular diseases, and immune system 
decline (Ames, 1993). 
Nucleic acids play an important role in protein synthesis. In the 
brain the nucleic acids provide for the storage and transmission of 
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genetic as well as translation of this information leading to the synthesis 
of cellular proteins in the brain (White et. al., 1978). The average 
amount of DNA per diploid nucleus is constant for all normal tissues of 
the body including brain tissues (Haller and Elliot, 1954), measurement 
of DNA quantity therefore, provides a convenience method for 
estimating total cell population in entire brain or its various regions. The 
amount of DNA in white matter approx. equals to that in cortex, and 
regional differences in the amount of brain DNA are relatively small 
(Haller and Elliot, 1957). However, only cerebellum has exceptionally 
high amounts of DNA (May & Grenell, 1959). Oxidative damage to 
DNA usually involves damage to single bases. It is estimated that atleast 
35 different base modifications are formed in reactions with reactive 
oxygen species (ROS) (McBride et. al., 1991). 
Protein, one of the important biochemical components in the 
vertebrate brain, constitutes 40% of the dry weight (McLlwain & 
Bachalard, 1971). The specific neuronal functions such as conduction of 
action potentials, and synaptic transmission are extensively mediated by 
protein (Block, 1978). ROS also catalyze oxidative modification of 
proteins including enzymes, rendering them degradable by cytosolic 
proteases further affecting cell function (Stadtman, 1992). 
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Lipid peroxidation is a free radical chain process leading to the 
deterioration of lipid and lipid-containing materials. Especially the group 
of polyunsaturated fatty acids (PUFAs) is highly susceptible to reactions 
o 
with free radicals. In lipid peroxidation, one substrate radical (R) may 
result in the formation of many equivalent of lipid peroxides (LOOH) 
(deZwart, 1999). 
2+ 
Fe 
LH ^ > L ^ * LOO ^^^ » LOOH *- LO + OH 
R RH O2 LH 
-*- L LOO etc 
°2 
Since lipid peroxidation is a self propagating reaction, it can result 
in significant tissue damage if it is not controlled by antioxidants 
(Mylonas and Kouretas, 1999). Lipid peroxidation end products e.g., 
toxic aldehydes like, MDA and 4-hydroxynoneal causes damage to 
proteins and DNA for instance, by forming DNA base adducts (El-
Ghissassi et. al., 1995). Lipid peroxidation and free radicals are major 
factors in coronary artery diseases, stroke, ischemic dementia, and 
various other atherosclerotic disorders (Knight, 1995; Gutteridge, 1993). 
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Membrane lipids are highly susceptible to lipid peroxidation and it can 
damage the cell membranes and interfere with the activity of membrane-
associated enzymes. Furthermore, it induces damage in membrane 
fluidity and potential and in its permeability to ions (Sandhir et. al, 
1994). Moreover the localization of major antioxidant defense systems 
in glial cells rather than in neurons may cause the nerve cells to be more 
susceptible to oxidants present in the brain (Bondy, 1992). 
The nervous system is extremely sensitive to peroxidative 
damage, since it is rich in oxidizable substrates, has a high oxygen 
tension and low antioxidant capacity (Anderson, 1985; Metodiewa and 
Koska, 2000). Reactive oxygen species (ROS) and free radicals induce 
membrane damage, DNA base oxidation, DNA strand breaks, 
chromosomal aberrations, and protein alterations (Olinski et. al., 2002). 
Recently various stresses have been associated with enhanced free 
radical generation causing oxidative stress (Siers, 1985). Immobilization 
stress increases lipid peroxidation of both plasma and the cerebral 
cortex; decreases protection in the plasma against iron-induced oxidation 
and free radical scavenging; decreases membrane fluidity, Na^ f¥^-
ATPase activity; and increases brain monoamine levels and their 
metabolic rate (Liu et. al., 1994; Liu and Mori, 1994). 
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Damage induced by ROS in cells is normally held in check by 
natural enzymatic and non-enzymatic antioxidant systems (Halliwell and 
Cross, 1994). These cellular defenses reduce the steady-state 
concentrations of free radical species and repair oxidative cellular 
damage. Exposure to stress situations has been proposed to impair 
antioxidant defenses, leading to oxidative damage by changing the 
balance between oxidant and antioxidant factors (Mcintosh et. al., 1998 
a; Mcintosh et. al., 1998 b). Oxidative damage is induced in rats by 
immobilization stress and that antioxidant administration effectively 
inhibits the stress-induced oxidative damage (Zaidi, 2000). Besides the 
endogenous antioxidants, there is therefore, increasing interest in the 
protective and preventive function of foods and their constituents against 
oxidative stress caused by ROS. It has been suggested that antioxidant 
administration to rats would reduce the physiological response to stress. 
The antioxidants P-carotene, vitamin E, and GSH have attracted 
attention (Hasegawa, 1993; Armario, 1990). The purpose of this study 
was to determine if chalcones provide a neuroprotective effect against 
immobilization stress induced oxidative damage to lipids, proteins, and 
DNA. 
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Materials and Methods 
Animals 
Adult male albino rats weighing 200-250 gram were used for the study. 
The animals were procured from the central animal house facility at 
Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh. 
The rats were group housed in polypropylene cages (38x23x10 cm) 
under standard laboratory conditions with natural light and dark cycle. 
They were allowed free excess of dry rat diet and tap water ad libitum. 
All the procedures described were reviewed and approved by the 
Institutional Animal Ethics Committee. 
Materials 
Chalcones were prepared by the methods described in "review section". 
Chalcones used in the study were: 2',4',4-trihydroxychalcone (ISL, 
isoliquiritigenin); 2',4',3,4 tetrahydroxychalcone (BUT, butein); 2', 2-
dihydroxychalcone (DHC); 2'- hydroxy-3, 4-dimethoxychalcone 
(HDMC); 4', 4-dichlorochalcone (DCC); 4'-chloro, 4-methoxy- chalcone 
(CMC); 1,3-bis (4-chlorophenyl)-3 (carboxymethylthio) propan- 1-one 
(DCCP) and 1-(4-chlorophenyl)-3 (4-methoxyphenyl)-3-(carboxy-
methylthio) propan- I- one (CMCP). 
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Methods 
Sixty rats were used and they were randomly assigned to ten groups of 
six animals each. Chalcones were dissolved in DMSO-normal saline and 
the final concentration of DMSO in normal saline did not exceed 0.5%. 
The animals in experimental groups (eight groups) were administered 
with chalcones intraperitoneally at the dose of 25 mg/kg body weight for 
seven consecutive days. The animals of control groups (restraint control 
and plain control) received a similar volume of dimethylsulfoxide 
(DMSO)-normal saline intraperitoneally for seven consecutive days. 
Restraint stress was accompanied by placing individual animals in 
wire mesh cages of their size attached to a wooden board (Hasan and 
Ali, 1980). The rats were deprived of food and water during stress 
exposure. On the seventh day immediately after the treatments all the 
animals except of plain control group were subjected to 6 hour restraint 
stress. Plain controls were handled at the same time as the stressed 
animals and were placed in individual cages during the corresponding 
time. 
The animals were sacrificed 30 minutes after the termination of 
experiment by cervical dislocation. Their brains along with spinal cords 
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were removed quickly and placed on the petridish, over ice. The brains 
were dissected out into three regions-cerebrum, cerebellum and brain 
stem and rinsed with ice cold physiological saline solution. The brain 
parts and spinal cords were weighed and then subjected for the assay of 
lipid peroxidation, protein and DNA. 
Estimation of Lipid peroxidation 
Chemical and reagents: 
1) 0.15M KCl: 2231 g KCl dissolved in 200ml DDW. 
2) 10 % TCA: lOgm TCA dissolved in 100ml DDW. 
3) 0.67 % TBA: 0.67g TBA was dissolved in 25-50ml DDW by adding 2 
pellets of NaOH. The pH of the solution was adjusted to 7.2 with the 
help of INHCl and was made upto 100ml with water. 
Procedure: 
Different regions of brain i.e. cerebrum, cerebellum, brain stem and 
spinal cord were separately homogenized (10% w/v) in chilled 0.15 M 
KCl. Total homogenates were used for assaying malondialdehyde 
formation according to the method of Utley et. al. (1964). Aliquots of the 
homogenate (1ml) were incubated at 37°C for 3 hr in a metabolic shaker. 
Then 1 ml of 10% trichloroacetic acid was added and mixed. The 
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mixture was centrifuged at 2400 rpm for 10 min. One ml of the 
supernatant was removed and mixed with one mi of 0.67% thiobarbituric 
acid and 1 ml of distilled water and placed in a boiling water bath for 10 
min. The mixture was cooled and the absorbance of the solution was 
read at 535 nm. The content of malondialdehyde (rmiol/g wet tissue) was 
then calculated by reference to a standard curve of malondialdehyde 
solution. 
Nucleic Acids 
Principle: The procedure for the determination of nucleic acids is based 
on the finding that nucleic acids can be separated from other tissue 
compounds by their preferential solubility in hot TCA or PC A. The 
isolated nucleic acids were then quantitated by means of 
spectrophotometric reactions involving the pentose compounds of the 
nucleic acids. 
Isolation of Nucleic Acids: 
Nucleic Acids were isolated following the method of Searchy and 
Maclnnis (1970). Weighed tissue of the different brain regions were 
homogenized (5% w/v in 0.5 N HCIO4). The homogenates were heated 
on boiling water bath for 10 minutes, cooled and centrifuged at 3,000 x g 
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for 10 minutes. Supernatants were taken in graduated test tubes and the 
volume was maintained upto 5.0 ml with 0.5N perchloric acid. This 
extract was used in the estimation of DNA and Protein according to the 
following procedures: 
Estimation of DNA: 
DNA was estimated following the method of Burton (1956). 
Principle: 
Deoxyribose is converted into highly reactive hydroxy vulnaldehyde, 
which react with diphenylamine (DPA) to give a blue coloured complex. 
Deoxyribose sugar + DNA • hydroxy vulnaldehyde 
Chemicals and Reagents 
Diphenylamine reagent: 1.5 gm of DPA was dissolved in about 50-60 ml 
glacial acetic acid. 1.5 ml cone. H2SO4 was added to it and the final 
volume was made up to 100 ml with glacial acetic acid. 
Procedure: 
2.0 ml of the perchloric acid supernatant of nucleic acid extract was 
taken in a test tube. To this 4.0 ml diphenylamine (1.5 % in CH3COOH -
H2SO4) reagent was added and the tubes were heated on boiling water 
bath for 15 minutes. After cooling, the colour intensity was measured at 
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600 nm against a blank sample (2.0 ml DDW in place of supernatant). A 
standard curve was prepared by using standard solutions mg/ml in 0.5 N 
HCIO4 of DNA (100- 600 |j.g) according to the same procedure. The 
values were plotted by the least squares method. 
Cx V 
DNA quantity = y^^^^ 
where, 
C = Cone in mg (in 2.0 ml extract). 
V = Total volume of the extract (4.0 ml). 
Vt = volume taken for the estimation. 
Wt= Fresh weight of the brain in mg. 
DNA in the reaction product was calculated using the standard 
curve of DNA that was run simultaneously with the test sample. Results 
were expressed as mg DNA/g fresh tissue weight. 
Estimation of Protein: 
Protein estimation was done by the method of Lowry et. al. (1951). 
Principle: 
This method is based on colour reactions of amino acids tryptophan and 
tyrosine with Folin phenol reagent. By the reaction of these amino acids 
with phosphomolybdic acid and phosphotungstic acid (present in Folin's 
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reagent), a blue colour is formed. O.D was read at 625 nm. The colour is 
the reduction of phosphomolybdic acid and biuret reaction of proteins 
with Cu ^^  ions in alkaline medium. 
Chemicals and Reagents: 
i) Standard solution of Img BSA/ ml was prepared. Stock standard was 
diluted ten times to get the working standard of 100|ag/ ml. 
ii) Copper reagent. 
A: 4.0 % sodium carbonate in DDW. 
B: 2.0 % copper sulphate in DDW. 
C: 4.0 % sodium- potassium tartarate in DDW. 
Mix A, B and C reagents in a ratio of 100: 1: 1 respectively at the time 
of use. 
iii) Folin- Ciolcalteau phenol reagent 
2 N solution obtained commercially was diluted 1: 1 with DDW before 
use. 
Procedure: 
To 0.1 ml of tissue aliquot (residue left in the test tube) was dissolved in 
5.0 ml DDW. To this 5.0 ml of copper reagent was added and shaken 
well and incubated at 37°C. After 10 minutes 1.0 ml of Folin-Ciolcalteau 
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reagent was added. O. D of the blue colour thus developed was read at 
625 nm exactly after 30 minutes using Beckmann DU spectrophoto-
meter. Standard protein solution (BSA, 20-100|Lig) and blank were also 
run simultaneously. 
Calculation: 
Protein in the sample was calculated using the standard curve of BSA 
and the results were expressed as mg/ g weight of wet tissue. 
Statistical analysis 
All the data are expressed as the mean ± SEM of six animals. Statistical 
analysis was performed using one way ANOVA followed by post hoc 
analysis (Tukey) using software SPSS (Version 11.0). The level of 
significance was set at P< 0.05 or less. 
RESULTS 
Effects of stress and chalcones on MDA content 
The data depicted in Table 11 represents the stress related changes in the 
different regions of the brain and spinal cord of rats following 6 hrs 
continuous restraint stress and the protective effects of chalcones on 
stress-enhanced MDA content. 
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Analysis of biochemical data showed that the difference between 
the animals of plain control and restraint stress control groups was 
significant in cerebrum [F ^ io)= 11.208, p< 0.008], cerebellum [F o lo 
= 20.477, p< 0.001], spinal cord [F (,, io)= 15.271, p< 0.003], and non 
significant in brain stem. Pretreatment with chalcones reversed the 
restraint stress induced changes significantly in cerebrum [F (4, 25) 
= 9.838, P < 0.001], cerebellum [F (2, isr 14.246, P < 0.001], brain stem 
[F(2, 15)= 5.570, P < 0.04] and non significant in spinal cord in 
comparison to restraint stress control group. 
Effects of stress and chalcones on levels of DNA 
The data represented in Table 12 showed the amount of DNA in various 
regions of brains and spinal cord following 6 hours restraint stress. 
Restraint stress of 6 hours inhibited the levels of DNA in cerebrum, 
cerebellum, brain stem, and spinal cord. 
Analysis of biochemical data showed that the difference between 
plain control group and control restraint stress group was significant in 
cerebrum [F d, io)= 217.806, P< 0.001], cerebellum [F (,, ,o)= 39.878, P< 
0.001], while it was non significant in brain stem and spinal cord. 
Pretreatment with chalcones significantly increased the DNA levels in 
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cerebrum [F (4,25)= 91.869, P < 0.001], cerebellum [F (2,15) = 17.142, P < 
0.001], and non-significant increase in brain stem and spinal cord in 
comparison to restraint stress control group. 
Effects of stress and chalcones on levels of Protein 
The data depicted in Table 13 represents the stress related changes in the 
different regions of the brain and spinal cord of rats following 6 hrs 
continuous restraint stress and the protective effects of chalcones on the 
levels of protein. 
Analysis of biochemical data showed that the difference between 
the animals of plain control and restraint stress control groups was 
significant in cerebrum [F (i_ io)= 40.943, P < 0.001], cerebellum [F (i. lo) 
= 73.384, P < 0.001], brain s.tem [F (,, ,o)= 10.905, P < 0.001], spinal cord 
[F (1, 10)= 14.020, P < 0.001]. Pretreatment of chalcones significantly 
increased the protein levels in cerebrum [F (3, 20)= 5.85, P < 0.006], 
cerebellum [F (4^  j s r 14.322, P< 0.001], and non significant increase in 
brain stem and spinal cord in comparison to restraint stress control 
group. 
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Table-11. Effects of chalcones and stress on MDA content in the cerebrum, 
cerebellum, brain stem and spinal cord. The data are expressed 
as mean ± SEM. 
MDA nmoles / g tissue 
Groups Cerebrum Cerebellum Brain stem Spinal cord 
Plain control 3.7940±0.23 3.5927±0.93 3.1233±0.17 1.4300±0.05 
rats (6) 
Stress treated 4.7108±0.15""= 4.323310.13'" 3.5798±0.21 1.8000±0.07' 
rats (6) 
Chalcones + 
stress treated 
rats 
ISL (6) 3.9100±0.11''''''=' 3.7093 ±0.68^'''3.1970±0.12 1.6033±0.08 
BUT (6) 3.8538±0.26''''''='3.7432±0.54'' 2.9935±0.23'' 1.6100±.008 
DHC (6) 4.000010.76^' 3.8848±0.73 3.1853±0.47 1.6200±0.09 
HDMC (6) 4.063310.14^' 3.909310.54 3.270510.66 1.6367+0.06 
DOC (6) 4.699310.91 4.092710.14 3.367210.10 1.701710.05 
DCCP (6) 4.685010.11 4.038310.19 3.359710.11 1.773310.10 
CMC (6) 4.605010.10 4.0467i0.15 3.301710.12 1.708310.08 
CMCP (6) 4.693310.10 4.208310.18 3.3333+0.82 1.7917+0.08 
Figures in parenthesis indicate number of rats. ^^ p < 0.05, ''" p< 0.01, ^'^ p< 
0.001, where a,b,c as compared to non stressed control rats , where a, 
b, c stressed treated rats. 
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Table- 12. Effect of chaicones on the levels of DNA in the cerebrum, 
cerebellum, brain stem and spinal cord modulated after 
restraint stress. The data are expressed as mean ± SEM. 
Levels of DNA (mg/ g wt fresh tissue) 
Groups Cerebrum Cerebellum Brain stem Spinal cord 
Plain control 2.1050±0.03 5.2867±0.08 1.8378±0.02 1.3800±0.05 
rats (6) 
Stress treated 1.5833±0.02^''M.1875±0.15"' 1.7000+0.44 1.3167±0.03 
rats alone (6) 
Chaicones + 
stress treated 
rats 
ISL (6) 2.060010.01'"'='5.2033 ±0.13^'"'1.7267±0.02 
BUT (6) 1.1017±0.01'''''''5.0533±0.11"' 1.7433±0.01 
DHC (6) 1.8550±0.06'' 4.5250+0.22 1.6983±0.03 
HDMC(6) 1.7667±0.14 4.4167±0.30 1.7115±0.02 
DOC (6) 1.5733±0.02 4.1908±0.13 1.7083±0.03 
DCCP(6) 1.6033±0.02 4.1932±0.13 1.7133±0.03 
CMC (6) 1.585010.08 4.2567±0.19 1.7100±0.05 
CMCP(6) 1.5800±0.11 4.2722±0.16 1.7100±0.05 
1.3433±0.01 
1.3300±0.04 
1.320010.02 
1.3250+0.01 
1.296710.01 
1.298310.01 
1.296710.01 
1.298310.01 
Figures in parenthesis indicate number of rats. '^^  p < 0.05,'''' p< 0.01/' ' 
p< 0.001, where a,b,c as compared to non stressed control rats , where a 
b , c stressed treated rats. 
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Table- 13. Effect of chalcones on the protein content in the cerebrum, 
cerebellum, brain stem and spinal cord modulated after restraint 
stress. The data are expressed as mean ± SEM. 
Levels of Protein (mg / g tissue) 
Groups Cerebrum Cerebellum Brain stem Spinal cord 
Plain control 115.0967±2.08 113.6483±1.64 100.7650±1.69 92.3917±1.26 
rats (6) 
Stress treated 91.2983±3.08"''88.2003±2.48"'"76.2750±7.21' 78.3917±3.52' 
rats (6) 
Chalcones + 
stress treated 
rats 
ISL (6) 106.9273±3.00^'^' 102.4017±1.06^"'='84.2867±1.11 84.1817±1.34 
BUT (6) 110.8217+4.68^"'^'106.8983±1.33^'''<''90.7750±2.44 86.5050±1.87 
DHC (6) 103.3333±3.24^' 97.5717±2.70'' 82.0050±4.90 83.2233±2.23 
HDMC(6) 96.2533±1.79 98.716010.70''"' 83.3483±7.24 83.2967±2.04 
DOC (6) 91.4167i0.90 87.4433±1.86 80.8867±3.81 81.7250±2.79 
DCCP(6) 91.4267i1.04 88.7660i2.19 80.1533i1.94 82.1170+4.72 
CMC (6) 91.3717i0.90 88.8111i2.10 80.3067i3.71 83.2200i0.94 
CMCP(6) 91.3483i1.42 88.8127i1.71 79.2267i5.22 1.2633i4.60 
Figures in parenthesis indicate number of rats. *''' p < 0.05, ^^' p< 0.01,"'' p< 0.001, 
where a,b,c as compared to non stressed control rats , where a, b , c stressed 
treated rats. 
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DISCUSSION 
The original point of this study is examining the brain parts affected 
from restraint stress for the changes in protein, DNA and lipid 
peroxidation levels. The inherent biochemical and physiological 
characteristics of the brain including high lipid concentrations and 
energy requirements make it particularly susceptible to free radical 
mediated insult. The brain, like many other tissues, has a range of 
antioxidant defences, which help to maintain a balanced redox status 
(Huh, 1994). 
There have been many reports of stress-induced lipid-
peroxidation in animal plasma (Oishi, 1999), lung (Kowacheva-Ivanova, 
1992), myocardium (Ceremuzynski, 1991) (Herbaczynska-Cedro, 1990), 
liver (Hidalgo, 1991) (Seredenin, 1992), stomach (Bulon, 1990; Yegen, 
1992) and brain (Sosnovskii, 1992). We extended the observations of 
these previous studies by examining the protective effects of chalcones 
against immobilization stress induced oxidative damage to lipids, 
proteins and DNA. 
Lipid peroxidation measured by MDA increased significantly 
upon stress in the cerebrum, cerebellum and brain stem and non-
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significantly in the spinal cord. Lipid peroxidation causes cellular 
damage and may explain why stress causes neuronal loss in the brain. 
The damage caused by stress plays a significant role in aging (Stein and 
Sapolsky, 1992). Our results provide evidence to support the hypothesis 
of the involvement of oxidants in stress. Measurement of elevated MDA, 
one of the many reactive aldehydes end products of lipid peroxidation, is 
the evidence most frequently quoted in support of the involvement of 
oxidants in tissue damage and aging (Halliwell et. al., 1992; Gutteridge 
and Halliwell, 1990). Therefore, these results also support the hypothesis 
that oxidants from stress could contribute to aging acceleration and to 
the degenerative disease of aging (Olanow, 1992). The elevated lipid 
peroxidation in the cortex, cerebellum, midbrain and hippocampus could 
play an important role in acceleration of aging because lipid 
peroxidation gives rise to an array of reactive mutagens: lipid epoxides, 
lipid hydroperoxides, lipid alkoxyl and peroxyl radicals, and enals 
(Ames, 1993). This is further supported by the results from plasma and 
liver, in which MDA levels were significantly increased by the stress, 
consistent with previous reports on the observed increase in 
thiobarbituric acid reactive substances (Liu et. al., 1996; Sosnovsky et. 
al., 1992). Oxidative stress in lipid metabolism is involved in a variety of 
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biological phenomena such as carcinogenesis, diabetes and neuro-
degenerative disease. 
Administration of chalcones for seven continuous prior to stress 
resulted in the decreased levels of lipid peroxidation and also the extent 
of inhibition depends on the substitution pattern of chalcones. All the 
four hydroxy substituted chalcones significantly inhibited the stress-
induced increase in lipid peroxidation. BUT (2', 4', 3, 4,-tetrahydroxy-
chalcone), ISL (2',4',4-trihydroxychalcone), DHC (2',2-dihydroxy-
chalcone) having hydroxyl groups on both rings are more active than 
HDMC (2'-Hydroxy-3, 4-dimethoxychalcone) having only one hydroxyl 
group. Presence of groups such as, chloro or thioglycolic acid moiety as 
in compounds DCC, DCCP, CMC, CMC? cause no significant effect on 
inhibitory potential. Thus, for the inhibitory activity against lipid 
peroxidation presence of hydroxyl groups on both the rings is required. 
Isoliquiritigenin (ISL) has been reported to have the property to 
scavenge free radicals and have the antioxidative capacity toward LDL 
oxidation and lipid peroxidation (Vaya, 1997; Haraguchi, 1998). Butein 
(BUT) is an effective metal ion chelator and also a powerful- chain 
breaking antioxidant in LDL systems (Cheng, 1998). Hydroxy 
substituted chalcones possess significant antioxidant activity and inhibit 
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lipid peroxidation (Anto et. al., 1995). These previous studies also 
support our findings. LPO level can be easily correlated with the 
decrease of antioxidative defense observed with stress. Hence, the 
chalcones inhibit lipid peroxidation, increased antioxidative status and 
thus protect the cell membranes from free radical- induced cell damage 
due to their free radical scavenging and antioxidative effects. 
Protein oxidation, similar to lipid peroxidation may contribute to 
cell damage, brain dysfunction, aging, and age-related degenerative 
disease of the central nervous system (Starke-Reed, 1989). Oxidative 
attack on proteins results in site-specific amino acids modifications, 
fragmentation of the peptide chain, aggregation of cross-linked reaction 
products, altered electrical charge and increased susceptibility to 
proteolysis (Farr and kogama, 1991). Oxidized protein accumulates 
progressively during aging in rat liver and lens, in normal human dermal 
fibroblasts as a function of age (Starke-Reed and Oliver, 1989; Oliver et. 
al., 1987), rheumatoid arthritis (Chapman et. al., 1989), in brain tissues 
of individuals suffering from Alzheimer's disease (Smith et. al., 1991), 
respiratory distress syndrome (Gladstone et. al., 1994), Parkinson's 
disease (Yorikata et. al., 1996), and atherosclerosis (Uchida et. al., 
1994). Protein oxidation is induced by immobilization stress in 
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peripheral tissues (Sahin, 2007). Our results show clearly that stress 
resulted in remarkable decrease in proteins in different regions of the 
brain and spinal cord. According to Ahmad et. al. (1978) protein 
decreased under stress due to increased proteolytic activity necessitated 
by greater energy demands. Protein inhibition is an indication of 
disequilibrium of normal energy metabolism (Amaiz, 1975). As shown 
from the results, intraperitoneal administration of chalcones such as 
BUT, ISL, and HDMC prior to stress resulted in an increased level of 
protein. ATP is necessary for adequate work of the cells in tasks 
including active transport, protein biosynthesis and preservation of 
cellular integrity. ATP is a critical source for maintaining the ion 
pumping of Na^ K^ ATPase, necessary to generate action potentials by 
neurons (Erecinska, 1989). Isoliquiritigenin (ISL) significantly improved 
the brain energy metabolism in a dose-dependent manner and also 
significantly increases the activity of Na"^  K^ ATPase (Zhan and Yang, 
2006). Thus, it could be concluded that the chalcones increased the 
protein levels by enhancing the energy status. 
Since the average amount of DNA per diploid nucleus is constant 
for all normal tissues of the body, including brain tissues, measurements 
of DNA amounts provide a convenient method for estimating the total 
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cell population in various regions of the brain, or in the entire brain 
(Heller, 1954). Stress-induced DNA damage has been studied by Adachi 
et. al. (1993). Cardozo-Pelaez et. al. (2000) has shown correlation 
between DNA damage, repair and antioxidative defense system in some 
brain regions. In the present study, DNA levels showed depletion in all 
the regions of brain and spinal cord following restraint stress. Thus, 
suggesting that stress can induce oxidative DNA damage in the brain and 
supporting the hypothesis of involvement of oxidants in stress. Our 
results clearly showed that administration of chalcones such as BUT, 
ISL, and DHC for 7 days prior to stress increase the levels of DNA and 
thus decrease the oxidative stress. Reactive oxygen species can attack 
almost any cellular molecule, but with respect to aging and cancer, DNA 
considered a major target (Ames and Gold, 1991). Oxidative attack of 
DNA by ROS, particularly hydroxyl radicals can lead to strand breaks, 
DNA-DNA- and DNA-protein cross-linking and translocation. ROS 
attack of DNA can lead to the generation of more than 20 oxidized base 
adducts, the most prominent being 8-hydroxyguanine (8-OHG) 
(Markesbery et. al., 2006). 
Thus, stress may add to antioxidant burden associated with normal 
aerobic metabolism and its consequent damage to lipid, protein and 
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DNA that appears to be a major contributor to aging (Ames et. al., 1993; 
Shigenaga et. al., 1994). It also appears that chalcones have the potential 
to protect the cell against restraint stress induced damage and 
substitution of chalcone skeleton with hydroxy and methoxy groups is 
required for the antioxidative activity. 
Conclusion 
Restraint stress of 6 hr caused a significant damage to lipids, protein and 
DNA that appears to be a major contributor to aging and a significantly 
lower incidence of oxidative damage to lipids, proteins, and DNA was 
recorded in the rats treated with hydroxy 1 and methoxy groups. 
Therefore, it could be concluded that chalcones eliminate the harmful 
effects of free radicals, decreases oxidative damage induced upon stress 
and thus may play an important role in degenerative diseases related to 
stress and aging. 
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CHAPTER 5 
DIFFERENTIAL EFFECTS OF CHALCONES ON 
GLYCOGEN CONTENTS OF LIVER, BRAIN, AND 
SPINAL CORD IN RATS 
Introduction 
Glycogen stores in the brain are small relative to the liver especially 
muscle. Nevertheless, brain glycogen turns over rapidly (Pentreath & 
Kai kai, 1982; Swanson et. al., 1989) and contributes significantly to 
normal brain energy metabolism (Swanson, 1992; Wender et. al., 2000). 
Brain glycogen is located entirely in astrocytes (Phelps, 1972; Koizumi, 
1974) which are distributed throughout the brain but are more 
concentrated in fiber bundle and white matter (Savchenko et. al., 2000; 
Sloano et. al., 2001). In the mammalian liver, glycogen is present in the 
form of rosettes (Luft, 1956). Glycogen is present in central nervous 
system (CNS) although at much lower concentrations than liver or 
skeletal muscle with the commonly accepted ratio of liver/ skeletal 
muscle/ brain: 100:1:1 (Nelson et. al., 1968). The concentration of the 
glycogen in the liver can vary according to the nutritional state of the 
animal. In the liver of fasted rats or mice, this concentration is about 
1-5 mg/g of wet wt and increases rapidly at the rate of about 10 mg 
(g wet wt)" h' (Cori, 1926). The accepted role of glycogen is that of a 
carbohydrate reserve utilized when glucose falls below need. However, 
there is a rapid continuous breakdown and synthesis of glycogen (17|J 
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mol/kg/min) (Watanabe & Passonneau, 1973). The enzyme systems that 
synthesize and catabohze glycogen in other tissues are also found in 
brain, but their kinetic properties and modes of regulation appear to 
differ. 
Aldose reductase (AlditoliNADP^ oxidoreductase, E.G. 1.1.1.21, 
ALR2) is the first enzyme of the polyol pathway, glucose flux through 
this pathway, during diabetes, has been linked to the development of 
long-term diabetic complications. Thus ALR2 inhibitors (ARIs) have 
been developed as potential agents to prevent or delay the onset of 
diabetic complications (Tomlinson et. al., 1994). There is strong 
evidence to show that diabetes is associated with increased oxidative 
stress (Mohamed, 1999; Yue, 2003). 
Flavonoids with insulin-trigerring and/or insulin like properties 
have been extracted from plants (Hii and Howell, 1985). Chalcones 
considered as precursors of flavonoids and isoflavonids are abundant in 
edible plants, and also have been shown to display a diverse array of 
pharmacological activities (Dimmock et. al., 1999). Several hydroxy-
lated and methoxylated chalcones showed good level of inhibitory 
activity towards bovine lens aldose reductase (AR) (Severi, 1998) and 
165 
have been shown the promising compound for the prevention or 
treatment of diabetic complications (Lim et. al., 2001). In recent report 
3- nitro- 2'-benzyloxychalcone showed potent insulin-stimulated glucose 
uptake in a concentration dependent manner in 3T3-L1 adipocytes in a 
cell based glucose uptake screening assay (Rothman et. al., 1995). 
ALR2 inhibitors have been shown to prevent or delay significantly 
diabetic complications (Raskin and Rosenstock, 1987) and chalcones 
display significant inhibitory activity towards this enzyme. Thus, the aim 
of the present study was to determine the effects of variably substituted 
chalcones on glycogen contents of liver, brain and spinal cord. 
Materials and Methods 
Animals 
Adult male albino rats weighing 200-250 gram were used for the study. 
The animals were procured from the central animal house facility at 
Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh. 
The rats were group housed in polypropylene cages (38x23x10 cm) 
under standard laboratory conditions with natural light and dark cycle. 
They were allowed free excess of diy rat diet and tap water ad libitum. 
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All procedures described were reviewed and approved by the 
Institutional Animal Ethics Committee. 
Materials 
Chalcones were prepared by the methods described in "review section". 
Chalcones used in the study are: 2',4',4-trihydroxychalcone (ISL, 
isoliquiritigenin); 2',4',3,4 tetrahydroxychalcone (BUT, butein); 2', 2- di-
hydroxychalcone (DHC);2'-hydroxy-3,4-dimethoxychalcone (HDMC); 
4', 4- dichlorochalcone (DCC); 4 - chloro , 4- methoxychalcone (CMC); 
1,3-bis (4-chlorophenyl)-3 (carboxymethylthio) propan-1-one (DCCP) 
and 1- (4-chlorophenyl)- 3 (4-methoxyphenyl)-3- (carboxymethylthio) 
propan-1- one (CMCP). 
Methods 
Rats were divided into nine groups of six animals each. The animals in 
experimental groups were administered with chalcones intraperitoneally 
(i.p.) at the dose of 25mg/ kg body weight daily for 7 consecutive days. 
The animals of control group received a similar volume of 
dimethylsulfoxide-normal saline. Chalcones were dissolved in DMSO-
nornial saline. The fmal concentration of DMSO in normal saline did not 
exceed 0.5 %. On the seventh day, after the last dose the animals were 
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sacrificed by cervical dislocation. Their brains, spinal cord, and liver 
were removed quickly and placed on the petridish over ice and rinsed 
with ice cold physiological saline solution. The brain, spinal cord and 
liver were weighed and then subjected for the assay of glycogen 
estimation. 
Glycogen estimation 
Glycogen content was estimated colorimetrically by the method 
described by Hassid and Abraham (1957). 
Reagents: 
30 % KOH 
95 % ethanol 
95 % H2SO4 
Anthrone reagent: 0.2 % anthrone was made by dissolving 0.2g of 
anthrone in 100ml of 95 % H2SO4. 
Procedure: 
The tissue (approx Igm) was placed in a pre-weighed centrifuge tube 
containing 3 ml of 30% KOH. After the weight of the tissue had been 
recorded, the tubes were placed in a boiling water bath for about 20-30 
min. When the tissue was dissolved, the glycogen was precipitated by 
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the addition of 5 ml of 95% ethanol. The precipitate obtained was 
dissolved in 1 ml of distilled water and again precipitated with 95% 
ethanol and centrifuged at 3000 rpm for 10 min. The glycogen 
precipitate was then dissolved in distilled water, and this solution was 
used to estimate the quantity of glycogen. To 0.1 ml of aliquot, 5 ml of 
anthrone reagent was added and mixed by swirling the tube. The tubes 
were heated for 10 min in boiling water, followed by cooling, and the 
absorbance was recorded at 590 mm. The readings were compared with 
that of standard glycogen. 
Statistical analysis 
The data was represented as mean ± SEM. The statistical analysis of the 
results was carried out with a SPSS 11.0 program and based on an 
analysis of variance (ANOVA) followed by post hoc test (Tukey). 
Differences were considered as significant for p < 0.05 or less. 
Results 
Effects of chalcones on the glycogen content 
Table 14 depicts the values of glycogen in the brain, spinal cord and 
liver after intraperitoneal administration of variably substituted 
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chalcones at the dose of 25mg/kg body weight for 7 days. The results 
showed that chalcones caused no significant alterations of glycogen 
content in brain and spinal cord as compared to vehicle treated group. 
ANOVA followed by Tukey post hoc test showed that 
intraperitoneal administration of chalcones at the dose of 25mg/kg body 
weight significantly reduced the glycogen content in liver [F(4, 25) = 
15.337, p < 0.001) as compared to vehicle treated control group. 
!70 
Table-14 Effects of chaicones on glycogen content. Data are expressed as 
means ± SEM. 
Glycogen content (mg/g tissue) 
Groups Liver Brain Spinal Cord 
Control (6) 51.3533 ±2.94 1.8970 ±0.02 0.7953 ±0.02 
ISL (6) 32.2627 ± 0.88"'^ ' 1.9050 ±0.08 0.8033 ± 0.02 
BUT (6) 35.1220 ±2.01''' ' 1.9133 ±0.03 0.7833 ± 0.04 
DHC (6) 39.1705 ±0.09''' 1.9005 ±0.02 0.7900 ±0.04 
HDMC (6) 41.2540 ± 1.75' 1.9243 ±0.06 0.7700 ±0.04 
DCC (6) 48.0687 ±1.71 1.8482 ±0.03 0.7637 ±0.02 
DCCP (6) 49.9385 ±1.72 1.8833 ±0.05 0.7865 ± 0.06 
CMC (6) 49.9778 ±3.03 1.8035 ±0.05 0.7575 ±0.03 
CMCP (6) 49.5712±2.97 1.8750±0.03 0.7772 ± 0.05 
Figures in parenthesis indicate number of rats. '""^Indicate statistical significance 
in comparison to vehicle treated group at P < 0.05, P < 0.01, P < 0.001, 
respectively with ANOVA followed by post hoc Tukey test. 
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Discussion 
Results of in vitro studies in diabetic and in non-diabetic rats have 
suggested a hypoglycemic/insulin- like effect of certain individual 
flavonoid- containing seed extracts (Ahmed et. al., 2000; Anila and 
Vijayalakshmi, 2000). Both citrus fruits and apples are rich dietary 
sources of chalcones and dihydrochalcones, and these compounds could 
even make a greater contribution to the total daily intake of natural 
phenolics than the more extensively studied flavonoids (Tomas-
Barberan & Cliford, 2000). It is a largely unresolved question at present, 
whether a significantly enhanced intake as to be expected from dietary 
food supplements or certain functional foods, is consistent with 
beneficial effects on human health or whether adverse effects are also to 
be taken into account. 
Chalcones have been reported to undergo extensive metabolism 
by many routes, such as reversible conjugate addition of glutathione, 
demethylation of methoxy groups, oxidation of aromatic rings, and 
reduction of the enone moiety (Hawkins, 1980; Chabannes, 1973; Nozu, 
1980; Brown, 1983). 
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In the present study, we used rat liver, brain and spinal cord as an 
easily accessible model system to measure the inhibitory potential of 
chalcones on glycogen content. Comparing effects of chalcones on the 
glycogen content allowed concluding on structural elements responsible 
for effective glycogen inhibition. Presence of hydroxy and methoxy 
groups seems to be a mandatory element for potential inhibition of 
glycogen content, but this inhibition is observed only in liver and not in 
brain and spinal cord. The order of inhibition of glycogen content in 
liver is as follows: 
ISL > BUT > DHC > HDMC 
Compound ISL (isoliquirtigenin; 2',4',4- trihydroxychalcone) and 
BUT (butein; 2', 4', 3, 4- tetrahydroxychalcone) with three and four 
hydroxy groups in positions 2 and 4 on both rings (A and B) are found to 
be more potent inhibitor than compound DHC (2',2-dihydroxychalcone) 
having only two hydroxy groups. Presence of two additional methoxy 
groups with hydroxy group as in HDMC may suffice to achieve effective 
glycogen inhibition. Presence of chloro groups as in DCC and CMC 
showed no activity. According to Severi et. al. (1998) the introduction of 
thioglycolic group in the chalconic structure gave an increase in the 
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inhibitory activity against ALR2 (aldose reductase enzyme). However, 
in our study introduction of thioglycolic group in the chloro substituted 
chalcones (CCP and CMCP) has no influence on the glycogen inhibitory 
activity. Thus altogether, these data shows that for an efficient inhibition 
of glycogen presence of hydroxy groups in the 'A' ring or methoxy 
groups in 'the' B ring is responsible for inhibition. 
Our study indicated that ISL caused a significant reduction of 
glycogen content in the liver (37.17 %), without affecting the brain and 
spinal cord glycogen values. Recently it has been published that 
isoliquiritigenin found in licorice roots increases glycogenolysis in rat 
hepatocyte perfusion (AbdoUahi et. al., 2003). This is consistent with our 
study that isoliquiritigenin (ISL) increased the glycogen depletion in the 
liver of rats. The liver plays a major role in blood glucose homeostasis 
by maintaining a balance between the uptake and storage of glucose as 
glycogen and release of glucose formed by glycogenolysis and/or 
gluconeogenesis (Nordlie, 1999). There is also evidence that c-AMP 
increasing agents exert a glycogenolytic effect by maintaining glycogen 
phosphorylase in a phosphorylated state (BoUen, 1998). PDE inhibitors 
can increase serum glucose levels (Gilfrich & Dieterich, 1991) Isoliqui-
ritigenin is a PDE 3 inhibitor with significant cardiac inotropic and 
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vasodialatory effect which were attributed to an increase in c-AMP 
levels (AbdoUahi, 2003; Kusano, 1991; Wegener and Nawarth, 1997). 
Isoliquiritigenin was found to decrease sorbitol levels in blood cells, the 
sciatic nerve and the lens of the diabetic rats and thus could have 
implications in diabetic neuropathy (Aida et. al., 1990). There is also 
evidence that the antidiabetic drug metformin which acts through 
inhibition of hepatic gluconeogenesis is produces concurrent antioxidant 
effects that are most beneficial in treatment of diabetes (Kosic 2001). 
Isoliquiritigenin has been reported to have the property to scavenge free 
radicals and have the antioxidative capacity (Vaya et. al., 1997; 
Haraguchi et. al., 1998). 
The disturbance of gluconeogenesis and glycogenolysis could 
have significant influences on glucose metabolism and pathogenesis of 
diabetes (Atefi et. al., 2004; Abdollahi et. al., 2004). Therefore, it could 
be concluded that isoliquiritigenin stimulates glycogenolysis and thus 
depletes hepatic glycogen storage which in turn needs to be compensated 
by blood glucose because hepatic gluconeogenesis pathway is occluded 
and this may be a mechanism for antidiabetic effect of isoliquiritigenin 
and seems to be in relation with it antioxidant properties. Since the 
hyperaggregability of platelets has been implicated in the pathogenesis 
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of diabetic complications and isoliquiritigenin showed inhibitory effect 
on platelet aggregation, comparable to that of aspirin (Tawata et. al, 
1992). Thus, the dual or triple effects of isoliquiritigenin i.e having 
aldose reductase inhibition, antioxidant and platlet aggregation inhibition 
may offer a unique process for maintaining the glucose by increasing the 
glycogenolysis rate. 
Compound BUT (butein; 2', 4', 3, 4- tetrahydroxychalcone) also 
caused a significant reduction of glycogen content in the liver (31.60 %), 
but caused no alterations in the brain and spinal cord glycogen values. It 
has been reported that increase of c-AMP formation is elicited by butein 
(Sheu-Meei et. al., 1995); c-AMP also affects storage of glycogen 
(Lamer et. al., 1968) which is hydrolysed or reduced with the rise in 
blood sugar level (Vane, 1962). Butein showed strong lens AR 
inhibitory activity. It also showed strong activity in transition metal 
chelation and free radical scavenging activity and the most promising 
compound for the treatment of diabetic complications (Lim et. al., 2001). 
Recent human studies have demonstrated that ACE inhibition improves 
glucose disposal rate and that the effect may be primarily due to 
increased muscle glucose uptake (MGU). Butein inhibit contraction-
stimulated glucose transport by inhibiting the glucose transporter 
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function (David et. al., 2005). In insulin-resistant conditions, ACE 
inhibitors can also enhance whole-body glucose disposal and glucose 
transport activity in skeletal muscle (Henriksen et. al., 1996). Butein 
significantly inhibited the ACE activities in a dose-dependent manner 
(Chen and Lin, 1992). Tumor necrosis factor-a is implicated in induction 
of insulin resistance seen in type- 2 diabetes (Ruan & Lodish, 2003). 
Butein suppressed the nuclear factor (NF)KB activation and also the 
expression of COX (Pandey et. al., 2007). Butein (BUT) is an effective 
metal ion chelator and also a powerful-chain breaking antioxidant in 
LDL systems (Cheng, 1998). Also, butein inhibit the platelet aggregation 
response (Jeon et. al., 2006). Butein also have properties like aldose 
reductase inhibition, antioxidant and platelet aggregation inhibition. 
Thus, it might be concluded that butein increases the glycogenolysis rate 
by depleting the hepatic glycogen and the resulted higher level of 
glucose is compensated by increased rate of glucose uptake by muscles 
in order to balance the blood glucose level. 
Compounds DHC (2*, 2-dihydroxychalcone) and HDMC (2'-
hydroxy-3, 4-dimethoxychalcone) also caused a significant reduction of 
glycogen content in the liver (23.72 % and 21.29 %), but caused no 
alterations in the brain and spinal cord glycogen values. a-Glucosidase 
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plays a physiologically important role for the digestion process of 
dietary carbohydrates to suppress postparandial hypoglycaemia 
(Matsuur, 2002). The inhibitors of a-glucosidase are effective for 
delaying glucose absorption, which makes them potent drugs to control 
glucose levels in blood (Matsui et. al., 1996). Also, a-glucosidase 
inhibitors are used to ameliorate insulin- resistance (stumvoll et. al., 
2005) and lower blood glucose concentration (Fukumori, 2000). a-
glucosidase inhibitors are widely used for the treatment of non-insulin-
dependent diabetes mellitus (NIDDM) (Hasegawa et. al., 1998). Ansari 
et. al. (2005) showed that hydroxy and methoxy substituted chalcones 
are potent inhibitors of a-glucosidase. Also PPARy agonists improve 
insulin- resistance by opposing the effect of TNF-a in adipocytes 
(Moller, 2000). Moreover, hydroxy and methoxy chalcones have more 
potent or similar PPAR-agonistic activity compared with troglitazone 
(insulin sensitizing CTZP drug) (Jung et. al., 2006). Therefore, it may be 
concluded that these chalcones increase the glycogenolysis rate but delay 
the absorption of glucose to control the glucose levels in blood. 
Conclusion 
Chalcones, which are potent inhibitors of aldose reductase, caused an 
increase in glycogenolysis rate by decreasing the liver glycogen content. 
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CONCLUSION 
Chalcones continue to attract considerable scientific attention because of 
their association witli a variety of biological activities. A perusal of the 
results indicates that the chalcones used in the present study possess 
interesting properties: 
Chalcones evaluated for anxiety, using various anxiety paradigms such 
as open field behaviour and elevated plus maze test revealed that 
chalcones (ISL and BUT) possess interesting anxiolytic effects with no 
discernible effects on general motor coordination. Increase in rota rod 
fall out and decrease in grip strength by other tested chalcones suggest 
sedative and muscle relaxant effects. 
Chalcones tested for their effects on the memory deficits induced by 
cholinergic disturbances using scopolamine showed significant 
improvement in memory on the Y-maze by increasing spontaneous 
alterationations and elevated plus maze by decreasing the transfer 
latencies, suggesting their ability to improve or ameliorate memory 
dysfunction, in part, by facilitating the cholinergic transmission and 
inhibiting the acetylcholinersterase activity. 
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Chalcones investigated for tlieir protective effects on restraint stress-
induced changes in behavior and antioxidant enzymes, SOD, CAT and 
GST showed that chalcones attenuated both stress induced behavioral 
suppression as well as brain oxidative stress. These findings confirm the 
claims of their potential for scavenging free radicals generated by 
restraint stress. 
Chalcones significantly lower the restraint- stress induced alterations in 
lipids, proteins, and DNA describing potential of chalcones to eliminate 
the harmful effects of free radicals and thus decreases oxidative damage. 
Chalcones exhibited significant inhibitory effects on liver glycogen with 
no changes in brain and spinal cord glycogen levels, indicating the 
increase in the rate of glycogenolysis by chalcones. 
But, it is interesting to note that the response of chalcones differs 
to these above tested activities depending upon their substitution pattern. 
Hydroxy and methoxy substituted chalcones are found to be active in 
most of the parameters. Hence, skilftil structural manipulation of the 
chalcones framework may yet narrow its range of biological activity but 
enhance its potency for a targeted pharmacological profile. 
!79b 
RFERENCES 
References 
Abdollahi M., Chan T.S., Subrahmanyam V., O'Brien P.J. Effects of 
phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glyco-
genolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. 
Mol Cell Biochem, 2003, 252: 205- 211. 
Abdollahi M., Donyavi M., Poumourmohammadi S., Saadat M. 
Hyperglycaemia associated with increased hepatic glycogen phosphor-
rylase and phosphoenolpyruvate carboxykinase in rats following subchr-
onic exposure to malathion. Comp Biochem Physiol Toxicol Pharmacol, 
2004, 137: 343- 347. 
Adachi S., Kawamura K., Takemoto K. Oxidative damage of nuclear 
DNA in liver of rats exposed to psychological stress. Cancer Res, 1993, 
53:4153-4155. 
Adewunmi CO., Ogungbamila F.O., Oluwadiya J.O. Molluscicidal 
activities of some synthetic chalcones. Planta Med, 1987, 53: 110-112. 
Aebi H. Catalase in vitro. Methods Enzymol, 1984, 105: 121-126. 
Ahlemeyer B., Krieglstein J. Pharmacological studies supporting the 
therapeutic use of Ginkgo biloba extract for Alzheimer's disease. 
Pharmacopsychiatry, 2003, 36: S8-S14. 
Ahmad A.L.M., Tyrrell D.A.J. Synergism between anti-rhinovirus 
antivirals: various human interferons and a number of synthetic 
compounds. Antiviral Research, 1986, 6: 241-252. 
Ahmad M., Akhtar M.S., Malik T., Gilani A.H. Hypoglycaemic action 
of the flavonoid fraction of Cuminum nigrum seeds. Phytother Res, 
2000; 14: 103-106. 
Ahmed I.K., Begum M.R., Sivaiah S., Ramana R.K.V. Effect of 
malathion on free amino acids, total proteins, glycogen and some 
enzymes of Pelecypod Lamellidons marginalis (Lamark). Proc Indian 
Acad Sci Sec B, 1978, 87: 377-380. 
180 
Ai J., Dekermendjian K., Wang X., Nielson M., Witt M.R. 6 -Methyl-
flavone, a benzodiazepine receptor ligand with antagonistic properties 
on rat brain and human recombinant GABAA receptor in vitro. Drug 
Development Research, 1997, 41: 99-108. 
Aida K., Tawata M., Shindo H., Onaya T., Sasaki H., Yamaguchi T., 
Chin M., Mitsuhashi H. Isoliquiritigenin: a nev/ aldose reductase 
inhibitor from Glycyrrhizae radix. Planta Med, 1990, 56: 254- 258. 
Alcaraz M.J., Vicente A.M., Araico A., Dominguez J.N., Terencio 
M.C., Ferrandiz M.L. Role of nuclear factor-A:B and heme oxygenase-1 
in the mechanism of action of an anti-inflammatory chalcone derivative 
in RAW 264.7 cells. British Journal of Pharmacology, 2004, 142: 1191-
1199. 
Al-Nakib W., Higgins P.O., Barrow I., Tyrell D.A., Lenox-Smith I., 
Ishitsuka H. Ro 09-0410, as prophylaxis against rhino virus infection in 
human volunteers. J Antimicrob Chemother, 1987, 20: 887- 892. 
Alston J.Y., Fry A.J. Substituent effects on the reduction potentials of 
benzalacetophenones (chalcones) - Improved substituent constants for 
such correlations._Electrochem Acta, 2004, 49: 455- 459. 
Ames B.N., Gold L.S. Endogenous mutagens and the causes of aging 
and cancer. Mutat Res, 1991, 250: 3-16. 
Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and 
degenerative diseases of aging. Proc Natl Acad Sci USA, 1993, 91: 
7915-7922. 
Anderson D.K., Saunders R.D., Demediuk P., Dugan L.L., Raughler 
J.M., Hall E.D., Horrocks L.A. Lipid hydrolysis and peroxidation in 
injured spinal cord: partial protection with methylprednisolone or 
vitamin E and selenium. Cent Nerv Syst Trauma, 1985, 2: 257-267. 
Anila L., Vijayalakshmi N.R. Beneficial effects of flavonoids from 
Sesamum indicum, Emblica officinalis and Momordica charantia. 
Phytother Res, 2000, 14: 592- 595. 
Anisman H., Matheson K. Stress, depression, and anhedonia: Caveats 
concerning animal models. Neurosci Biobehav Res, 2005, 29: 525-546. 
Ansari F.L., Umbreen S., Hussain L., Makhmoor T., Nawaz S.A., Lodhi 
M.A., Khan S.N., Shaheen F., Choudhary M.I., Rahman A.U. Synthesis 
and biological activities of chalcone and 1,5- benzothiazepine deriva-
tives: promising new free radical scavengers, and esterase, urease, and a-
glucosidase inhibitors. Chemistry and Biodiversity, 2005, 2: 487- 496. 
Anto R.J., Sukumaran K., Kuttan G., Rao M.N.A., Subbaraju V., Kuttan 
R. Anticancer and antioxidant activity of synthetic chalcones and related 
compounds. Cancer Letters, 1995, 97: 33-37. 
Arivazhagan P., Thilakovathy T., Panneerselvan S. Antioxidant lipate 
and tissue antioxidants in aged rats. J Nutr Biochem, 2000, 11: 122-127. 
Armario A., Campmany L., Borras M., Hidalgo J. Vitamin E- supple-
mented diets reduce lipid peroxidation but do not alter either pituitary-
adrenal, glucose, and lactate response of immobilization stress or gastric 
ulceration. Free Radic Res Commun, 1990, 9: 113-118. 
Arnaiz Z., Esteves B.R., Pacheco M.M. Inhibition of protein synthesis 
and ATPase in mitochondria by the administration of the convulsant 3-
mercaptopropionic acid. Life Sci, 1975, 16: 385-394. 
Arranz L., Guayerbas N., De la Fuente M. Impairment of several 
immune functions in anxious women. J Psychosom Res, 2007, 62: 1- 8. 
Atefi M., Ghazanfari S., Ostad S.N., Ghahremani M.H., Abdollahi M. 
Alteration of glucose homeostasis by rolipram and milrinone but not 
sidenafil in rat primary hepatocytes culture. Prog Med Res, 2004, 2: 1-
12. 
Augusto Y.R., Domeneghini C.A., Cesar L.P., Cechinel-filho V., Torres-
Santos E.C., Falcao Camila A.B., Rossi-Bergmann B. Chalcones as new 
drugs leads against Leishmaniasis. Current Trends in Medicinal 
Chemistry, 2006, 4: 47-56. 
182 
Baba M., Asano R., Takigami T., Takahashi T., Ohmura M., Okada Y., 
Sugimoto H., Arika T., Nishino H., Okuyama T. Studies on cancer 
chemoprevention by folk medicines. XXV Inliibitory effects of isoliqu-
iritigenin on azoxymethane-induced murine colon abberant crypt focus 
formation and carcinogenesis. Biol Pharm Bull, 2002, 25: 247- 250. 
Babior B.M. Oxygen-dependent microbial killing by phagocytes (second 
of two parts). The New England Journal of Medicine, 1978, 298: 659-
668. 
Bail J.L., Pouget C, Fagnere C, Basly J.P., Chulia A.J., Habrioux. 
Chalcones are potent inhibitors of aromatase and 17(3- hydroxysteroid 
dehydrogenase activities. Life Science, 2001, 68: 751- 761. 
Ballard C.G. Advances in the treatment of Alzheimer's disease: benefits 
of dual cholinesterase inhibition. European Neurology, 2002, 47: 64-70. 
Ballinger C.A., Chamindrani Mendis-Handagama S.M.L., Kalmar J.R., 
Arnold R.R., Kinkade J.M. Changes in the localization of catalase during 
differentiation of neutrophilic granulocytes. Blood, 1994, 83: 2654-2668. 
Ban H.S., Suzuki K., Lim S.S., Jung S.H., Lee S., Ji J., Lee H.S., Lee 
Y.S., Shin K.H., Ohuchi K. Inhibition of lipopolysaccharide-induced 
expression of inducible nitric oxide synthase and tumor necrosis factor-a 
by 2'-hydroxychalcone derivatives in RAW 264.7 cells. Biochem 
Pharmacol, 2004, 67: 1549- 1557. 
Barford L., Kemp K., Hansen M., Kharazmi A. International Immuno-
pharmacology, 2002, 2: 545- 555. 
Barnes J.M., Barnes N.M., Costall B., Coughlan J., Horovitz Z.P., Kelly 
M.E., Naylor R.T., Tomkins D.M. ACE inhibition and cognition. In: 
MacGregor G.A and Sever P.S., Editors, Current Advances in ACE 
Inhibition, Proceedings of an International Symposium, Churchill 
Livingstone, Edinburgh, 1989, pp 159-171. 
Barz W., Welle R. Biosynthesis and metabolism of isoflavones and 
pterocarpan phytoalexins in chickpea, soyabean and phytopathogenic 
fungi. In Phenolic Metabolism in Plants. New York, Plenum Press, 1992, 
pp 139- 164. 
183 
Batt D.G., Goodman R., Jones D.G., Kerr J.S., Mantegna L.R., 
Macallister C, Newton R.C., Numberg S., Welch P.K., Covington M.B. 
2'- Substituted chalcone derivatives as inhibitor of interleukin-1 biosyn-
thesis. J Med Chem, 1993, 36: 1434-1442. 
Beckman J.S. The double-edged role of nitric oxide in brain function and 
superoxide-mediated injury. J Dev Physiol, 1991, 15: 53- 59. 
Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. 
Apparent hydroxyl radical production by peroxynitrite: implications for 
endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 
USA, 1990, 87: 1620-1624. 
Beers R.F., Sizer I.W. A spectrophotometric method for measuring the 
breakdown of hydrogen peroxide by catalase. J Biol Chem, 1952, 195: 
133. 
Bergmann B.R., Torres Dos Santos E.C., Yunes R.A., Cechinel- filho 
v., Boeck P. Preparation of parasitic diseases. Brazil PI 0204079-4, 
2004, pp40. 
Berr C. Oxidative stress and cognitive impairment in the elderly. J Nutr 
Health Aging, 2002, 6: 261-266. 
Berry A., Capone P., Giorgio M., Pelicci P.G., de Kloet E.R., Alleva E., 
Minghetti L., Cirulli F. Deletion of the life span determinant p66Shc 
prevents age- dependent increases in emotionality and pain sensitivity in 
mice. Exp Gerontol, 2007, 42: 37- 45. 
Beutler J.A., Cardellina J.H., Gray G.N., Prather T.R., Shoemaker R.H., 
Boyd M.R., Lin CM., Hamel E., Cragg G.M. Taxinine M, a new 
tetracyclic texane from Taxus brevifolia. Journal of Natural Products, 
1993,56: 1718. 
Bhattacharya S.K., Chakrabarti A., Sandler M., Glover V. Rat brain 
MAO-A & B inhibitory (tribulin) activity during withdrawal activity. 
Neurosci Lett, 1995a, 199: 103-106. 
184 
Bhattacharya S.K., Chakrabarti A., Sandler M., Glover V. Effects of 
some anxiogenic agents on rat brain monoamine oxidase (MAO) A & B 
inhibitory (tribulin) activity. Ind J Experimental Biol, 1996, 34: 1190-
1193. 
Bhattacharya S.K., Satyan K.S. Experimental methods for the evaluation 
of psychotropic agents. Indian Journal of Experimental Biology, 1997, 
35:565-575. 
Bhattacharya S.K., Upadhyay S.N., Jaiswal A.K. Effect of piracetam on 
electroshock induced amnesia and decrease in brain acetylcholine in rats. 
Indian J Exp Biol, 1993, 31: 822-824. 
Bian J.S., Wang Y.L., Li D.X. Immobilization stress induced changes of 
ventricular electric stability in damaged heart depends on the extent of 
free radical damage. Shengli Xuebao, 1997, 49: 526-530. 
Bilgin A.A., Yulug N., Sarac S., Tayhan A., Berkman E.D. Hacettepe 
Univ Eczacilik Fak Derg, 1987, 7, 39 (Chem. Abstr.,109, 89593k). 
Black P.H. Central nervous system- immune system interactions: 
psychoneuroendocrinology of stress and its immune consequences. 
Antimicrob Agents Chemother, 1994, 38: 1-6. 
Blanco J.G., Gill R.R., Alvarez C.I., Patrito L.C., Genti- Raimondi S., 
Flury A. A novel activity for a group of sesquiterpene lactones: 
inhibition of aromatase, FEBS Lett, 1997, 409: 396- 400. 
Block E. Nervous system specific proteins. J Neurochem, 1978, 30: 7-
14. 
Bohm B.A. (1993) The major Flavonoids. In The Flavonoids: Advances 
in Research Since 1986 (Harbome J.B., Ed.), London: Chapman 8c Hall, 
pp 387- 440. 
Bohm B.A. Chalcones, aurones and dihydrochalcones. In Harborne J.B., 
Mabry T.J., Mabry H. (eds): "The Flavonoids". New York: Academic 
Press, 1975, pp 442-504. 
185 
Bohm B.A. Introduction to Flavonoids, Harwood Academic, 
Amsterdam, 1998. 
Bollen M., Keppens S., Stalmans W. Specific features of glycogen 
metabolism in the liver. Biochem J, 1998, 336: 19-31. 
Bondy S.C. Reactive oxygen species: relation to aging and neurotoxic 
damage. Neurotoxicology, 1992, 13: 87-100. 
Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., 
Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus 
nerve stimulation attenuates the systemic inflammatory response to 
endotoxin. Nature, 2000, 405: 458-462. 
Bors W., Michell C, Stettmaier K. Antioxidant effects of flavonoids. 
Biofactors, 1997, 6: 399-402. 
Bouayed J., Rammal H., Younos C, Soulimani R. Positive correlation 
between peripheral blood granulocyte oxidative status and level of 
anxiety in mice. Eur J Pharmacol, 2007, 564: 146- 149. 
Boulenger J.P. Treatment of generalized anxiety: new pharmacological 
approaches. Encephale, 1995, 21: 459-466. 
Boyland E., Chasseaud L.F. The role of glutathione and GST in 
mercapturic acid biosynthesis. Adv Enzymol, 1969,32: 172-219. 
Branham W.S., Dial S.L., Moland C.L., Hass B.S., Blair K.M., Fang H., 
Shi L., Tong W., Perkins R.G., Sheehan D.M. Phytoestrogens and 
Mycoestrogens bind in the rat uterine estrogen receptor. Journal of 
Nutrition, 2002, 132: 658- 664. 
Bravo L. Polyphenols: chemistry, dietary sources, metabolism and 
nutritional significance. Nutrition Reviews, 1998, 56: 317-333. 
Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and 
nutritional significance. Nutr Rev, 1998, 56: 317-333. 
186 
Briganti S., Camera R., Picardo M. Chemical and instrumental appro-
aches to treat hyperpigmentation. Pigment Cell Res, 2003, 16: 101-110. 
Briot A., Baehr C, Brouillard R., Wagner A., Mioskowski C. Concise 
synthesis of dihydrochalcones via palladium-catalyzed coupling of aryl 
halides and l-aryl-2-propen-l-ols. J Org Chem, 2004, 69: 1374-1377. 
Brouillard R., Dangles O. (1993a), In the Flavonoids: Advances in 
Research Since 1986 (Chapman & Hall), London, pp 565- 588. 
Brouillard R., Dangles O. In the Flavonoids: Advances in Research 
Since 1986, Chapman & Hall, London ( 1993b) pp 387- 440. 
Brown S., Griffiths L.A. Metabolism and excretion of butein, 2', 3, 
4- trihydroxychalcone, 3-o-methylbutein, 4-o- methylbutein and 2',4',4-
trihydroxychalcone in rat. Xenobiotica, 1983, 13: 669- 682. 
Brown J.P., Crosby G.A., DuBots G.E., Enderlin F.E., Hale R.L., 
Wingard Jr R.E. Flavonoid Sweeteners. Synthesis and intestinal 
absorption of selected sulfoalkylated Hesperetin-3-''* C derivative in the 
rat. Journal of Agriculture and Food Chemistry, 1978, 26: 1418- 1422. 
Brown S., Griffiths L.A. Metabolism and excretion of butein, 2',3,4-
trihydroxychalcone, 3-o-methylbutein, 4-o- methylbutein and 2',4',4-
trihydroxychalcone in the rat. Xenobiotica, 1983, 13: 669. 
Bulon V.V., Zavodskaia I.S., Khnychenko L.K. (1990) The effect of 
GABA-ergic agents on the development of a neurogenic stomach lesion 
in rats. Bull Exp Biol Med, 1990, 110: 504-506. 
Burton K.A. Study of the conditions and mechanisms of the 
diphenylamine reaction for the colorimetric estimation of deoxyribo-
nucleic acid. Biochem J, 1956, 62: 315- 323. 
Butterfield D.A., Howard B.J., Yatin S., Allen K.L., Carney J.M. Free 
radical oxidation of brain proteins in accelerated senescence and its 
modulation by N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci 
USA, 1997,94:674-8. 
187 
Butterfield D.A., Lauderback CM. Lipid peroxidation and protein 
oxidation in Alziieimer's disease: potential causes and consequences 
involving amyloid-beta peptide associated free radical oxidative stress. 
Free Radic Biol Med, 2002, 32: 1050-1060. 
Buzzi F.C., Campos J.P., Tonini P.P., Correa R., Yunes R.A., Boeck P., 
Cechinel-filho V. Antinociceptive effects of synthetic chalcones 
obtained from xanthoxyline. Arch Pharm, 2006, 339: 541-546. 
Cacabelos R., Franco-Maside A., Alvarez X.A. Interleukin-1 in Alzhe-
imer's disease and multi-infarct dementia: neuropsychological corre-
lations. Methods Find Exp Clin Pharmacol, 1991, 13: 703-708. 
Calliste C.A,, Le Bail J.C., Trouillas P., Pouget C, Habrioux G., Chulia 
A.J., Duroux J.L. Chalcones: structural requirements for antioxidant, 
estrogenic and antiproliferative activities. Anticancer Research, 2001, 
21: 3949-3956. 
Cardozo-Pelaez F., Brooks P.J., Stedeford T., Song S., Sanchez-kamos J. 
DNA damage, repair and antioxidative defense system in some brain 
regions: a correlative study. Free Radic Biol Med, 2000, 28: 779- 785. 
Carli M., Prontera C, Samanin R. Effects of 5HTIA agonist in stress 
induced deficit in the open field locomotor activity of rats, evidence that 
this model identifies anxiolytic activity. Neuropharmacology, 1989, 28: 
471-476. 
Carrasco G.A., Vandekar L.D. Neuroendocrine pharmacology of 
stress. European Journal of Pharmacology, 2003, 463: 235- 272. 
Carreiras CM., Marco J.L. Recent approaches to Novel Anti- Alzheimer 
Therapy. Current Pharmaceutical Design, 2004, 10: 3167- 3175. 
Ceremuzynski L., Barcikowski B., Lewicki Z., Wutzen J., Gordon-
Majazak M., Famulski K.S., Klos J., Herbaczynska-Cedeo K. Stress-
induced injury of pig myocardium is accompanied by increased lipid 
peroxidation and depletion of mitochondrial ATP. Exp Pathol, 1991, 
43:213-220. 
188 
Chabannes B., Grandgeorge M., Duperray B., Pacheco H. Studies on 
the metabolism of a choleretic 2',4 ,4'- trimethoxychalcone. Chim Ther, 
1973; 621. 
Chan C, Yang J. Protective effects of isoliquiritigenin in transient 
middle cerebral artery occlusion - induced focal cerebral ischemia in 
rats. Pharmacological Research, 2006, 53: 303-309. 
Chan S.C, Chang Y.S., Wang J.P., Chen S.C, Kuo S.C. Three new 
flavonoids and antiallergic, anti-inflammatory constituents from 
heartwood of Dalbergia odorifera. Planta Medica, 1998, 64: 153-158. 
Chanal J.L., Cousse H., Sicart M.T., Borinaud B., Marignan R. 
Absorption and elimination of (14C) hesperidin methylchalcone in the 
rat. Eur J Drug Metab Pharmacokin, 1981, 6: 171. 
Chapman M.L., Rubin B.R., Gracy R.W. Increased carbonyl content of 
proteins in synovial fluid from patients with rheumatoid arthritis. J 
Rheumatol, 1989, 16: 15-18. 
Chamey D.S., Mihie S.I., Harris A.D. Hypnotics and sedatives, In: 
Hardman J.G. & Limbird L.E. (Eds.), Goodman's and Oilman's. The 
Pharmacological Basis of Therapeutics, 10 ed, The McGraw Hill 
Companies Inc., USA, 2001, pp 399-428. 
Chaudiere J., Ferrari-Illiou R. Intracellular antioxidant from chemical to 
biochemical mechanism. Food Chem Toxicol, 1999, 37: 949-962. 
Chen C.H., Lin J.Y. Inhibition of angiotensin 1- converting enzyme by 
tetrahydroxy xanthones isolated from Tripterospermum lanceolatum. J 
Nat Prod, 1992,55:691-695. 
Chen M., Christensen S.B., Blom J., Lemmich E., Nadelmann L., Fich 
K., Theander T.G., Kharazmi A. Licochalcone A, a novel antiparasitic 
agent with potent activity against human pathogenic protozoan species 
of Leishmania. Antimicrob Agents Chemother, 1993, 37: 2550-2556. 
Chen M., Zhai L, Brogger S., Christensen S.B., Theander T.G., 
Kharazmi A. Inhibition of fumarate reductase in Leishmania major and 
189 
Leishmania donovani by chalcones. Antimicrob Agents Chemother, 
2001,45:2023-2029. 
Cheng Z.J., Kuo S.C., Chan S.C. Antioxidant properties of butein 
isolated from Dalbergia odorifera. Biochimica et Biophysica Acta, 1998, 
1392:291-299. 
Christensen S.B., Theander T.G., Kharazmi A., Chem M, 1999, US 
Patent 5985935. 
Chrousos G.P. Stress as a medical and scientific idea and its implication. 
Adv Pharmacol, 1988, 42: 553-555. 
Chrousos G.P., Gold P.W. The concept of stress and stress system disor-
ders. JAMA, 1992, 26: 1244- 1252. 
Cini M., Fariello R.G., Bianchetti A., Moretti A. Studies on lipid peroxi-
dation in the rat brain. Nerochem Res, 1994, 19: 238- 283. 
Clemens M.R. Free radical in chemical carcinogenesis. Klin Wochen-
schr, 1991, 15: 1123-1134. 
Clifford M.N. Review. Anthocyanins- nature, occurance and dietary 
burden. J Sci Food Agric, 2000, 80: 1063-1072. 
Coles M.E., Heimberg R.G. Memory biases in the anxiety disorders: 
current status. Clin Psychol Rev, 2002, 22: 587-627. 
Collerton D. Cholinergic function and intellectual decline in Alzheimer's 
disease. Neuroscience, 1986, 19: 1-28. 
Cori C.F. The fate of sugar in the animal body. J Biol Chem, 1926, 70: 
577-585. 
Cosic v., Antic S., Pesic M., Jovanovic O., Kundalic S., Djordjevic V.B. 
Monotherapy with metformin: does it improve hypoxia in type 2 diabetic 
patients ?. Clin Chem Lab Med, 2001, 39: 818-821. 
190 
Crespy V., Aprikian D., Morand C, Besson C, Manach C, Demigne C, 
Remesy C. Bioavailability of phloretin and phloridzin in rats. Journal of 
Nutrition, 2001b, 131: 3227- 3230. 
Crespy V., Morand C, Besson C, Manach C, Demigne C, Remesy C. 
Comparison of the intestinal absorption of quercetin, phloretin and their 
glucoside in rats. Journal of Nutriion 2001a, 131: 2109- 2114. 
Dandekar T. Free radicals and memory loss. Redox Reports, 1997, 3: 71-
73. 
Das B.P., Choudhury T.R., Das G.K., Choudhury B., Chowdhury D.N. 
EnvironEcol,1995, 13:694. 
Das M., Bickers D.R., Mukhtar H. Plant phenols as in vitro inhibitors of 
glutathione- S-transferase. Biochem Biophys Res Commun, 1984, 120: 
427-433. 
Davey W., Gwilt J.R. Chalcones and related compounds. Part I. 
Preparation of Nitro-, Amino-, and Halogeno- chalcones. J Chem Soc, 
1957, 1: 1008-1019. 
David C, Geiger P.C, Han D.H., Holloszy J.O. Are tyrosine kinases 
involved in mediating contraction- stimulated muscle glucose transport ? 
Am J Physiol Endocrinol, 2005, E123- E128. 
Davies S.L., Bozzo J. Targeting SIRTl- A multitasker. Drugs Fut, 2006, 
31:461. 
Davies S.L., Maloney A.J. Selective loss of central cholinergic neurons 
in Alzheimer's disease. Lancet, 1976, 2: 1403. 
Davis M., Rainnie D., Cassell M. Neurotransmission in the rat amygdala 
related to fear and anxiety. Trends Neurosci, 1994, 17: 208-214. 
Davydov V.V., Shvets V.N. Age-dependent differences in the 
stimulation of lipid peroxidation in the heart of rats during 
immobilization stress, Exp Gerontol, 2003, 38: 693-698. 
19! 
Dawson G.R., Iverson S.D. The effects of novel cholinesterase inhibitors 
and selective muscarinic receptor agonists in tests of reference and 
working memory. Behavioral Brain Research, 1993, 57: 143- 153. 
de Duve C, Baudhuin P. Peroxisomes (microbodies and related 
particles). Physiol Rev, 1966, 46: 323-357. 
DeLeo J.A., Floyd R.A., Carney J.M. Increased in vitro lipid peroxi-
dation of gerbil cerebral cortex as compared with rat. Neurosci Lett, 
1986,67:63-67. 
Desrumaux C, Risold P.Y., Schroeder H., Deckert V., Masson D., 
Athias A., Laplanche H., Le Guem N., Blache D., Jiang X.C, Tall A.R., 
Desor D., Lagrost I. Phospholipid transfer protein (PLTP) deficiency 
reduces brain vitamin E content and increases anxiety in mice. FASEB J, 
2005, 19: 296-297. 
Devia CM., Pappano N.B., Debattista N.B. Structure- Biological 
activity relationship of synthetic trihydroxylated chalcones. Revista de 
Microbiologia, 1998, 29: 307- 310. 
Dewick P.M. Medicinal Natural Products: a biosynthetic approach. 
Cichestes: John Wily & Sons, 1997. 
Dhingra D., Parle M., Kulkarni S.K. Memory enhancing activity of 
Glycyrrhiza glabra in mice. J Ethnopharmacol, 2004, 91: 361-365. 
Dietrich- Muszalaska A., Olas B., Rabe- Jablonska J. Oxidative stress in 
blood platelets from schizophrenic patients. Platelets, 2005,16: 386- 391. 
Dimmock J.R., Elias D.W., Beazely M.A., Kandepu N.M. Bioactivities 
of chalcones. Current Medicinal Chemistry, 1999, 6: 1125- 1149. 
Dinkova-Kostava A.T., Abeygunawardana C, Talalay P.J. Chemo-
protective properties of phenylpropenoids, bis(benzylidene)-
cycloalkanones, and related Michael reaction acceptors: correlation of 
potencies as phase 2 enzyme inducers and radical scavengers. 
Journal of Medicinal Chemistry, 1998, 41: 5287-96. 
192 
Dinkova- kostava A.T., Massiah M.A., Bozak R.E., Hicks R.J., Talalay 
P. Potency of Michael reaction acceptors as inducers of enzymes that 
protect against carcinogenesis depends on their reactivity with sulfhydryl 
group. Proc Natl Acad Sci USA, 2001, 98: 3404-3409. 
Dixon R.A., Pavia N.L. Stress- induced phenylpropanoid metabolism. 
Plantcell, 1995, 7: 1085-1097. 
Dominguez J.N., Leon C, Rodrigues J., Dominguez de N.G., Gut J., 
Rosenthal P.J. Syntheis and antimalarial activity of sulfonamide 
chalcones derivatives. Farmaco, 2005, 60: 307- 311. 
Doody R.S. Clinical profile of donepezil in the treatment of Alzheimer's 
disease. Gerontology, 1999, 45 (Suppl): 23-32. 
Drachman D.A. Memory and cognitive function in man: does the 
cholinergic system have a specific role ?. Neurology, 1977, 27: 783-790. 
Dringen R., Kussmaul L., Gutterer J.M., Hirrlinger J., Hamprecht B. The 
glutathione system of peroxide detoxification is less efficient in neurons 
than in astroglial cells. J Neurochem, 1999, 72: 2523-2530. 
Ducki S., Forrest R., Hadfield J.A., Kendall A., Lawrence N.J., 
McGrown A.T., Renninson D. Potent antimitotic and cell growth 
inhibitory properties of substituted chalcones. Bioorg Med Chem Lett, 
1998,8: 1051- 1056. 
DuPont M.S., Bennett R.N., Mellon F.A., Williamson G. Polyphenols 
fron alcoholic apple cider are absorbed, metabolized and excreted by 
humans. Journal of Nutrition, 2002, 132: 172. 
Ebert U., Kirch W. Scopolamine model of dementia: electroence-
phalogram findings and cognitive performance. European Journal of 
Clinical Investigation, 1998, 28: 944 - 949. 
Eddarir S., Cotelle N., Bakkour Y., Ronaldo C. An efficient synthesis of 
chalcones based on the Suzuki reaction. Tetrahedron Lett, 2003, 44: 
5359-5363. 
193 
Edwards M.L., Stemerick D.M., Sunkara S.P. Chalcone derivatives 
useful in controlling growth of tumor tissue and other preparation. Eur 
Pat Appl Ep, 1988, 288, 794. Cem Abstr III, 17706t. 
El- Ghissassi, F., Barbin, A., Nair, J., Bartsch, H. Formation of 1, N6-
ethenoadenine and 3, N4-ethenocytosine by lipid peroxidation products 
and nucleic acid bases. Chem Res Toxicol, 1995, 8: 278-283. 
Eldjam L., Pihl A. Mechanisms of protective and sensitizing action, 
Academic Press, New York, 1960, pp. 231-296. 
Ellman G.L., Courtney K.D., Andres Jr. V., Feather-Stone R.M. A new 
and rapid colorimetric determination of acetylcholinesterase activity. 
Biochemical Pharmacology, 1961, 7: 88- 95. 
Enz A., Amstutz R., Boddeke H., Gmelin G., Malanowski J. Brain 
selective inhibition of acetylcholinesterase: a novel approach to therapy 
for Alzheimer's disease. Progress in Brain Research, 1993, 98: 431-438. 
Erecinska M., Silver I.A. ATP and brain function. J Cereb Blood Flow 
Metab, 1989, 9: 2-19. 
Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., 
Chown M.J., Hebert L.E., Hennekens C.H., Taylor J.O. Prevalence of 
Alzheimer's disease in a community population of older persons. Higher 
than previously reported. JAMA, 1989, 262: 2551-2559. 
Fahn S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early 
Parkinson's disease. Ann Neurol, 1992, 32: S128-S132. 
Farlow M.R. Do cholinestesterase inhibitors slow progression of 
Alzheimer's disease?. Int J Clin Pract Suppl, 2002, 127: 37- 44. 
Farr S.B., Kogama T. Oxidative stress responses in Escherichia coli and 
Salmonella typhimurium. Microbiol Rev, 1991, 54: 561-585. 
Fiander H., Schneider H. Dietary ortho phenols that induce glutathione-
s-transferase and increase the resistance of cells to hydrogen peroxide 
are potential cancer chemopreventives that act by two mechanisms: the 
194 
alleviation of oxidative stress and the detoxification of mutagenic 
xenobiotics. Cancer Letters, 2000, 156: 117- 124. 
Fillit H., Ding W.H., Buee L., Kalman J., Altsteil L., Lawlor B., Wolf-
klein G. Elevated circulating tumor necrosis factor levels in Alzheimer's 
disease. Neurosci Lett, 1991, 129: 318-320. 
Forkmann G., Dangelmayr B. Genetic control of chalcone isomerase 
activity in flowers of Dianthus caryophyllus. Biochemical Genetics, 
1980, 18:519-527. 
Forster M.J., Dubey A., Dawson K.M., Stutts W.A., Lai H., Sohal R.S. 
Age-related losses of cognitive function and motor skills in mice are 
associated with oxidative protein damage in the brain. Proc Natl Acad 
Sci USA, 1996, 93: 4765-^769. 
Fraser CM., Fisher A., Cooke M.J., Thompson LD., Stone T.W. Purine 
modulation of dizocilpine effects on spontaneous alternation. 
Psychopharmacology, 1997, 130: 334- 342. 
Fridovich I. Superoxide radical and superoxide dismutase. In: Oxygen 
and living processes. (Gilbert D.L., Edn.), Springer Verlag, New York, 
1981, pp 250-272. 
Gambi F., Reale M., larlori C, Salone A., Toma L., Paladini C, De 
Luca G., Feliciani C, Salvatore M., Salerno R.M., Theoharides T.C., 
Conti P., Exton M., Gambi D. Alzheimer patients treated with an AChE 
inhibitor show higher IL-4 and lower IL-beta levels and expression in 
peripheral blood mononuclear cells. J Clin Psychopharmacol, 2004, 24: 
314-321. 
Gan Li. Therapeutic potential of sirtuin activating compounds in 
Alzheimer's Disease. Drug News & Perspectives, Copyright Prous 
Science, 2007, 20: 233. 
Giacobini E. Do cholinesterase inhibitors have disease- modifying 
effects in Alzheimer's disease?. CNS Drugs, 2001, 15: 85- 91. 
195 
Giacobini E. New trends in cholinergic therapy for Alzheimer's disease: 
nicotin agonists or cholinesterases inhibitors? Progress in Brain Res-
earch, 1996,109:311-323. 
Gibney M.J., Sigmman- Grant M., Stanton Jr J.L., Keast D.R. 
Consumption of sugars. American Journal of Clinical Nutrition, 1995, 
62(Suppll): 178S-194S. 
Gilfrich H.J., Dieterich H.A. Tolerance of enoximone in patients with 
heart failure. Z Kardiol (Suppl 4), 1991, 80: 93- 97. 
Gingrich J.A. Oxidative stress is the new stress. Nat Med, 2005, 12: 
1281- 1282. 
Giralt M., GasuU T., Hernandez J., Garcia A., Hidalgo J. Effect of stress, 
adrenolectomy and changes in glutathione metabolism on rat kidney 
metallothionein content: comparison with liver metallothionein. Bio-
Metals, 1993, 6: 171-178. 
Giunta B., Ehrhart J., Townsend K., Sun N., Vendrame M., Shytle D., 
Tan J., Fernandez F. Galanthamine and nicotine have a synergistic effect 
on inhibition of microglial activation induced by HIV-lgp 120. Brain 
Research Bulletin, 2004, 64: 165-170. 
Gladstone I.M., Levine R.L. Oxidation of proteins in neonatal lungs. 
Pediatrics, 1994, 93: 764-768. 
Glock I., Blaschke G., Veit M. Validated methods for direct 
determination of hydroquinone and sulfate in human urine after oral 
intake of bearberry leaf extract by capillary zone electrophoresis. J 
Chromatography B, 2001, 761: 261- 266. 
Grimaldi L.M., Casadei V.M., Ferri C, Veglia F., Licastro F., Annoni 
G., Biunno I., De Bellis G., Sorbi S., Mariani C, Canal N., Griffin W.S., 
Franceschi M. Association of early onset Alzheimer's disease with an 
interleukin-1 alpha gene polymorphism. Annals of Neurology, 2000, 47: 
361-365. 
Grossman N. Inhibitory acdvity of phloretin on histamine release from 
isolated mast cells. Agents Actions, 1998, 25: 284- 290. 
196 
Gulati K., Ray A., Vijayan V.K. Possible role of free radicals in 
theophylline seizures in mice. Pharmacol Biochem Behav, 2005, 82: 
241-245. 
Gumuslu S., Sarikcioglu S.B., Sahin E., Yargicoglu P., Agar A. 
Influences of different stress models on the antioxidant status and lipid 
peroxidation in rat erythrocytes. Free Radic Res, 2002, 36: 1277-1282. 
Gupta S.R., Ravindranath B., Sheshadri T.R. The glycosides of Butea 
monosperma. Phytochemistry, 1970, 9: 2231- 2235. 
Gutteridge J.M.C. Free radicals in disease processes: A compilation of 
cause and consequence. Free Radic Res Commun, 1993, 49: 577-587. 
Gutteridge J.M.C., Halliwell B. The measurement and mechanism of 
lipid peroxidation in biological systems. Trends Biochem Sci, 1990, 15: 
129-135. 
Habig W.H., Pabst M.J., Jakoby W.B. Glutathione-S-Transferase in 
mercap- turic acid formation. J Biol Chem, 1974, 249: 7130-7139. 
Hackett A.M., Marsh L., Barrow A., Griffiths L.A. The biliary excretion 
of fiavanones in the rat. Xenobiotica, 1979, 9; 491. 
Haenen G.R.M.M., Jansen F.P., Bast A. The antioxidant properties of 
five 0-(P-Hydroxyethyl)-rutosides of the flavonoids mixture venoruton. 
Phlebology Suppl, 1993, 1: 10-17. 
Hall C.S. Emotional behavior in the rat. I. Defecation and urination as 
measures of individual differences in emotionality. Journal of 
Comparative and Physiological Psychology, 1971, 20: 169-171. 
Halliwell B. Role of free radicals in the neurodegenerative diseases: 
therapeutic implications for antioxidant treatment. Drugs Aging, 2001, 
18:685-716. 
Halliwell B., Cross C.E. Oxygen-derived species: their relation to human 
disease and environmental stress. Environ Health Perspect, 1994, 102: 5-
12. 
197 
Halliwell B., Gutteridge J.M.C. Free radicals in Biology and Medicine, 
2"^* ed Oxford, Clarendon Press, 1989. 
Halliwell B., Gutteridge J.M.C. Free radicals in Biology and Medicine. 
Oxford: Oxford University Press, 1999. 
Halliwell B., Gutteridge J.M.C. Oxygen radicals and the central nervous 
system. Trends Neurosci, 1985, 8: 22- 26. 
Halliwell B., Gutteridge J.M.C, Cross C.E. Free radicals, antioxidants, 
and human disease: where are we now? J Lab Clin Med, 1992, 119: 
598-620. 
Handley S. H., Blane J. W. M. 5- HT drugs in animal models of 
anxiety. Psychopharmacology, 1993, 112: 13-20. 
Haraguchi H., Ishikawa H., Mizutani K., Tamura Y., Kinoshita T. 
Antioxidative and superoxide scavenging activities of retrochalcones in 
Glycyrrhiza inflata. Bioorg Med Chem, 1998, 6: 339-347. 
Harborne J.B. Comparative Biochemistry of the Flavonoids. Academic 
Press, London. 1967. 
Harborne J.B., Baxter H. The Handbook of Natural Flavonoids, Wiley, 
New York, 1999. 
Hasan A., Khan K.M., Sher M., Maharvi G.M., Nawaz S.A., Choudhary 
M.I., Rahman A.U., Supuran C.T. Synthesis and inhibitory potential 
towards acetylcholinesterase, butyrylcholinesterase and lipoxygenase of 
some variably substituted chalcones. J Enzyme Inhib Med Chemistry, 
2005,20:41-47. 
Hasan M., Ali S.F. Organophosphate pesticide dichrovos induced 
increase in the rate of lipid peroxidation in the different region of rat 
brain, supporting ultrastructural findings. Neurotoxicity, 1980, 2: 43-52. 
Hasegawa T., Yoneda M., Nakamura K., Ohnishi K., Harada H., Kyouda 
T., Yoshida Y. Long-term effect of a-glucosidase inhibitor on late 
198 
dumping syndrome. Journal of Gastroenterology and Hepatology, 1998, 
13: 1201-1206. 
Hassid W.J., Abraham S. Chemical procedures for analysis of 
polysaccharides. In: Methods in Enzymology, Vol III. Academic Press, 
New York, USA, pp 34-37. 
Hatano T., Yasuhara T., Miyyamoto K., Okuda T. Anti-human 
immunodeficiency virus phenolics from licorice. Chem Pharm Bull, 
1988, 36: 2286-2288. 
Havsteen B. Flavonoids, A class of natural products of high 
pharmacological potency. Biochem Pharmacol, 1983, 32: 1141-1148. 
Hawkins D.R., Chasseaud L.F., Weston K.T. Aspects of the peripheral 
vasodilator mecinarone in rat, dog and man. European Journal of Drug 
Metabolism and Pharmacokinetics, 1980, 5: 145. 
Hayashi K, Nagamatsu T, Honda S, Suzuki Y. Butein ameliorates 
experimental ,anti- glomerular basement membrane antibody- associated 
glomerulonephritis. Eur J Pharmacol, 1996, 316: 297- 306. 
Heller W, Forkman G. Biosynthesis of flavonoids: Advances in 
Research Since 1980 (Harbome JB ed) London: Chapman & Hall, 1988, 
pp 399- 425. 
Heller W, Forkman G. Biosynthesis of flavonoids: Advances in 
Research Since 1986 (Harbome JB ed) London: Chapman & Hall, pp 
499- 536. 
Hellor I.H., Elliott K.A.C. DNA content and cell density in rat brain and 
human brain tumors. Cand J Biochem, 1954, 32: 584- 592. 
Helton D.R., Berger J.E., Czachura J.F., Rasmussen K., Kalman M.J. 
Central nervous system characterization of the new 
cholecystokinin B antagonist LY 288513. Pharmacology Biochemistry 
and Behavior, 1996, 53: 493-502. 
Henke P.G., Ray A., Sullivan R.M. The amygdala, emotions and gut 
functions Digest Dis Sci, 1991 36: 1633- 1643. 
199 
Henriksen E.J., Jacob S., Augustin H.J., Dietze G.I Glucose transport 
activity in insulin-resistant rat muscle. Effects of angiotensin-converting 
enzyme inhibitors and bradykinin antagonism. Diabetes. 1996, 45 Suppl 
1:S125-S128 
Herbaczynska-Cedro K., Lewicki Z., Bercikowski B., Famulski K., 
Gordon-Majszak W., Klos J., Wutzen J., Ceremuzynski L. Effect of 
nisoldipine on stress- induced myocardial damage in conscios pig. Clin 
Exp Pharmacol Physiol, 1990, 17:1-10. 
Herencia F., Ferrandiz M.L., Ubeda A., Guillen I., Dominguez J.N., 
Gharris J.E., Lobo G.M., Alcaraz M.J. Novel anti- inflammatory 
chalcone derivatives inhibit the induction of nitric oxide synthase and 
cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Lett, 1999, 
453: 129-134. 
Hidalgo J., Gasull T., Garcia A., Blanquez A., Armario A. Role of 
glucocorticoids and catecholamines on hepatic thiobarbituric acid react-
ants in basal and stress conditions in the rat. Hormone Metabol Res, 
1991,23: 104-109. 
Hii C.S., Howell S.L. Effect of flavonoids on insulin secretion and 45 
Ca handling in rat islets of Langerhans. J Endocrinol, 1985, 107: 1- 8. 
Hirohata M., Ono K., Naiki H, Yamada M. Non- steroidal anti-
inflammatory drugs have anti-amyloidogenic effects for Alzheimer's 
beta-amyloid fibrils in vitro. Neuropharmacology, 2005, 49: 1088-1099. 
Hodnick W.F., Kung F.S., Roettger W.J., Bohmont C.W., Pardini R.S. 
Inhibition of mitochondrial respiration and production of toxic oxygen 
radicals by flavonoids A structure-activity study. Biochemical 
Pharmacology, 1986, 35: 2345-2357. 
Hoggs S. A review of the validity and variability of the elevated plus -
maze as an animal model of anxiety. Pharmacol Biochem Behav, 1996, 
54:21-30. 
Holland H.C., Gupta B.D. Some correlated measures of activity and 
reactivity in two strains of selectively bred for differences in the 
200 
acquisition of a conditioned avoidance response. Animal Behaviour, 
1996, 14: 574-580. 
Hovatta I., Tennant R.S., Helton R., Marr R.A., Singer O., Redwine 
J.M., Ellison J.A., Schadt E.E., Verma I.M., Lockhart D.J., Barlow C. 
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. 
Nature, 2005, 438: 662- 666. 
Howitz K.T., Bitterman K.J., Cohn H.Y., Lamming D.W., Lavn S., 
Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Schener 
B., Sinclair DA. Small molecule activators of sirtuins extend 
Saccharomyces cerevisiae lifespan. Nature, 2003, 425: 191-196. 
Hsieh H.K., Lee T.H., Wang J.P., Wang J.J., Lin C.N. Synthesis and 
anti- inflammatory effect of chalcones and related compounds. 
Pharmaceutical Research, 1998, 15: 39-46. 
Hsieh H.K., Tsao L.T., Wang J.P., Lin C.N. Synthesis and anti-
inflammatory effect of chalcones. J Pharm Pharmacol, 2000, 52: 163-
171. 
Huh K., Shin U., Choi J.W., Lee S.L Effect of sex hormone on lipid 
peroxidation in liver. Arch Pharmacol Research, 1994, 17: 109-14. 
Inoue B., Inaba K., Mori T., Izushi F., Eto K., Sakai R., Ogata M., 
Utsumi K. The effects of echinatin and its related compounds on the 
mitochondrial energy transfer reaction. J Toxicol Sci, 1982, 7: 245-254. 
Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus maze for 
the evaluation of memory in mice: effects of nootropics, scopolamine 
and electroconvulsive shock. Psychopharmacology, 1990, 101: 27- 33. 
Iwata S., Nishino T., Inoue H., Ngata N., Satomi Y., Nishino W., 
Shibata S. Antitumorigenic activities of chalcones (II). Photo-
isomerization of chalcones and the correlation with their biological 
activities. Biol Pharm Bull, 1997, 20: 1226-1270. 
Jakoby W.B. Detoxification, conjugation and hydrolysis in liver biology 
and pathology. 1988. In: Arias I.M., Jakoby W.B. (Eds.), Raven Press, 
New York, pp. 375- 385. 
201 
Jang M.H., Jung S.B., Lee M.H., Kim C.J., Oh Y.T., Kang I., Kim J., 
Kim E.H. Melatonin attenuates amyloid beta25-35- induced apoptosis in 
mouse microglial BV2 cells. Neuroscience Letters, 2005, 380: 26- 31. 
Jeon W.K., Lee J.H., Kim H.K., Lee Y.A., Lee S.O., Kim Y.S., Ryu 
S.H., Kim S.Y., Lee Y.J., Ko B.S. Anti- platelet effects of bioactive 
compounds isolated from the bark of Rhus vemiciflua stokes. Journal of 
Ethnopharmacology, 2006, 106: 62- 69. 
Joseph J.A., Denisova N.A,, Arendash G., Gordon M., Diamond D., 
Shukit-Hale B., Morgan D. Blueberry supplementation enhances 
signaling and prevents behavioral deficits in an Alzheimer's disease 
model. Nutr Neurosci, 2003, 6: 153-162. 
Joshi H., Parle M. Trikatu Chuma: A promising memory enhancer in 
mice. Planta indica, 2005, 1: 14-19. 
Joshi H., Parle M. Pharmacological evidences for antiamnesic potentials 
of Phyllanthus amarus in mice. African J Biom Res, 2007, 10: 165- 173. 
Jung S.H., Park S.Y., Pak Y.K., Lee H.K., Park K.S., Shin K.H, Ohuchi 
K., Shin H.K., Keum S.R., Lim S.S. Synthesis & PPAR- y- ligand 
binding activity of the new series of 2'- hydroxychalcone and 
thiazolidinedione derivatives. Chem Pharm Bull, 2006, 54: 368- 371. 
Kador P.P., Robindon W.G., Kinoshita J.H. The pharmacology of aldose 
reductase. Annual Review of Pharmacology and Toxicology, 1985, 25: 
691. 
Kamei A., Houdou S., Takashima S., Suzuki Y., Becker L.E., Armstrong 
D.L. Peroxisomal disorders in children: immunohistochemistry and 
neuropathology. J Pediatr, 1993, 122: 573-579. 
Kang D.G., Kim Y.C., Sohn E.J., Lee Y.M., Lee A.S., Yin M.H., Lee 
H.S. Hypotensive effect of butein via the inhibition of angiotensin 
converting enzyme. Biol Pharm Bull, 2003, 26: 1345- 1347. 
Kaplovitz N., Aw T.Y., Ookhtans M. The regulation of hepatic 
glutathione. Annual reviews of pharmacol. Toxicol, 1985, 25: 715-744. 
202 
Kashif S.M., Zaidi R., Al-Quirim TM, Hoda N., Banu N. Modulation of 
restraint stress induced oxidative changes in rats by antioxidant vitamins. 
J Nutr Biochem, 2003, 14: 633-636. 
Khatib S., Nerya O., Musa R., Shmuel M., Tamir S., Vaya J. Chalcones 
as potent tyrosinase inhibitors: The importance of a 2,4- substituted 
resorcinol moiety. Bioorg Med Chem, 2005, 13: 433- 441. 
Kim D.C., Choi S.K., Kim K.T. Isoliquiritigenin selectively inhibits 
H(2) histamine receptor. Molecular Pharmacology, 2006, 70: 493-500. 
Kim Y.P., Ban H.S., Lim S.S., Kimura N., Jung S.H., Ji J., Lee S., Ryu 
N., Keum S.R., Shin K.H., Ohuchi K. Inhibition of prostaglandin E2 
production by 2'- hydroxychalcone derivatives and the mechanism of 
action. Journal of Pharmacy and Pharmacology, 2001, 53: 1295-1302. 
Kinghom A.D., Su B.N., Jang D.S., Chang L.C., Lee D., Gu J.Q., 
Carcache- Blanco E.J., Pawlus A.D., Lee S.K., Park E.J., Cuendet M., 
Gills J.J., Bhat K., Park H.S., Mata- Greenwood E., Song L.L., Jang M., 
Pezzuto J.M. Natural inhibitors of carcinogenesis. Planta Medica, 2004, 
70:691-705. 
Knight J.A. Diseases related to oxygen-derived free radicals. Ann Clin 
LabSci, 1995,25: 111-121. 
Ko H.H., Tsao L.T., Yu K.L., Liu C.T., Wang J.P., Lin C.N. Structure-
activity relationship studies on chalcone derivatives, the potent inhibition 
of chemical mediators release. Bioorg Med Chem, 2003, 11: 105-111. 
Koizumi J. Glycogen in central nervous system. Prog Histochem 
Cytochem, 1974,6: 1-37. 
Kong L.D., Zhang Y., Pan X., Tan R.X., Cheng C.H. Inhibition of 
xanthine oxidase by liquiritigenin and isoliquiritigenin isolated from 
Sinofranchatia chinensis. Cell Mol Life Sci, 2000, 57: 500-505. 
203 
Kovacheva-Ivanova S., Bakalova R., Kagan V., Georgriev G. Activation 
of lipid peroxidation and changes in vitamin E contents in the lungs 
under oxidative stress. Bull Exp Biol Med, 1992, 113: 132-134. 
Kuhn B., Forkmann G., Seyffert W. Genetic control of chalcone-
flavanone isomerase activity in Callistephus chinensis. Planta, 1978, 
138: 199-203. 
Kusano A., Nikaido T., Kuge T., Ohmoto T., Delle Monache G., Botta 
B., Botta M., Saitoh T. Inhibition of adenosine 3',5'- cyclic 
monophosphate phosphodiesterase by flavonoids from licorice roots and 
4- arylcoumarins. Chem Pharm Bull (Tokyo), 1991, 39: 930- 933. 
Kvetnansky R., Mikulaj L. Adrenal and urinary catecholamine in rats 
during adaptation to repeated immobilization stress. Endocrinology, 
1970,87:738-743. 
Kwon H.M., Choi Y.J., Choi J.S., Kang S.W., Bae J.Y., Kang I.J., Jun 
J.G., Lee S.S., Lim S.S., Kang Y.H. Blockade of cytokine-induced 
endothelial cell adhesion molecule expression by licorice 
isoliquiritigenin through NF-KB signal disruption. Exp Biol Med, 2007, 
232:235-245. 
Kyle E.M., Miccadei S., Nakae D., Farber J.L. Superoxide dismutase 
and catalase protect cultural hepatocytes from the cytotoxicity of 
acetaminophen. Biochem Biophys Res Commun, 1987, 149: 889-896. 
Landfield P.W., Eldridge J.C. Evolving aspects of the glucocorticoid 
hypothesis of brain aging: hormonal modulation of neuronal calcium 
homeostasis. Neurobiology of aging, 1994, 15: 579-588. 
Earner J., Viilar- Palasic, Goldberg N.D., Bishop J.S., Huifmg F., 
Wenger J.I., Sasako H., Brown N.B. In: Weber G (ed.) Adv Enzyme 
Regulation, vol 6, T' Edition, Pergamon Press, 1968, pp 402- 423. 
Laskin D.L., Pendino K.J. Macrophages and inflammatory mediators in 
tissue injury. Annu Rev Pharmacol Toxicol, 1995, 35: 655-677. 
204 
Lazarow P.B., de Duve C. An fatty acyl-CoA oxidizing system in rat 
liver peroxisomes: enhancement by clofibrate, a hypolipidemic drug. 
Proc Natl Acad Sci USA, 1976, 73: 2043-2046. 
Lemer L.J., Turkheimer A.R., Borman A. Phloretin, a weak estrogen and 
estrogen antagonist. Proc Soc Exp Biol Med, 1963, 114: 115-117. 
Levai A. Synthesis of carboxylic acid derivatives of dihydrochalcones. 
Monatshefte Fur Chemie, 1991, 122: 127-129. 
Lewis R.A., Austen K.F., Soberman R.J. Leukotrienes and other 
products of the 5- lipoxygenase pathway. Biochemistry and relation to 
pathobiology in human disease. The New England Journal of Medicine, 
1990,323:645-655. 
Li J.T., Yang W.Z., Wang S.X., Li S.H., Li T.S. Improved synthesis of 
chalcones under ultrasound irradiation. Ultrason Sonochem, 2002, 9: 
237-239. 
Licastro F., Grimaldi L.M., Bonafe M., Martina C, Olivieri F., 
Cavallone L., Giovanietti S., Masliah E., Franceschi C. Interleukin-6 
gene alleles affect the risk of Alzheimer's disease and levels of the 
cytokine in blood and brain. Neurobiol Aging, 2003, 24: 921-926. 
Licastro F., Grimaldi L.M., Bonafe M., Martina C, Olivieri F., 
Cavallone L., Giovanietti S., Masliah E., Franceschi C. Interleukin-6 
gene alleles affect the risk of Alzheimer's disease and levels of the 
cytokine in blood and brain. Neurobiol Aging, 2003, 24: 921-926. 
Licastro F., Pedrini S., Caputo L., Annoni G., Davis L.J., Ferri C, 
Casadei V., Grimaldi L.M. Increased plasma levels of interleukin-1, 
interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's 
disease: peripheral inflammation or signals from the brain?. J 
Neuroimmunol, 2000, 103: 97-102. 
Lim S.S., Jung S.H., Ji J., Shin K., Keum S.R. Synthesis of flavonoids 
and their effects on aldose reductase and sorbitol accumulation in 
streptozotocin- induced diabetic rat tissue. J Pharm Pharmacol, 2001: 53: 
653. 
205 
Lin C.N., Lee T.H., Hsu M.F., Wang J.P., Ko F.N., Teng CM. 2',5'-
Dihydroxychalcones as a potent chemical mediator and cyclooxygenase 
inhibitor. J Pharm Pharmacol, 1997, 49: 530- 536. 
Lin Y.M., Zhou Y., Flavin M.T., Zhow L.M., Nie W., Chen F.C. 
Chalcones and flavonoids as anti- Tuberculosis agents. Bioorganic and 
medicinal Chemistry, 2002, 10: 2795- 2802. 
Lindley M.G. NHDC: recent findings and technical advances, in 
Advances in Sweeteners, Ed. by Grenby TH, 1996, Blackie Academic 
and Professional, London, pp 240-252. 
Liochev S.I., Fridovich I. The Haber-Weiss cycle- 70 years later: an 
alternative view. Redox Repoet, 2002, 7: 55-57. 
Lister R. G. The use of a plus-maze to measure anxiety in the 
mouse. Psychopharmacology, 1987, 92: 180-185. 
Liu J., Mori A. Involvement of reactive oxygen species in emotional 
stress: a hypothesis based on the immobilization stress- induced 
oxidative damage and antioxidant defense changes in rat brain and 
the effect of antioxidant treatment with reduced glutathione. Int J Stress 
Management, 1994, 1: 249-263. 
Liu J., Wang X., Mori A. Immobilization stress-induced antioxidant 
defense changes in rat plasma: effect of treatment with reduced 
glutathione. Int J Biochem, 1994, 26: 511-517. 
Liu J., Wang X., Shigenaga M.K., Yeo H.C., Mori A., Ames B.N. 
Immobilization stress causes oxidative damage to lipid, protein, and 
DNA in the brain of rats. The FASEB Journal, 1996, 10: 1532-1538. 
Lopez J., Jacquot R., Figueras F. Heterogeneous catalysis of 
aldolisations on activated hydrotalcites. Stud Surf Sci Catal, 2000, 130: 
491-496. 
Lopez S.N., Castelli M.V., Zacchino S.A., Dominguez J.N., Lobo G., 
Charris J.C, Cortes J.C.G., Ribas J.C., Devia C, Rodriguez A.M., Enriz 
R.D. In vitro antifungal evaluation and structure-activity relationships of 
a new series of chalcone derivatives and synthetic analogues, with 
206 
inhibitory properties against polymers of the fungal cell wall. 
Bioorganic Medicinal Chemistry, 2001, 9: 1999- 2013. 
Lovell M.A., Ehmann W.D., Beutler S.M., Markesbery W.R. Elevated 
thiobarbituric acid-reactive substances and antioxidant enzyme activity 
in the brain in Alzheimer's disease. Neurology, 1995, 45: 1594-1601. 
Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement 
with the folin phenol reagent. J Biol Chem, 1951, 193: 265-275. 
Luft J.H. Permanganate, a new fixative for electron microscopy. J 
Biophys and Biochem Cytol, 1956, 2: 799. 
Lugaresi A., Di lorio A., larlori C, Reale M., De Luca G., Sparvieri E., 
Michetti A., Conti P., Gambi D., Abate G., Paganelli R. IL-4 in vitro 
production is upregulated in Alzheimer's disease patients treated with 
acetylcholinesterase inhibitors. Exp Gerontol, 2004, 39: 653- 657. 
Lunardi F., Guzela M., Rodrigues A.T., Correa R., Eger- Mangrich L, 
Steindel M., Grisard E.G., Assreuy J., Calixto J.B., Santos A.R.S. 
Trypanocidal and Leishmanicidal Properties of Substitution- Containing 
Chalcones. Antimicrob Agents Chemother, 2003, 47: 1449- 1451. 
Machala M., Kubinova R., Horavova P., Suchy V. Chemoprotective 
potentials of homoisoflavonoids and chalcones of Dracaena cinnabari 
modulations of drug-metabolizing enzymes and antioxidant activity. 
Phytotherapy Research, 2001, 15: 114- 118. 
Macheix J.J., Fleuriet A., Billot J. Fruit Phenolics. CRC Press, Boca 
Raton, FL, 1990. 
Madan B., Batra S., Ghosh B. 2'- Hydroxychalcone inhibits nuclear 
factor (a) and lipopolysaccharide- induced adhesion of neutrophils to 
human umbilical vein endothelial cells. Mol Pharmacol, 2000, 58: 526-
534. 
Makita H., Tanaka T., Fujitsuka H., Tatematsu N., Satoh K., Hara A., 
Mori H. Chemoprevention of 4- nitroquinoline 1-oxide-induced rat oral 
carcinogenesis by the dietary flavonoids, chalcone, 2- hydroxychalcone 
and quercetin. Cancer Research, 1996, 56: 4904- 4909. 
207 
Mannervick B., Danielson U.H. Glutathione-S-Transferase structure and 
catalase activity. Crit Rev Biochem, 1998, 23: 283-337. 
Markesbery W.R., Lovell M.A. DNA oxidation in Alzheimer's disease. 
Antioxidants & Redox Signalling, 2006, 8: 2039-2045. 
Marklund S., Marklund G. Involvement of superoxide anion radical in 
the autoxidation of pyrogallol and a convenient assay for superoxide 
dismutase. European Journal of Biochemistry, 1974, 47: 469-474. 
Masood A., Banerjee B.D., Vijayam V.K., Ray A. Modulation of stress 
induced neurobehavioral changes by nitric oxide in rats. Eur J 
Pharmacol, 2003, 458: 138-139. 
Masood A., Banerjee B.D., Vijayam V.K., Ray A. Pharmacological and 
biochemical studies on the possible role of nitric oxide in stress 
adaptation in rats. Eur J Pharmacol, 2004. 49: 111-115. 
Masood A., Nadeem A., Mustafa S.J., O' Donnell J.M. Reversal of 
oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in 
mice. JPET, 2008, 326: 369-379. 
Masur J., Martz R.M.W., Carlini E.A. Effects of acute and chronic 
administration of Cannabis Sativa and (-) A°- trans- tetrahydro-
cannabinol on behavior of rats in open field arena. Psychopharmacology, 
1971, 19:338-397. 
Mates J.M., Perez-Gomez C, Castro I.N. Antioxidant enzymes and 
human diseases. Clin Biochem, 1999, 32, 595603e. 
Matsui T., Yoshimoto C, Osajima K., Oki T., Osajima Y. In vitro 
survey of a- glucosidase inhibitory food components. Biosci Biotechnol 
Biochem, 1996, 60: 2019. 
Matsuur H., Asakawa C, Kurimoto M., Mizutani J. Alpha-glucosidase 
inhibitor from the seeds of balsam pear (Momordica charantia) and the 
fruit bodies of Grifola frondosa. Biosci Biotechnol Biochem, 2002, 66: 
1576. 
208 
May L., Grenell R.G. Nucleic Acid content of various areas of the rat 
brain. Proc Soc Exp Biol Med, 1959, 102: 235-239. 
McBride T.J., Preston B.D., Loeb L.A. Mutagenic spectrum resulting 
from DNA damage by oxygen radicals. Biochemistry, 1991, 30: 207-
213. 
Mcintosh L., Sapolsky R. Glucocorticoids increase the accumulation of 
reactive oxygen species and enhance adrimycin-induce toxicity in 
neuronal culture. Exp Neurol, 1996, 141: 201-206. 
Mcintosh L.J., Cortopassi K.M., Sapolsky R.M. Glucocorticoids may 
alter antioxidant enzyme capacity in the brain: kainic acid studies. Brain 
Research, 1998 a, 79: 215- 222. 
Mcintosh LJ, Hong KE, Sapolsky RM. Glucocorticoids may alter 
antioxidant enzyme capacity in the brain: baseline studies. Brain 
Research, 1999 b, 791: 209- 214. 
McLlwain H., Bachelard H.S. Biochemistry and the central nervous 
system, 4"" Edn, Churchill, London, 1971. 
Metodiewa D., Koska C. Reactive oxygen species and reactive nitrogen 
species: relevance to cyto(neuro)toxic events and neurologic disorders. 
An overview. Neurotox Research, 2000, 1: 197-233. 
Metzger W.J., Page C.P. Biology of platelets, in Allergy: Principles and 
Practice, 1998, pp 99- 117, Mosby, St Louis. 
Middleton E., Kandaswami C. Effects of flavonoids on immune and 
inflammatory cell functions. Biochem Pharmacol, 1992, 43: 1167-1179. 
Miksicek R.J. Commonly occurring plant flavonoids have estrogenic 
activity. Molecular Pharmacology, 1993, 44: 37- 43. 
Miksicek R.J. Estrogenic flavonoids: structural requirements for 
biological activity. Proc Soc Exp Biol Med, 1995, 208: 44- 50. 
209 
Miranda C.L., Aponso G.L.M., Stevens J.F., Deinzer M.L., Buhler D.R. 
Prenylated chalcones and flavanones as inducers of quinone reductase in 
mouse Hepa IclcV cells. Cancer Letters, 2000, 149: 21-29. 
Mishra H., Fridovich I. The generation of superoxide radical during the 
autoxidation of hemoglobin. J Biol Chem, 1972, 247: 6960-6962. 
Mitsutoshi Y., Yasushi I., Atsushi I., Hiroshi S., Hisashi K., Yuji M. 
Effects of drugs acting as histamine releasers or histamine receptor 
blockers on an experimental anxiety model in mice. Pharmacol Biochem 
Behavior, 2000, 67: 145-150. 
Miyajima I., Maehara T., Kage T., Fujieda K. Identification of the main 
agent causing yellow color of yellow- flowered cyclamen mutant. 
Journal of the Japanese Society for Horticultural Science, 1991, 60: 409-
414. 
Moertal C.G., Fleming T.R., MacDonald J.S., Haller D.G., Laurie J.A., 
Goodman J.A., Ungerleider J.S., Emerson W.A., Tormey D.C., Glick 
J.H., Veeder M.H., Maillard J.A.N. Levamisole and fluorouracil for 
adjuvant therapy of resected colon carcinoma. New England Journal of 
Medicine, 1980, 322: 352-358. 
Mohamed A.K., Bierhaus A., Schiekofer S., Tritschler H., Ziegler H., 
Nawroth P.P. The role of oxidative stress and NF (B) activation in late 
diabetic complications. Biofactors, 1999, 10: 175- 179. 
MoUer D.E. Potential Role of TNF-a in the Pathogenesis of Insulin 
Resistance and Type 2 Diabetes Trends in Endocrinology and 
Metabolism. 2000, 11: 6212-6217. 
Monge P., Solheim E., Scheline R.R. Dihydrochalcone metabolism in 
the rat: phloretin. Xenobiotica, 1984, 14: 917- 924. 
Monostory K., Tamasi V., Vereczkey L., Perjesi P. A study on CYPIA 
inhibitory action of E-2-(4'-methoxybenzylidene)-1-benzosuberone and 
some related chalcones and cyclic chalcone analogues. Toxicology, 
2003, 184:203-210. 
210 
Moran P.M., Higgins L.S., Cordel B., Moser P.C. Age related learning 
deficits in transgenic mice expressing tiie 721- amino acid isoform of 
human beta - amyloid precursor protein. Proceedings of the National 
Academy of Sciences, USA, 1995, 92: 5341-5345. 
Muir S.R., Collins G.J., Robinson S., Hughes S., Bovy A., Ric de Vos 
C.H., Van Tunen A.J., Verhoeyen M.E. Overexpression of Petunia 
chalcone isomerase in tomato results in fruit containing increased levels 
of flavonols. Nat Biotechnol, 2001, 19: 470-474. 
Mukherjee S., Kumar V., Prasad A.K., Raj H.G., Bracke M.E., Olsen 
C.E., Jain S.C., Parmar V.S. Synthetic and biological activity: evaluation 
studies on novel 1,3-diarylpropenones. Bioorg Med Chem, 2001, 9, 337-
345. 
Murray T.K., Cross A.J., Green A.R. Reversal by tetrahydroamino-
acridine of scopolamine-induced memory and performance deficits in 
rats. Psychopharmacology, 1991, 105: 134- 136. 
Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In vivo, 
1999, 13:295-310. 
Nabeshima T. Behavioral aspects of cholinergic transmission: role of 
basal forebrain cholinergic system in learning and memory. Progress in 
Brain Research, 1993, 98: 405- 411. 
Nakadate T., Aizu E., Yamamoto S., Fujiki H., Sugimura T., Kato R. 
Inhibition of teleocidin- caused epidermal ornithine decarboxylase 
induction by phospholipase A2 -cyclooxygenase- and lipoxygenase-
inhibitors. Japanese Journal of Pharmacology, 1985, 37: 253- 258. 
Nam N.H., Kim Y., You Y.J., Hong D.H., Kim H.M., Ahn B.Z. 
Cytotoxic 2',5'-dihydroxychaIcones with unexpected antiangiogenic 
activity. European Journal of Medicinal Chemistry, 2003, 38: 179-187. 
Nelson S.R., Schulz D.W., Passonneau J.V., Lowry O.H. Control of 
glycogen levels in brain. JNeurochem, 1968, 15: 1271- 1279. 
21 
Nerya O., Vaya J., Musa R., Izrael S., Ben- Aric R., Tamir S. Glabrene 
and isoliquiritigenin as tyrosinase inhibitors from licorice roots. Jounal 
of Agriculture and Food Chemistry, 2003, 51: 1201- 1207. 
Ni L., Meng C, Sikorski J. Review: Recent advances in therapeutic 
chalcones. Expert Opin Ther Patents, 2004, 14: 1669-1691. 
Nielson S.F., Boesen T., Larse M., Schonning K., Kromann H. 
Antibacterial chalcones- bioisosteric replacement of the 4'-hydroxy 
group. Bioorg Med Chem, 2004, 12: 3047-3054. 
Nishikawa T., Scatton B. Evidence for a GABAergic inhibitory 
influence on serotonergic neurons originating from the dorsal raphe. 
Brain Res, 1983, 279: 325-329. 
Nishikawa T., Scatton B. Inhibitory influence of GAB A on central 
serotonergic transmission. Involvement of the habenuloraphe pathways 
in the GABAergic inhibition of ascending cerebral serotonergic neurons. 
Brain Research, 1985a ,331: 81-90. 
Nordlie R.C., Foster J.D., Lange A.J. Regulation of glucose production 
by the liver. Annu Rev Nutr, 1999, 19: 379- 406. 
Nozu T., Suwa T., Fukushima K., Ohzeki M. Metabolism of 2'-
carboxymethoxy- 4,4'-bis-(3-methyl-2-butenyloxy)- chalcone (SU- 88) 
in rats. Oyo Yakuri, 18, 835 Chem Abstr, 1980, 92: 208714t. 
Oishi K., Yokoi M., Maeowa S., Shirashi T., Kondo R., Kuriyama T., 
Machida K. Oxidative stress and haematological changes in immobili-
zed rats. Acta Physiol Scand, 1999, 165: 65-69. 
Olanow C.W. An introduction to the free radical hypothesis in 
Parkinson's disease. Ann Neurol, 1992, 32: S2-S9. 
Olinski R., Gackowski D., Foksinski M., Rozalski R., Roszkowski K., 
Jaruga P. Oxidative DNA damage: Assessment of the role in carcino-
genesis, atherosclerosis, and acquired immunodeficiency syndrome. 
Free Radic Biol Med, 2002, 33: 192-200. 
212 
Oliver C.N., Ahn B.W., Moerman E.J., Goldstein S., Stadtman E.R. 
Age-related changes in oxidized proteins. J Biol Chem, 1987, 262: 5488-
5491. 
Onyilagha J.C, Malhotra B., Elder M., French C.J., Towers G.H.N. 
Comparative studies of inhibitory activities of chalcones on tomato 
ringspot virus (ToRSV). Canad J Plant Pathol, 1997, 19: 133-137. 
Ozcan M.E., Gulec M., Ozeror E., Polat R., Akyol O. Antioxidant 
enzyme activities and oxidative stress in affective disorders. 
International Clin Psychopharmacol, 2004, 19: 89- 95. 
Ozturk Y., Aydini S., Beis R., Baser K.H.C. Effect of Hypericum 
perforatum L. and Hypericum calycinum L. extracts on the central 
nervous in mice. Phytomedicine, 1996, 3: 139-146. 
Paganelli R., Di lorio A., Patricelli L., Ripanie F., Sparvieri E., Faricelli 
R., larlori C, Porreca E., Di Gioacchino M., Abate G. Proinflammatory 
cytokines in sera of elderly patients with dementia: levels in vascular 
injury are higher than those of mild-moderate Alzheimer's disease 
patients. Exp Gerontol, 2002, 37: 257- 263. 
Paker L., Roy S., Sen C.K. Alpha- lipoic acid: a metabolic antioxidant 
and potential redox modulation of transcription. Adv Pharmacol, 1997, 
38:79-101. 
Pandey M.K., Sandur S.K., Sung B., Sethi G., Kunnumakkara A.B., 
Aggarwal B.B. Butein, a tetrahydroxychalcone inhibits nuclear factor 
(NF)-K B and TF-KB-regulated gene expressionthrough direct inhibition 
of 1KB kinase B on cysteine-179 residue. J Biol Chem, 2007, 282: 
17340-17350. 
Pandeya S.N., Sriram D., DeClerq E. Synthesis, antibacterial, antifungal 
and anti-HIV activities of Schiff and Mannich bases derived from isatin 
derivatives and N-[4-(4'- chlorophenyl) thiazol-2-yl] thiosemicarbazide. 
European Journal of Pharmaceutical Sciences, 1999, 9: 25-31. 
Pappano N.B., Centorbi O.P., Ferretti F.H. Determination of the 
responsible molecular zone for the chalcones bacteriostatic activity. Rev 
Microbiol, 1994,25: 168-174. 
213 
Pappano N.B., Puig de Centorbi O., Debattista N.B., Calleri De Milan 
C, Borkowski E.J., Ferretti F.H. Kinetics of the bacteriostatic activity of 
natural and synthetic chalcones on a strain of Staphylococcus aureus. 
Rev Argentina Microbiol, 1985, 17: 27- 32. 
Pare W.S. The effect of chronic environmental stress on premature aging 
in the rat. Journal of Gerontology, 1996, 20: 78-84. 
Parmar V.S., Sharma N.K., Husain M., Watterson A.C., Kumar J., 
Samuelson L.A., Cholli A.L., Prasad A.K., Kumar A., Malhotra S., 
Kumar N., Jha A., Singh A., Singh I., Himanshu, Vats A., Shakil N.A., 
Trikha S., Mukherjee S., Sharma S.K., Singh S.K., Kumar A., Prasad 
A.K., Hriday N.J., Olsen C.E., Stove C.E.,; Bracke M.E., Mareel M.M. 
Synthesis, characterization and in vitro anti-invasive activity screening 
of polyphenolic and heterocyclic compounds. Bioorganic Medicinal 
Chemistry, 2003, 11: 913-929. 
Patil C.S., Singh V.P., Satyanarayan P.S.V., Jain N.K., Singh A., 
Kulkami S.K. Protective effect of flavanoids against aging and LPS-
induced cognitive impairment in mice. Pharmacology, 2003, 69: 59- 67. 
Pellow S., Chopin P., File S.E., Briley M. Validation of open closed 
arm entries in an elevated plus maze as a measure of anxiety in 
the rat. Journal of Neuroscience Methods, 1985, 14: 149-167. 
Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on 
exploratory activity in an elevated plus - maze: a novel test of anxiety in 
the rat. Pharmacol Biochem Behav, 1986, 24: 525-529. 
Pentreath V., Kai- Kai M. Significance of the potassium signal from 
neurons to glial cells. Nature, 1982, 295: 59-61. 
Perry E.K. The cholinergic hypothesis-ten years on. Br Med Bull, 1986, 
42: 63-69. 
Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., 
Perry R.H. Correlation of cholinergic abnormalities with senile plaques 
and mental test scores in senile dementia. British Medical Journal, 1978, 
2: 1457- 1459. 
214 
Phelps C H. Barbiturate induced glycogen accumulation in brain. An 
electron microscopic study. Brain Res, 1972, 39: 225- 234. 
Pratt J.A. The neuroanatomical basis of anxiety. Pharmacology & 
Therapeutics, 1992, 55: 149 -181. 
Pryor W.A. Why is hydroxyl radical is only the radical that commonly 
add to DNA hypothesis. It has a rare combination of high 
electrophilicity, high thermochemical reactivity and mode of production 
that can occur near DNA. J Free Rad Biol Med, 1998, 4: 233-319. 
Pylman F., Woltesnik G., Vanree. Cheing J. Unavoidable physical but 
not emotional stress increase long term behaviour effects in rats. 
Behav Brain Research, 2002, 134: 393. 
Quintanilla R.A., Munoz F.J., Metcalfe M.J., Hitschfeld M., Olivares G., 
Godoy J.A., Inestrosa N.C. Trolox and 17beta-estradiol protect against 
amyloid beta-peptide neurotoxicity by a mechanism that involves 
modulation of the Wnt signaling pathway. J Biol Chem, 2005, 280: 
11615- 11625. 
Radak Z., Kaneko T., Tahara S., Nakamoto H., Pucsok J., Sasvari M., 
Nyakas C, Goto S. Regular exercise improves cognitive function and 
decreases oxidative damage in rat brain. Neurochem Int, 2001, 38: 17-
23. 
Ramanathan R., Das N.P., Tan C.H. Inhibitory effects of 2- hydroxy 
chalcone and other flavonoids on human cancer cell proliferation. 
International Journal of Oncology, 1993, 3: 115- 119. 
Ramanathan R., Tan C.H., Das N.P. Cytotoxic effects of plant 
polyphenols and fat- soluble vitamin on malignant human cultured cells. 
Cancer Letters, 1992, 62: 217-214. 
Rao Y.K., Fang S.H., Tzeng Y.M. Differential effects of synthesized 2'-
oxygenated chalcone derivatives: modulation of human cell cycle phase 
distribution. Bioorganic & Medicinal Chemistry, 2004, 12: 2679-2686. 
215 
Raskin P., Rosenstock J. Aldose reductase inhibitors and diabetic 
complications. Am J Med, 1987, 83: 298- 306. 
Rastelli R., Antonlini L., Benvenuti S., Costantino L. Structural bases for 
the inhibition of aldose reductase by phenolic compounds. Bioorganic 
Medicinal Chemistry, 2000, 8: 1151- 1158. 
Ravanel P., Tissut M., Douce R. Uncoupling activities of chalcones and 
dihydrochalcones on isolated mitochondria from potato tubers and mung 
bean hypocotyls. Phytochemistry, 1982, 21: 2845-2850. 
Ray A., Henke P.G., Gulati K., Sen P. The amygdaloid complex, 
corticotropin releasing factor and stress induced gastric ulcerogenesis in 
rats. Brain Res, 1993, 624: 286- 290. 
Ray A., Henko P.G. Enkephalin-dopamine interactions in the central 
amygdalar nucleus during gastric stress ulcer formation in rats. Behav 
Brain Res, 1990,36: 179-183. 
Ray A., Masood A., Banerjee B.D., Vijayam V.K. Nitric oxide: a target 
molecule for drug development in stress and anxiety. Clin Exp 
Pharmacol Physiol, 2004, 31: A51. 
Reale M., larlori C, Gambi F., Feliciani C, Salone A., Toma L., De 
Luca G., Salvatore M., Conti P., Gambi D. Treatment with an 
acetylcholinesterase inhibitor in Alzheimer patients modulates the 
expression and production of the pro-inflammatory and anti-
inflammatory cytokines. J Neuroimmunol, 2004, 148: 162- 171. 
Rezk B.M., Haenen G.R.M.M., van der Vijgh W.F.F, Bast A. The 
antioxidant activity of phloretin: the disclosure of a new antioxidant 
pharmacophore in flavonoids. Biochem Biophys Res Commun, 2002, 
295:9-13. 
Riederer P., Kondradi C, Shay V., Kienzl E., Birkmayer G., Danielczyk 
W., Sofic E., Youdim M.B. Localization of MAO-A and MAO-B in 
human brain: a step in understanding the therapeutic action of i- depre-
nyl. Advances in Neurology, 1986, 45: 111- 118. 
216 
Robards K., Prenzier P.D., Tucker G., Swastsitang P., Glower W. 
Phenolic compounds and their role in oxidative processes in fruits. Food 
Chemistry, 1999, 66: 401-436. 
Robins A.H., Lucke W., McFadyen M.L, Wright J.P. Effect of the H i 
receptor antagonist ranitidine on depression and anxiety in duodenal 
ulcer patients. Postgraduate Medical Journal, 1984, 60: 353-355. 
Robinson T.P., Hubbard R.B., Ehlers T.J,, Arbiser J.L., Goldsmith D.J., 
Bowen J.P. Bioorganic Medicinal Chemistry Letters, 2005, 13: 4007-
4013. 
Rocha de la N., Maria A. O. M., Gianello J. C, Pelzer L. Cytoprotective 
effects of chalcones from Zuccagnia punctata and melatonin on the 
gastroduodenal tract in rats. Pharmacological Research, 2003, 48: 97-99. 
Rodgers R.J. Animal models of anxiety: where next? Behavioural 
Pharmacol, 1997, 8: 477-496. 
Rodriguez M.J., Ortiz M., Vazquez A., Liuch M., Ponz F. Competitive 
kinetics in the inhibition of sugar intestinal transport by phloridzin in 
vitro. Revista Espanola de Fisiologia, 1982, 38: 397- 402. 
Rokyta R., Maresova S., Veliskova J., Kubik V., Bernaskova K. 
Changes in lipid metabolism in epileptic mirror foci. In: klee M.R., Lux 
H.D., Speckmann E.J. Editors. Physiology, Pharmacology and Dev of 
Epileptogenic Phenomena. Heidelberg: Springer-Verlag, Berlin, 1991, p. 
187-189. 
Rothman D.L., Magnusson I., Cline G., Gerard D., Kahn C.R., Shulman 
R.G., Shulman G.L Decreased muscle glucose transport/phosphor-
rylation is an early defect in the pathogenesis of non- insulin dependent 
diabetes mellitus. Proc Natl Acad Sci USA, 1995, 92: 983- 987. 
Ruan H., Lodish H.F. Insulin resistance in adipose tissue: direct and 
indirect effects of tumor necrosis factor alpha. Cytokine Growth Factor 
Rev, 2003, 14: 447- 455. 
217 
Sabzevari O., Galati G., Moridani M.Y., Siraki A., O' Brien P.J. 
Molecular cytotoxic mechanisms of anticancer hydroxychalcones. 
Chemico- Biological Interactions, 2003, 148: 57-67. 
Sagrera GJ, Seoane GA. Microwave accelelrated solvent- free synthesis 
of flavanones. Journal of the Brazilian Chemical Society, 2005: 16, 851. 
Sahin E., Gumuslu S. Immobilization stress in rat tissues: Alternations in 
protein oxidation, lipid peroxidation and antioxidant defense system. 
Comparative Biochem Physiol. Part C: Toxicol & Pharmacol, 2007, 144: 
342-347. 
Sandhir R., Julka D., Dip G.K. Lipoperoxidative damage in lead 
exposure in rat brain and its complications on membrane bound 
enzymes. Pharmacol Toxicol, 1994, 74: 66-71. 
Sarter G., Bodewitz G., Stephens D.N. Attenuation of scopolamine-
induced impairment of spontaneous alternation behavior by antagonist 
but not inverse agonist and beta-carboline. Psychopharmacol, 1988, 94: 
491-495. 
Sato M., Tsuchiya H., Miyazaki T., Fujiwara S., Yanaguchi R., 
Kureshiro H., linuma M. Antibacterial activity of hydroxychalcone 
against methicillin-resistant Staphylococcus aureus. Int J Antimicrob 
Agents. 1995,6:227-231. 
Sato T., Nakayama T., Kikuchi S., Fukui Y., Yonekura-Sakakibara K., 
Ueda T., Nishino T., Tanaka Y., Kusumi T. Enzymatic formation of 
aurones in extracts of yellow snapdragon flowers. Plant Science, 2001, 
160: 229- 236. 
Satomi Y. Inhibitory effects of 3'- methyl-3- hydroxychalcone on 
proliferation of human malignant tumor cells and on skin carcinogenesis. 
Int J Cancer, 1993, 55: 506- 514. 
Satyanarayan M., Tiwar P., Tripathi B.K., Srivastava A.K., Pratap R. 
Synthesis and antihyperglycemic activity of chalcone based aryloxy 
propanolamines Bioorganic & Medicinal Chem, 2004, 12: 883- 889. 
218 
Savchenko V., Mckanna J.A., Nikonenko I.R., Skibo G.G. Microflia and 
astrocytes in the adult rat brain: comparative immunohistochemical 
analysis demonstrates the efficacy of lipocortin 1 immunoreactivity. 
Neurosci, 2000, 96: 195- 203. 
Saydam G., Ayden H.H., Sahin F., Kucukoglu O., Erciyas E., Terzioglu 
E., Buyukkececi F., Omay S.B. Cytotoxic and inhibitory effects of 4,4'-
dihydroxychalcone (RVC-588) on proliferation of human leukemic HL-
60 cells. Leukemia Research, 2003, 27: 57- 64. 
Searchy D.G., Maclnnis A.J. Determination of RNA by Dische-
Orcinol technique. In: Maclnnis A.J., Voge M. (Ed.), Experimentals and 
techniques in parasitology: WH Freeman and Co., Sanfrancisco, 1970, 
pp 189-190. 
Sebti S., Solhy A., Tahir R., Boulaajaj S., Mayoral J.A., Fraile J.M., 
Kossir A., Oumimoun H. Calcined sodium nitrate/natural phosphate: an 
extremely active catalyst for the easy synthesis of chalcones in 
heterogeneous media. Tetrahedron Lett, 2001, 42: 7953- 7955. 
Seckin S., Alptekin N., Dogru-abbasoglu S., Kocak-Toker N., Toker G., 
Uysal M. The effect of chronic stress on hepatic and gastric lipid 
peroxidation in long- term depletion of glutathione in rats. Pharmacol 
Res, 1997, 36: 55-57. 
Seredenin S.B., Badyshtov B.A., Egorov D.L Contents of lipid 
peroxidation products in inbred mice with different types of emotional 
stress reaction. Bull Exp Biol Med, 1992, 108: 46-48. 
Severi F., Costantino L., Benvenuti S., Vampa G., Mucci A. Synthesis 
and description of chalcone -like compounds, inhibitors of aldose 
reductase. Med Chem Res, 1996, 6: 128-136. 
Severi F., Benevenuti S., Costantino L., Vampa G., Melegari M., 
Antalini L. Synthesis and activity of a new series of chalcones as aldose 
reductase inhibitors. European J Med Chem, 1998, 33: 859- 866. 
Sheshadri T.R., Thakur R.S. The colouring matter of the flowers of 
Carthamus tinctorius. Current Science (India), 1960, 29: 57. 
219 
Shukla G.S., Hussain T., Chandra S.V. Possible role of superoxide 
dismutase activity and lipid peroxide levels in cadmium neurotoxicity: in 
vivo and in vitro studies in growing rats. Life Sci, 1987, 14: 2215-2225. 
Siers H. Oxidative stress. New York: Academic Press, 1985, p, 1-8. 
Sies H. Oxidative Stress: Oxidants and Antioxidants. London, San 
Diego, Academic Press, 1991. 
Sies H., Koch O.R., Martino E., Boveris A. Increased biliary glutathione 
disulfide release in chronically ethanol treated rats. FEBS Lett, 1979, 
103:287-290. 
Sinclair A.J., Bayer A.J., Johnston J., Warner C, Maxwell S.R. Altered 
plasma antioxidant status in subjects with Alzheimer's disease and 
vascular dementia. Int J Geriatr Psychiatry, 1998, 13: 840- 845. 
Singh L.K., Rang X., Alexacos N., Netaumen R. Theoharides, Acute 
immobilization stress triggers skin mast cell degranulation via 
corticotropin releasing hormone neurotensin and substance link to 
neurogenic skin disorders. Brain Behaviour and Immunity, 1993, 3: 225-
239. 
Skjevrak I., Solheim E., Scheline R.R. Dihydrochalcone metabolism in 
the rat: trihydroxylated derivatives related to phloretin Xenobiotica, 
1986, 16:35-45. 
Sloane J.A., Hollander W., Rosene D.L., Moss M.B., Kemper T.A., 
Abraham C.R. Astrocytic hypertrophy and altered GFAP degradation 
with age in subcortical white matter of the rhesus monkey. Brain Res, 
2000,862: 1-10. 
Smith CD., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman 
E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and 
enzyme dysfunction in normal aging and in Alzheimer's disease. 
Proc Natl Acad Sci USA, 1991, 88: 10540-10543. 
Sogawa S., Nihro Y., Ueda H., Izumi A., Miki T., Matsumoto H., Satoh 
T. 3,4- Dihydroxychalcones as potent 5- lipoxygenase and cyclo-
220 
oxygenase inhibitors. Journal of Medcinal Chemistry, 1993, 36, 3904-
3909. 
Sogawa S., Nihro Y., Ueda H., Miki T., Matsumoto H., Satoh T. 
Protective effects of hydroxychaicones on free radical-induced cell 
damage. Biol Pharmacol Bull, 1994, 17: 251-256. 
Sosnovskii A.S., Tsvetkova M.A., Uzunnova P.I., Glbova T.D., 
Peneva V.I., Sokolova T.I., Ribarov S.R., Nikolov N.A. Lipid 
peroxidation in emotional stress in rats: correlation with parameters of 
open field behavior. Bull. Exp ^Biol Med, 1992, 113:19-21. 
Sosnovsky A.S., Kozlov A.V. Increased concentration of thiobarbituric 
acid-reactive material in the hypothalamus of rats subjected to a one 
hour emotional stress. Bull Exp Biol Med, 1992, 113: 486-488. 
Sothmann M., Kastello G.K. Stimulated weightlessness to induce 
chronic hypoactivity of brain norepinephrine for exercise and stress 
studies. Medicine and science in sports and exercise, 1997, 29: 39- 44. 
Stadtman E.R. Protein oxidation and aging. Science, 1992, 257: 1220-
1224. 
Stafford H. Flavonoid evaluation: An enzymatic approach. Plant Physiol, 
1991,96:680-685. 
Starke-Reed P.E., Oliver C.N. Protein oxidation and proteolysis during 
aging and oxidative stress. Arch Biochem Biophys, 1989, 275: 559-567. 
Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., Wu J.F., 
Floyd R.A. Reversal of age-related increase in brain protein oxidation, 
decrease in enzyme activity, and loss in temporal and spatial memory by 
chronic administration of the spin-trapping compound N-tert-butyl-a-
phenylnitrone. ProcNatl Acad Sci USA, 1991, 88: 3633-3636. 
Stein B.B., Sapolsky R.M. Stress, glucocorticoids, and aging. Aging 
(Milano), 1992,4: 197-210. 
Stoll R., Renner C, Hansen S., Palme S., Klein C, Belling A., Zeslaws-
ki W., Kamionka M., Rehm T., Miihlhahn P., Schumacher R., Hesse F., 
221 
Kaluza B., Voelter W., Engh R.A., Holak T.A. Chalcone derivatives ant-
agonize interactions between tlie human oncoprotein MDM2 and p53. 
Biochemistry, 2001, 40: 336-344. 
StroHn B.N., Cini M., Fusi R., Marrari P., Dostert P. The effects of 
aging on MAO activity and amino acid levels in rat brain. J Neural 
Transm (Suppl), 1990, 29: 259- 268. 
StumvoU M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: 
principles of pathogenesis and therapy. Lancet, 2005, 365: 1333- 1346. 
Swanson R.A., Sagar S.M., Sharp F,R. Regional brain glycogen stores 
and metabolism during complete global ischaemia. Neurol Res, 1989, 
11:24-28. 
Swanson R.A. Physiologic coupling of glial glycogen metabolism to 
neuronal activity in brain. Can J Physiol Pharmacol (Suppl), 1992, 70: 
S138-S144. 
Szajda M., Kedzia B. New alkoxycarbonylalkyloxychalcones and their 
alpha, beta-dibromo derivatives of potential antimicrobial activity. 
Pharmazie, 1989,44: 190-191. 
Takahashi T., Baba M., Nishino H., Okuyama T. Cyclooxygenase-2 
plays a suppressive role for induction of apoptosis in isoliquiritigenin-
treated mouse colon cancer cells. Cancer Lett, 2000, 231: 319- 325. 
Takamura T., Miyajima I. Colchicine induced tetraploids in yellow-
flowered cyclamens and their characteristics. Scientia Horticulturae, 
1996,65:305-312. 
Takashi S., Toyoshima T., Utsonu K., Suga S. Kanko Shikiso, 1984, 89, 
1 (ChemAbstr, 102, 55766J). 
Tan R.X., Meng J.C, Hostettman K. Phytochemical investigation of 
some traditional Chinese medicines and endophyte cultures. 
Pharmaceutical Biology (Supp), 2000, 38: 25-32. 
222 
Tanaka S., Kuwai Y., Tabata M. Isolation of monoamine oxidase 
inhibitors from Glycyrrtiiza uralensis roots and tlie structure-activity 
relationship. PlantaMed, 1987, 53: 5-8. 
Tanny J.C, Dowd G.J., Huang J., Hilz H., Moazed D. An enzymatic 
activity in the yeast Sir2 protein that is essential for gene silencing. Cell, 
1999,99:735-745. 
Tatarczynska E., Klodzinska A., Stachowicz K., Chojnacka W.E. Effect 
of selective 5- HTl B receptor agonists and antagonists in animal models 
of anxiety and depression. Behavioral Pharmacology, 2004, 15: 523-
534. 
Tauber A.I., Babior B.M. Neutrophil oxygen reduction: The enzymes 
and the products. Adv Free Radic Biol Med, 1985, 1: 265- 307. 
Tawata M., Aida K., Noguchi T., Ozaki Y., Kummes S., Sasaki H., Chin 
M., Onaya T. Anti-platelet action of isoliquiritgenin, an aldose reductase 
inhibitor in licorice. Eur J Pharmacol, 1992, 212: 87-92. 
Tomas-Barberan F.A., Clifford M.N. Review. Flavanones, chalcones, 
and dihydrochalcones - nature, occurance and dietary burden. Journal of 
the Science of Food and Agriculture, 2000, 80: 1073-1080. 
Tomlinson D.K., Steven E.J., Diemel L.T. Aldose reductase inhibitors 
and their potential for the treatment of diabetic complications. Trends in 
Pharmacological Sciences, 1994, 15: 293-297. 
Torres-Santos E.C., Moreira D.L., Meirelles M.N., Bergmann B.K. 
Selective effect of 2',6'- dihydroxy-4'- methoxychalcone isolated from 
P. aduncum on leishmania amazonensis. Antimicrobial Agents and 
Chemotherapy, 1999,43: 1234- 1241. 
Uchida K., Toyokuni S., Nishikawa K., Kawakishi S., Oda H., Hiai H., 
Stadtman E.R. Michael addition-type 4-hydroxy-2-nonenaI adducts in 
modified low density lipoproteins: markers for atherosclerosis. 
Biochemistry, 1994,333: 12487-12494. 
Utley H.G., Bernheim F., Hoschtein P. Effect of sulphydryl reagents on 
peroxidation in microsomes: Arch Biochem Biophys, 1967, 118: 29- 32. 
223 
van Acker F.A., Schouten O., Haenen G.R., van der Vijgh WJ., Bast A. 
Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett, 
2000,473: 145-148. 
van den Bosch H., Schutgens R.B., Wanders R.J., Tager J.M. 
Biochemistry of peroxisomes. Annu Rev Biochem, 1992, 61: 157-197. 
Vane J.R. Recent advances in Pharmacology. 3"^  ed , J & A. Churchill 
Ltd, London, 1962, pp 95- 121. 
Varma S.D., Kinoshita J.H. Inhibition of lens aldose reductase by 
flavonoids- their possible role in the prevention of diabetic cataracts. 
Biochemical Pharmacology, 1976, 25: 2505- 2513. 
Vaya J., Belinky P.A., Aviram M. Antioxidant constituents from licorice 
roots: isolation, structure elucidation and antioxidative capacity toward 
LDL oxidation. Free Radic Biol Med, 1997, 23: 302-313. 
Vendemiale G., Grattagliano L, Altomare E. An update on the role of 
free radicals and antioxidant defense in human disease. Int J Clin Lab 
Res, 1999,29:49-55. 
Vogel A.I. A text book of practical organic chemistry, Longman, 
London, 4"" edition, 1978. 
Vogel AI. Textbook of practical organic chemistry, 5"^  Ed., Longman 
Inc., New York, 1989, 1053. 
Vogel J.R., Beer B., Clody D.E. A simple and reliable conflict procedure 
for testing anti anxiety agents. Psychopharmacologia, 1971, 21: 1-7. 
Watanabe H., Passonneau J.V. Factors affecting turnover of cerebral 
glycogen and limit dextrin in vivo. J Neurochem, 1973, 20: 1543- 1554. 
Watson B., Hughes A.L. Pharmacological treatment of addiction. 
Psychiatry, 2007, 6: 309-312. 
224 
Wattenberg L.W. Chalcones, myo-inositol and other novel inhibitors of 
pulmonary carcinogenesis. J Cell Biochem (Suppl) 1995, 22: 162- 168. 
Wattenberg L.W., Coccia J.B., Galbraith A.R. Inhibition of carcinogen-
induced pulmonary and mammary carcinogenesis by chalcone 
administered subsequent to carcinogen exposure. Cancer Letters, 1994, 
83: 165- 169. 
Wegener J.W., Nawrath H. Cardiac effects of isoliquiritigenin. European 
Journal of Pharmacology, 1997, 326: 37- 44. 
Wei A.N., Yang J., Ying A.O. Metallothionein indicates 
cardioprotection of isoliquiritigenin against ischemia-reperfusion 
through JAK2 / STAT3 activation. Acta Pharmacologica Sinica, 2006, 
27: 1431-1437. 
Weiss S.M., Wadsworth G., Fletcher A., Dourish C.T. Utility of 
ethological analysis to overcome locomotor confounds in elevated maze 
models of anxiety. Neuroscience and Biobehavioral Reviews, 1998, 23: 
265-71. 
Weksler B.B. Platelets and the inflammatory response. Clinical 
Laboratory and Medicine, 1983, 3: 667- 677. 
Wender R., Brown A.M., Fern R., Swanson R.A., Farrell K., Ransom 
B.R. Astrocytic glycogen influences axon function and survival during 
glucose deprivation in central white matter. J Neurosci, 2000, 20: 6804-
6810. 
White A., Handler P., Smith E.L., Hill R.L., Lehman LR. The lipids 
metabolism. In: Principles of Biochemistry. 6"^  Ed. Tokyo: McGraw 
Hill Hogakusha Ltd, 1978, 38: 1133. 
Wilkinson D.G., Francis P.T., Schwam E., Payne-Perrish J. 
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: 
the relationship between pharmacological effects and clinical efficacy. 
Drugs Aging, 2004, 21: 453-478. 
225 
Winslow J.T., Insel T.R. Infant rat separation is a sensitve test for novel 
anxiolytics. Prog Neuropsychopharmacology Biol Psychiatry, 1991, 15: 
745-757. 
Wolfman C, Viola H., Paladini A.C., Dajas F., Medina J.H. Possible 
anxiolytic effects of chrysin, a central benzodiazepine receptor ligand 
isolated from passiflora coerulea. Pharmacol Biochem Behav, 1994, 47: 
1-4. 
Woods J.H., Winger G. Current benzodiazepine tissue. 
Psychopharmacology, 1995, 118: 107-115. 
Yamamoto K., Kakegawa H., Ueda H., Matsumoto H., Sudo T., Miki T. 
Gastric cytoprotective anti- ulcerogenic actions of hydroxychalcones in 
rats. Planta Med, 1992, 58: 389- 393. 
Yamamoto K., Volkl A., Hashimoto T., Fahimi H.D. Catalase in guinea 
pig hepatocytes in localized in cytoplasm, nuclear matrix and 
peroxisomes. Eur J Cell Biol, 1988, 46: 129-135. 
Yamamoto S., Aizu E., Jiang H., Nakadate T., Kiyoto I., Wang J.C, 
Kato R. The potent anti-tumor promoting agent isoliquiritgenin. 
Carcinogenesis, 1991, 12: 317-323. 
Yargicoglu P., Yaras N., Agar A., Gumusulu S., Abidin I., Bilmen S. 
Effects of N-nitro-arginine methyl ester (1-NAME), a potent nitric oxide 
synthase inhibitor, on visual evoked potentials of rats exposed to 
different experimental stress models. Acta Physiol Scand, 2004, 180: 
307-316. 
Yegen B.C., Alican I., Yalcin A.S., Oktay S. Calcium channel blockers 
prevent stress- induced ulcers in rats. Agents Actions, 1992, 35: 130-
134. 
Yit C.C., Das N.P. Cytotoxic effects of butein on human colon 
adenocarcinoma cell proliferation. Cancer Letters, 1994, 82: 65-72. 
Yokoi M., Maekawa S., Sodeyama C, Shiraishi T., Kondo R., Kuriyama 
T., Machida K. Oxidative stress and haematological changes in 
immobilized rats. Acta Physiologica Scandinavica, 1999, 165: 65-69. 
226 
Yorikata A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno 
Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts 
in Parkinson's disease. Proc Nat Acad Sci USA, 1996, 93: 2696-2701. 
Yu B.P. Cellular defense against damage fro reactive oxygen species. 
Physiol Rev, 1994, 74: 139- 162. 
Yu S.M., Cheng Z.J., Kuo S.C. Endothelium-dependent relaxation of rat 
aorta by butein, a novel cyclic AMP-specific phosphodiesterase 
inhibitor. Eur J Pharmacol, 1995b, 280: 69-77. 
Yu S.M., Kuo S.C. Vasorelaxant effect of isoliquiritigenin, a novel 
soluble guanylyl cyclase activator, in rat aorta. Br J Pharmacol, 1995a, 
114: 1587-1594. 
Yu S.Q., HoUoway H.W., Utsuki T., Brossi A., Greig N.H. Syntheis of 
novel phenserinebased- selective inhibitors of butyrylcholinesterase for 
Alzheimer's disease. J Med Chem, 1999, 42: 1855-1861. 
Yue K.K.M., Chung W.S., Leung A.W.N., Cheng C.H.K. Redox 
changes precede the occurance of oxidative stress in eyes and aorta, but 
not in kdney's of diabetic rats. Life Sciences, 2003, 73: 2557- 2570. 
Zaidi S.M.R.K., AI-Quirim T.M., Hoda N., Banu N. Modulation of 
restraint stress induced oxidative changes in rats by antioxidant 
vitamins. Journal of Nutritional Biochemistry, 2003, 14: 633- 636. 
Zaidi S.M., Al-Qirim T.M., Banu N. Effects of antioxidant vitamins on 
glutathione depletion and lipid peroxidation induced by restraint stress in 
the rat liver. Drugs RD, 2005, 6: 157-165. 
Zarr K . Structure and function of peroxisomes in the mammalian 
kidney. Eur J Cell Biol, 1992, 59: 233-254. 
Zarrindast M.R., Valizadegan F., Rostami P., Rezayof A. The effects of 
histaminergic agents in the elevated plus- maze test of anxiety. 
Pharmacol Biochem Behav, 2006, 85: 500-506. 
Zhai L., Blom J., Chen M., Christensen S.B., Kharazmi A. The 
antileishmanial agent licochalcone A interferes with the function of 
227 
parasite mitochondria. Antimicrob Agents Chemother, 1995, 39: 2742-
2748. 
Zhan C, Yang J. Protective effects of isoUquiritigenin in transient 
middle cerebralartery occlusion-induced focal cerebral ischemia in rats. 
Pharmacological Research, 2006, 53: 303-309. 
Zimatkin S.M., Lindros Ko. Distribution of catalase in rat brain: 
aminergic neurons as possible targets for ethanol effects. Alcohol 
Alcohol, 1996,31: 167-174. 
Zuanazzi J.A.S. Flavonoids In: Simoes C.M.O. et al (orgs). 
Farmacognosia: da planta ao medicamento. 3 ed. Florianopolis: Editoria 
da UFSC, Porto Alegre: Editoria da UFRGS, 2001, 499. 
Zwart de L.L., Meerman N.P.E. Biomarkers of free radical dam- age 
applications in experimental animals and in humans. Free Radical 
Biology & Medicine, 1999, 26: 202-226. 
228 
PUBLICATION 
Publication; 
1. Evaluation of chalcones, a flavonoid sub class for, their anxiolytic 
effects using elevated plus maze and open field behavior tests. 
Huma Jamal, Wajid Hussain Ansari, Shamim Jahan Rizvi 
Fundamental & Clinical Pharmacolgy. (Accepted). 
2. Modulation of restraint-stress induced neurobehavioral and 
oxidative changes in rats by chalcones, a flavonoid sub class 
Huma Jamal, Wajid Hussain Ansari, Shamim Jahan Rizvi 
Fundamental & Clinical Pharmacolgy. (Communicated). 
